Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABHD18	"C4orf29, FLJ21106"	ENSG00000164074	"Abhydrolase domain containing 18"	Q0P651	4	127965306-128039927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050168, HPA051676"	Approved		Approved	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"		"HPA050168: AB_2681040, HPA051676: AB_2681571"	"unprognostic (1.91e-1)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.74e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.32e-2)"	"prognostic favorable (9.13e-4)"	7.6	8.2	7.4	13.2	10.5	9.9	8.4	14.1	7.9	7.1	13.6	8.6	8.3	13.7	9.2	9.8	7.2	7.8	9.6	25.1	7.0	7.5	9.1	15.7	9.2	12.0	7.2	5.2	10.8	24.5	8.0	16.3	7.0	8.4	6.8	10.2	7.5	8.9	11.1	18.7	10.6	19.0	9.8	9.7	10.0	8.2	4.0	8.1	18.2	9.2	10.9	10.5	8.4	7.5	10.2	8.8	14.2	7.1	5.2	8.8	3.5	3.5	2.9	3.7	4.5	2.9	4.1	5.5	3.6	2.9	3.2	4.2	6.8	6.3	9.7	5.9	1.4	2.9	3.5	7.7	4.2	3.5	8.0	2.5	7.1	4.7	5.4	4.1	12.0	9.0	3.4	2.9	3.4	2.2	3.8	5.6	7.4	11.7	7.1	2.9	6.4	15.7	5.7	3.8	7.6	2.9	8.8	1.3	6.2	4.7	3.7	8.5	3.1	3.4	6.1	3.7	5.5	5.2	5.0	4.8	2.0	2.7	5.2	3.4	12.7	12.6	11.5	3.5	13.0	3.3	11.1	7.1	9.5	6.3	5.9	4.6	6.8	8.0	7.3	5.7	10.2	8.7	8.8	14.2	5.2	4.2	8.8	8.2	3.5	7.4	10.5	14.1	7.9	7.0	7.5	7.2	5.2	8.4	8.1	6.0	12.5	5.3	8.0	0.0	13.0	0.0	5.1	6.7	10.3	7.0	19.6	4.5	0.0	4.0	2.8	3.0	8.5	0.0	6.4	3.9	2.1	10.7	1.1	20.2	6.7	17.5	5.8	9.2	17.0	0.9	5.8	10.9	0.0	3.6	11.7	6.5	6.5	3.5	5.3	6.2	17.4	12.9	0.0	5.5	3.6	0.0	7.7	5.0	10.1	7.8
ACRBP	"CT23, OY-TES-1, SP32"	ENSG00000111644	"Acrosin binding protein"	Q8NEB7	12	6638075-6647460	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 170.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 884.1;Late spermatids: 605.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.7;intermediate monocyte: 9.8;myeloid DC: 11.0;non-classical monocyte: 17.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 11.0;monocytes: 17.6"	"Cell line enhanced"	"Detected in some"		"HEL: 5.5;HMC-1: 7.3;U-266/70: 16.3;U-266/84: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039081, HPA039082"	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA039081: AB_10670920, HPA039082: AB_10671036"	"unprognostic (7.76e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-4)"	0.8	0.4	0.3	0.9	0.8	2.5	0.5	1.3	0.6	0.4	1.6	0.6	0.5	2.2	0.4	4.2	0.5	0.6	1.7	1.0	0.6	0.3	0.9	0.7	0.8	3.6	0.4	0.3	0.4	1.5	0.0	0.5	0.4	0.8	0.7	0.4	0.8	0.5	0.1	0.3	0.4	3.3	0.6	0.6	2.3	0.6	170.4	0.3	0.5	3.9	0.3	0.8	0.7	0.5	1.2	11.0	1.6	17.6	0.3	0.1	6.5	0.2	0.1	0.9	2.7	1.0	1.3	1.4	0.0	0.0	0.1	0.1	0.0	1.9	0.3	0.9	0.2	0.1	0.0	0.5	0.0	0.2	0.6	0.0	5.5	0.6	0.0	2.1	0.1	7.3	0.1	3.7	1.0	0.1	0.7	0.6	1.9	3.6	0.0	0.1	0.4	0.2	1.9	1.7	4.5	0.0	0.3	0.1	0.3	0.6	0.1	1.1	0.2	0.0	0.7	1.2	1.4	0.0	2.0	0.8	0.1	0.8	0.6	0.0	16.3	10.7	0.5	0.6	2.0	0.0	0.9	7.7	0.7	0.1	9.8	0.0	0.8	0.0	0.0	11.0	1.2	0.1	0.1	1.6	0.3	17.6	2.8	0.0	6.5	0.3	0.8	1.3	0.6	0.6	0.3	0.4	0.3	0.8	0.3	0.0	2.2	0.0	0.2	0.1	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	884.1	0.5	1.2	0.0	0.4	0.2	0.4	0.0	5.8	0.0	9.0	0.0	0.0	2.5	11.7	605.9	7.5	3.9	0.0	0.0	0.9	1.0	0.2	0.9	4.2	0.8	1.5	6.5	0.1	127.7	7.2	0.0	0.1	0.0	0.9	0.1
ACRV1	"D11S4365, SP-10, SPACA2"	ENSG00000134940	"Acrosomal vesicle protein 1"	P26436	11	125671522-125681123	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"testis: 57.2"	"Group enriched"	"Detected in some"	77	"Early spermatids: 687.8;Late spermatids: 204.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 6.1;HEL: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038718, HPA038719"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA038718: AB_2676171, HPA038719: AB_10670787"	"unprognostic (3.58e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-3)"	"unprognostic (8.39e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.80e-8)"	"unprognostic (5.26e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.75e-1)"	0.1	0.0	0.3	0.1	0.8	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	1.8	0.1	0.0	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	57.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.3	1.9	6.1	4.3	0.0	0.0	1.7	1.5	0.0	0.2	0.0	2.3	2.2	4.3	0.8	0.0	0.8	0.6	0.0	0.0	0.6	3.0	0.6	7.0	1.1	1.6	0.2	3.8	1.8	0.0	0.0	0.0	0.3	0.3	0.1	1.3	1.9	3.4	0.8	1.3	4.4	3.9	2.1	0.7	1.5	3.1	1.7	0.5	0.0	0.7	0.9	1.0	0.8	0.2	0.2	1.4	1.2	1.0	0.9	2.2	1.6	0.3	0.5	1.7	1.9	1.8	0.4	1.9	3.6	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.8	0.1	0.5	0.3	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	687.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	204.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	4.2	2.6	0.0	0.0	0.0	0.0	0.0
ADAM7	"EAPI, GP-83"	ENSG00000069206	"ADAM metallopeptidase domain 7"	Q9H2U9	8	24440930-24526970	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"epididymis: 309.9"	"Cell type enriched"	"Detected in some"	15	"Early spermatids: 89.5"	"Group enriched"	"Detected in some"	16	"prostate cancer: 1.0;renal cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"BEWO: 4.4;NB-4: 11.0;RPMI-8226: 2.8;SH-SY5Y: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA008879	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008879: AB_10601789"												"unprognostic (1.03e-3)"	"unprognostic (3.96e-4)"					0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	21.7	0.0	0.1	309.9	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	6.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 160.2;gallbladder: 147.0;seminal vesicle: 159.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 1045.3;Mucus-secreting cells: 2788.2;Paneth cells: 1013.4;Undifferentiated cells: 1404.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"OE19: 672.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		22000	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	0.9	0.9	0.9	23.0	0.9	0.0	5.3	0.9	0.9	52.8	58.8	1.3	160.2	36.5	4.8	51.9	4.0	23.7	147.0	0.9	0.9	0.9	3.3	0.9	19.0	0.0	0.8	0.0	4.0	59.2	0.0	11.3	1.6	0.1	18.8	97.7	0.0	70.0	159.4	0.9	1.1	62.2	3.3	0.8	0.9	107.6	0.9	0.0	0.1	1.1	20.0	97.7	13.2	3.7	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	0.0	0.0	0.0	0.2	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	672.3	5.3	0.0	0.0	0.1	21.3	12.6	0.0	0.0	0.0	3.4	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.8	0.0	0.1	0.0	47.6	221.9	2.2	104.9	2.5	0.0	0.0	351.6	1045.3	577.8	76.8	0.0	4.6	0.0	37.7	2.8	0.1	824.5	0.0	764.4	3.5	4.2	606.7	44.8	0.6	180.1	0.0	501.7	0.0	0.6	0.0	0.3	2.7	3.3	1.8	2788.2	0.0	180.9	1013.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	2.7	0.7	1404.9	754.7
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859405-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 40.5;intestine: 99.1"	"Cell type enhanced"	"Detected in many"	14	"Ciliated cells: 1287.5;Club cells: 422.0;Enterocytes: 526.8;Mucus-secreting cells: 499.0;Paneth cells: 524.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"OE19: 27.2;T-47d: 86.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		31000	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.0	0.6	7.5	0.7	0.0	13.1	0.7	0.6	4.4	45.8	0.6	0.6	29.2	1.2	5.4	0.9	40.5	11.8	0.6	0.6	0.3	1.5	0.6	26.3	0.6	0.6	0.6	5.1	1.9	0.0	12.9	2.8	1.9	1.1	38.9	0.6	9.4	0.6	0.6	0.3	99.1	1.2	0.8	0.6	17.1	1.0	0.6	0.6	1.4	1.9	3.9	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	27.2	0.0	0.0	0.0	0.5	2.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	86.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.6	0.6	0.3	0.6	0.6	1.9	0.6	309.7	310.7	0.0	9.4	2.4	0.0	0.0	35.7	1287.5	422.0	27.9	0.0	1.4	1.7	20.8	0.0	0.0	526.8	0.0	65.4	1.2	0.2	4.4	19.7	0.0	0.5	0.0	108.2	0.0	0.0	0.0	0.3	0.7	0.0	1.0	499.0	0.0	10.6	524.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.5	1.8	0.0	345.5	94.0
ANGEL1	"Ccr4e, KIAA0759"	ENSG00000013523	"Angel homolog 1"	Q9UNK9	14	76786178-76826246	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 45.0;Late spermatids: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000948	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA000948: AB_2227189"	"unprognostic (4.81e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (9.24e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.32e-2)"	7.2	13.0	14.7	8.1	16.4	4.3	9.0	10.0	16.6	7.2	7.1	17.9	3.3	6.6	11.0	18.8	5.1	9.1	8.0	11.6	15.1	10.8	7.0	11.3	10.5	8.6	22.5	11.7	15.2	35.8	13.1	18.9	7.7	14.5	6.7	8.2	11.7	10.7	6.7	8.1	4.7	6.3	9.2	16.5	18.6	11.5	27.5	14.9	6.1	9.3	4.6	7.8	7.2	5.3	9.0	9.3	1.9	8.3	6.6	10.2	6.7	9.5	10.4	11.6	10.4	9.5	8.7	10.8	5.7	8.3	6.0	7.7	9.9	13.6	17.5	8.5	5.0	8.2	12.1	11.0	10.3	10.1	7.3	9.9	10.5	6.5	7.6	6.2	5.6	6.7	9.2	12.9	5.6	11.1	8.6	15.1	18.7	10.4	4.6	6.2	18.6	10.1	8.5	13.3	15.3	13.9	12.3	7.9	10.3	9.1	13.6	16.5	7.3	8.7	12.0	5.4	11.0	23.5	5.9	7.2	7.0	6.2	5.2	4.7	12.0	9.0	10.8	6.0	9.9	8.7	0.7	5.9	1.9	7.9	6.7	9.6	9.0	7.1	7.4	9.3	7.7	10.2	7.5	1.8	6.6	8.3	6.2	5.7	6.7	14.7	16.4	10.0	15.0	15.1	10.8	22.5	11.7	14.5	14.9	6.0	10.9	4.5	1.4	1.0	2.2	6.1	10.2	0.0	2.3	3.5	9.8	1.3	0.0	2.9	45.0	5.8	1.3	0.0	2.8	2.3	1.9	2.3	1.1	8.1	6.4	0.0	4.1	6.2	4.7	52.1	2.0	4.3	1.7	0.0	4.1	4.3	2.5	0.0	4.6	1.0	8.0	6.5	1.4	17.4	3.2	0.4	1.0	2.5	3.7	1.0
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 166.5;tongue: 58.3"	"Group enriched"	"Detected in many"	10	"Cardiomyocytes: 153.6;Cone photoreceptor cells: 82.5;Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 20.1"	"Group enriched"	"Detected in some"	8	"memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	7	"B-cells: 10.6;dendritic cells: 3.5"	"Group enriched"	"Detected in some"	4	"HEL: 38.0;K-562: 39.9;RH-30: 50.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		33000000			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.2	0.3	0.6	0.7	0.6	14.8	0.3	20.1	3.8	0.2	0.2	0.0	0.0	0.4	0.2	2.7	1.8	0.2	0.3	18.0	0.6	1.2	0.3	0.2	0.4	0.9	4.0	0.4	0.2	0.3	4.3	0.3	0.8	8.3	0.9	0.2	0.5	2.9	0.3	166.5	0.2	0.3	0.2	1.0	0.7	1.1	0.3	0.0	0.0	1.0	58.3	3.8	0.3	0.4	10.6	3.5	1.0	0.2	0.1	0.9	0.7	0.0	5.1	0.1	0.0	0.0	0.9	0.0	1.5	10.2	0.5	0.2	0.0	0.0	2.3	0.4	1.0	0.1	0.8	0.2	0.1	0.2	0.9	0.0	38.0	0.2	0.0	0.0	0.1	0.1	1.3	0.2	0.1	0.0	0.2	0.0	0.0	39.9	0.8	0.6	0.1	0.0	0.5	0.5	0.0	0.0	0.3	50.5	0.2	0.2	0.1	0.7	0.4	0.0	0.7	0.0	1.9	0.6	0.9	0.2	0.1	0.2	8.7	0.0	0.0	0.0	1.4	0.9	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.5	10.6	0.3	0.5	0.1	9.1	0.0	0.0	0.5	0.1	0.0	3.5	0.9	0.7	0.6	0.6	20.1	3.8	0.6	1.2	4.0	0.4	8.3	0.0	0.0	0.0	3.2	1.3	0.6	7.4	153.6	0.0	0.0	0.0	0.0	82.5	0.7	1.7	0.1	6.6	2.1	0.0	210.2	0.0	0.7	0.6	2.2	0.0	0.0	14.9	3.2	1.2	0.0	0.3	2.4	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.4	0.2	4.7	0.0	3.6	0.2	0.7	0.0	0.3	0.0	0.0	1.5
ARMC5	FLJ13063	ENSG00000140691	"Armadillo repeat containing 5"	Q96C12	16	31458080-31467166	"Disease related genes, Predicted intracellular proteins"			"Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041524, HPA063706"	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"	"Focal adhesion sites"	"HPA041524: AB_10796676, HPA063706: AB_2685098"	"unprognostic (1.37e-1)"	"unprognostic (1.68e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.96e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.14e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (1.97e-6)"	"unprognostic (4.70e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	8.3	8.1	6.6	8.1	11.6	35.3	8.4	13.1	13.6	5.3	5.7	7.8	5.5	9.7	9.1	6.0	8.4	7.1	4.9	6.6	8.4	7.5	6.7	16.1	8.4	7.3	8.9	5.4	8.6	9.3	9.2	9.4	7.3	9.1	7.2	2.9	6.5	10.4	5.8	14.2	13.2	8.3	4.5	5.9	8.6	8.0	6.0	8.9	6.8	9.9	6.8	5.3	5.1	16.8	4.0	10.0	2.8	3.1	9.8	4.9	3.2	2.9	4.7	2.1	3.0	1.3	1.0	5.3	3.9	1.7	2.3	1.9	4.4	3.1	2.9	8.2	2.2	2.3	4.5	2.4	3.5	0.4	4.1	6.0	1.3	7.1	10.1	2.5	8.8	8.9	2.4	4.0	2.3	0.6	2.6	3.5	4.9	6.5	7.1	1.6	7.4	3.3	35.4	3.3	1.3	3.0	5.9	3.0	10.8	1.7	3.5	6.7	5.9	3.6	4.9	2.7	1.3	3.2	10.5	6.5	5.0	3.7	2.0	3.2	6.5	5.6	1.8	3.3	7.4	3.5	2.8	3.1	0.9	4.9	1.6	4.1	4.0	3.8	3.8	4.1	3.5	3.4	3.8	1.8	9.8	1.7	10.0	4.6	3.2	6.6	11.6	13.1	13.6	8.4	7.5	8.9	5.4	9.1	8.9	6.0	14.7	4.5	7.9	5.8	3.9	5.6	10.2	1.4	7.9	0.0	5.9	6.2	3.3	4.7	1.0	8.5	10.3	0.0	4.0	4.6	5.8	5.6	9.2	23.6	5.3	12.7	7.5	6.2	4.8	0.0	4.0	3.0	1.7	2.8	5.2	6.8	3.3	3.6	5.3	3.7	5.2	0.0	6.4	3.9	6.1	5.5	9.6	5.0	3.8	4.8
ATPAF1	"ATP11, Atp11p, FLJ22351"	ENSG00000123472	"ATP synthase mitochondrial F1 complex assembly factor 1"	Q5TC12	1	46632737-46673867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 73.4"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 236.9;Early spermatids: 241.4;Late spermatids: 261.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028382, HPA044950"	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA028382: AB_2672574, HPA044950: AB_2679151"	"unprognostic (1.34e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.18e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (5.33e-7)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.62e-1)"	20.6	32.0	32.9	7.5	34.5	7.9	14.0	15.9	31.0	11.1	15.2	16.1	9.3	12.0	7.8	10.8	10.6	9.8	9.0	73.4	22.3	20.8	33.3	31.9	7.5	8.6	28.2	24.9	10.6	18.8	39.5	14.6	11.0	28.5	11.6	16.9	11.9	15.9	10.8	66.9	5.7	11.7	12.7	18.6	6.9	12.8	13.4	18.2	10.8	13.0	13.1	9.4	9.8	6.1	3.1	2.4	5.8	4.2	9.2	6.6	1.8	20.8	17.0	23.0	20.5	25.2	20.4	19.3	15.6	19.6	23.5	19.0	13.6	9.1	12.4	21.0	19.7	20.9	16.2	36.2	20.3	31.8	27.1	28.6	21.9	21.2	23.6	20.3	21.6	1.3	19.9	24.4	25.1	22.0	18.8	14.7	23.3	10.0	24.6	17.9	18.9	31.8	12.0	36.2	18.1	25.7	13.8	6.2	26.9	26.8	16.6	27.3	20.4	26.5	28.2	40.7	27.8	26.0	30.5	12.7	8.1	20.0	16.2	21.2	30.6	27.7	8.5	13.3	8.4	15.1	0.0	2.5	5.8	3.5	4.2	4.6	3.1	3.7	4.0	2.4	1.7	5.2	2.4	2.1	9.2	1.7	1.8	6.6	1.8	32.9	34.5	15.9	31.0	22.3	20.8	28.2	24.9	28.5	18.2	3.0	15.2	20.4	17.4	8.4	34.1	236.9	22.9	8.1	12.5	29.6	25.5	54.8	145.9	19.3	241.4	11.3	22.6	0.0	17.5	23.1	16.9	15.2	16.1	37.5	32.6	44.5	18.5	8.0	16.4	261.4	17.5	11.1	23.6	10.8	33.8	29.9	12.2	10.5	25.1	85.7	23.3	25.8	29.3	25.6	40.1	11.8	39.2	12.5	43.6	16.1
BOLA1	CGI-143	ENSG00000178096	"BolA family member 1"	Q9Y3E2	1	149887890-149900798	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 24.1;MCF7: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007005	Approved				"Intracellular and membrane"	NA	NA					"HPA007005: AB_1078294"	"unprognostic (5.73e-2)"	"unprognostic (9.86e-3)"	"unprognostic (8.84e-2)"	"unprognostic (8.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (6.41e-4)"	"unprognostic (3.14e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.93e-3)"	13.9	24.5	14.5	14.3	16.4	8.2	10.9	10.2	15.4	11.9	15.0	12.0	21.2	30.1	15.3	11.5	13.6	10.7	14.2	13.4	13.6	11.3	13.7	17.6	9.3	12.5	14.2	14.9	16.1	24.6	10.9	13.3	9.9	12.5	16.6	5.6	11.2	36.8	18.7	35.5	16.5	23.6	12.0	12.0	15.5	17.8	8.3	14.0	22.6	16.7	13.4	12.3	13.6	9.4	12.7	15.6	9.7	8.0	6.9	16.9	7.6	8.5	11.8	1.2	2.6	0.4	2.2	2.3	3.6	0.9	2.8	2.2	7.6	13.4	1.3	9.3	1.4	1.4	9.0	0.0	2.2	0.1	11.0	3.4	0.4	2.7	1.0	3.8	0.0	8.9	2.0	2.9	0.9	0.3	0.6	3.4	24.1	4.9	3.4	1.4	27.6	11.2	2.7	0.8	7.9	3.0	8.8	0.7	2.4	1.2	1.1	7.5	8.2	5.2	8.2	8.4	0.7	15.2	2.5	1.4	3.8	6.1	8.1	0.1	14.1	11.5	0.1	4.9	2.4	3.7	6.1	8.0	9.7	12.8	6.7	13.4	12.7	11.8	10.2	8.2	11.4	16.9	16.1	4.0	6.9	4.1	15.6	15.0	7.6	14.5	16.4	10.2	15.4	13.6	11.3	14.2	14.9	12.5	14.0	3.0	7.4	13.7	13.8	3.9	7.0	15.3	22.9	14.7	5.7	22.7	3.9	16.7	58.0	20.0	5.5	11.9	13.5	23.3	17.4	21.1	10.8	17.5	4.7	30.8	14.6	9.5	12.1	20.3	11.0	1.8	14.7	8.4	5.0	10.0	18.2	16.6	15.4	15.3	19.4	34.9	8.9	38.8	11.4	18.5	16.2	5.8	11.7	13.8	19.6	7.9
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007600-33023709	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 218.0;salivary gland: 191.2"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 2.8;Glandular cells: 6.1;Hepatocytes: 1.5;Late spermatids: 7.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	552	"Hep G2: 69.5"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		68000	Vesicles		"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favorable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	191.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.6	218.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3
BPIFB3	"C20orf185, dJ726C3.4, LPLUNC3, RYA3"	ENSG00000186190	"BPI fold containing family B member 3"	P59826	20	33055424-33073628	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"blood: 1.2;pituitary gland: 2.8;salivary gland: 3.1;testis: 3.0"	"Cell type enhanced"	"Detected in single"	30	"Early spermatids: 1.6"	"Cancer enriched"	"Detected in single"	7	"ovarian cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	27	"HEL: 8.3;HMC-1: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045741	Uncertain				"Intracellular and membrane"	NA	NA					"HPA045741: AB_2679439"										"unprognostic (4.33e-2)"					"unprognostic (1.06e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.8	0.0		0.0	0.0		3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0			0.2		0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFB6	"BPIL3, LPLUNC6"	ENSG00000167104	"BPI fold containing family B member 6"	Q8NFQ5	20	33031648-33044047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"salivary gland: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043057	Uncertain				"Intracellular and membrane"	NA	NA					"HPA043057: AB_10796683"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C12orf10	"Gamm1, MYG, MYG1"	ENSG00000139637	"Chromosome 12 open reading frame 10"	Q9HB07	12	53299686-53307177	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 85.6"	"Group enriched"	"Detected in all"	6	"Early spermatids: 413.5;Late spermatids: 787.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038626, HPA038627"	Approved	Supported	Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA038626: AB_10674692, HPA038627: AB_2676123"	"unprognostic (5.33e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.61e-1)"	16.1	18.7	21.5	13.0	18.4	13.7	17.8	18.4	32.2	17.9	15.1	14.0	18.7	14.3	17.7	18.3	15.9	28.4	16.6	20.2	19.7	21.3	18.8	15.7	13.0	23.6	25.0	23.9	33.3	27.6	20.6	15.7	11.7	27.7	14.6	11.9	14.3	19.4	19.7	22.4	15.7	13.1	17.7	14.3	12.1	16.2	85.6	12.9	19.4	24.1	18.3	15.0	17.3	15.0	26.1	31.1	12.2	27.4	19.2	33.3	23.2	13.2	30.5	10.8	17.2	11.7	17.7	1.3	8.8	14.2	20.1	14.6	27.6	14.4	12.7	20.9	12.2	11.2	15.0	15.1	19.1	11.0	10.6	29.6	13.2	25.2	32.0	27.4	13.6	8.9	17.6	14.6	18.5	18.9	20.2	17.9	15.1	0.7	26.4	13.5	62.3	18.3	22.4	18.0	13.6	29.5	17.2	10.3	29.7	17.3	14.8	21.8	21.0	9.9	19.5	21.4	6.6	30.6	13.0	11.6	19.7	18.6	14.1	13.8	23.9	24.8	14.1	25.0	11.6	15.1	7.8	27.4	12.2	18.3	20.6	27.5	26.1	24.6	18.4	31.1	22.0	25.9	23.4	6.9	19.2	15.4	19.4	33.3	23.2	21.5	18.4	18.4	32.2	19.7	21.3	25.0	23.9	27.7	12.9	20.8	13.4	38.4	38.3	34.7	24.1	14.2	33.1	28.1	13.6	29.6	11.8	30.6	66.3	54.6	413.5	33.7	29.6	23.3	80.2	49.2	43.7	27.1	13.9	21.5	61.3	9.5	48.4	28.3	41.7	787.6	47.5	41.2	32.1	34.3	43.5	34.6	50.7	40.7	42.8	99.0	31.7	38.8	57.5	104.3	80.3	34.9	21.6	34.8	48.6	26.8
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 35.4;skeletal muscle: 118.0"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 20.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favorable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	3.2	2.9	4.5	4.2	5.7	4.7	4.4	5.8	9.1	3.5	3.3	9.2	3.6	3.8	3.8	3.1	7.4	2.8	3.5	35.4	4.2	3.8	2.9	4.4	3.4	4.5	6.2	5.0	3.6	3.8	3.7	3.7	4.8	5.6	4.5	2.5	3.6	4.9	4.6	118.0	5.2	3.6	3.7	4.8	3.7	3.0	10.0	5.3	5.0	3.8	6.4	4.7	4.1	5.0	2.1	1.6	20.2	1.6	1.7	2.3	1.3	12.9	19.9	8.4	9.1	5.0	4.5	11.6	13.4	6.2	12.7	15.4	16.5	5.4	15.1	7.5	6.3	6.7	6.5	10.2	12.3	5.3	18.5	12.5	12.3	12.4	12.5	3.7	12.4	8.0	4.5	7.3	17.1	6.1	3.4	7.7	14.1	15.0	8.9	10.7	12.6	18.5	7.0	5.4	10.4	7.6	18.4	13.8	7.6	4.1	11.4	10.8	8.8	14.4	13.6	5.2	5.2	8.1	10.3	10.1	16.0	11.2	10.8	18.3	10.7	14.7	15.0	6.8	11.9	11.0	20.2	1.6	4.7	1.3	1.4	1.6	1.6	2.3	2.1	1.6	2.1	1.6	1.2	5.7	1.7	1.6	1.6	1.6	1.3	4.5	5.7	5.8	9.1	4.2	3.8	6.2	5.0	5.6	5.3	3.0	3.2	0.0	2.4	4.2	2.9	39.1	2.5	1.4	2.3	0.0	2.0	9.1	0.0	3.2	8.0	3.7	2.9	0.0	3.9	11.7	4.7	1.6	4.6	3.8	5.8	3.2	3.5	5.5	5.6	17.1	1.7	2.6	5.0	2.8	2.8	2.9	3.3	0.0	6.3	2.4	1.8	6.5	2.1	14.9	5.5	6.0	13.3	2.2	2.3	1.4
C19orf70	"MIC13, P117, QIL1"	ENSG00000174917	"Chromosome 19 open reading frame 70"	Q5XKP0	19	5678421-5680896	"Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	13	"Late spermatids: 2933.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042672	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Nucleoplasm	"HPA042672: AB_10794531"	"unprognostic (9.54e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.04e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.47e-2)"	20.2	23.6	32.9	14.5	28.4	13.2	16.0	11.0	29.8	13.0	22.2	13.5	17.8	25.4	12.2	26.8	22.7	16.7	24.0	70.2	27.2	26.5	30.5	38.4	12.7	21.1	32.1	21.1	13.5	24.2	13.2	15.6	12.4	16.9	16.6	11.7	13.6	28.7	22.7	79.1	17.6	20.7	14.7	20.9	14.1	18.2	33.4	12.3	11.6	20.3	45.0	12.6	15.4	11.8	43.6	48.2	11.6	42.2	27.4	39.5	40.7	24.2	20.1	7.0	13.4	16.5	17.1	9.1	16.1	15.3	18.6	15.4	16.0	12.7	10.6	26.2	14.0	9.9	18.1	3.6	22.8	5.3	17.4	38.4	10.3	14.0	17.8	23.3	14.1	13.0	20.0	20.6	10.0	13.9	11.7	13.3	16.3	15.9	33.1	14.0	21.9	21.3	16.8	7.4	17.8	64.4	11.7	8.5	38.7	20.3	15.3	16.4	20.9	4.9	31.8	22.5	4.7	19.4	17.4	13.5	18.3	7.8	33.4	22.7	50.0	33.1	8.4	27.3	22.6	18.5	8.9	35.5	11.6	33.6	42.2	39.5	43.6	38.6	37.2	41.2	35.6	38.1	35.9	5.6	27.4	35.6	48.2	30.9	40.7	32.9	28.4	11.0	29.8	27.2	26.5	32.1	21.1	16.9	12.3	65.5	61.7	101.3	135.8	87.3	47.7	288.5	122.3	167.3	76.2	150.1	25.5	132.2	623.4	178.9	798.0	106.8	325.2	46.7	265.1	165.3	137.3	120.3	92.3	251.0	214.9	17.5	154.8	98.8	146.2	2933.3	115.3	157.0	163.6	263.3	176.9	49.5	211.4	214.0	112.8	383.4	42.2	109.9	170.0	106.7	73.5	109.3	105.3	94.8	219.4	109.5
C1orf198	"DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710"	ENSG00000119280	"Chromosome 1 open reading frame 198"	Q9H425	1	230837119-230869589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 178.6;Smooth muscle cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004798	Approved		Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA004798: AB_1848722"	"unprognostic (7.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (3.53e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.77e-2)"	22.6	8.8	25.7	6.6	30.4	2.9	18.6	5.2	31.9	23.4	12.9	66.2	3.5	7.4	17.4	10.2	10.2	13.8	20.4	26.9	27.5	19.4	8.2	6.7	41.9	8.3	44.9	16.2	18.2	17.2	17.1	3.4	19.3	37.4	11.8	7.7	9.1	12.0	21.5	39.0	17.3	7.8	29.2	57.4	10.6	13.0	4.4	36.7	1.5	14.8	6.8	5.7	12.9	10.9	2.8	2.3	10.6	3.6	4.2	3.9	6.6	7.0	5.4	14.8	10.0	28.3	20.8	25.4	13.0	21.0	6.8	6.9	17.2	4.0	8.4	8.3	44.9	3.4	4.6	7.8	2.8	5.1	27.7	7.3	1.3	5.1	5.7	12.1	4.3	1.3	24.9	4.5	2.6	3.0	14.8	4.3	5.4	2.7	2.9	4.7	4.8	3.4	2.1	17.2	15.9	4.4	8.0	10.5	1.9	5.4	8.5	8.5	13.7	6.6	8.8	4.6	8.3	11.2	3.8	3.2	11.1	11.2	2.5	7.7	5.3	2.4	2.5	2.9	2.7	31.0	10.6	1.7	0.5	2.8	3.6	3.5	2.8	1.9	1.1	2.3	1.9	3.9	3.2	1.4	4.2	1.7	0.3	0.8	6.6	25.7	30.4	5.2	26.8	27.5	19.4	44.9	16.2	37.4	36.7	178.6	21.0	0.8	9.8	23.1	1.9	33.8	28.1	6.7	20.5	10.4	9.8	14.6	1.7	37.4	9.1	10.2	1.6	0.0	22.6	26.6	56.3	16.9	2.3	3.9	9.4	23.8	5.2	11.1	2.2	7.3	12.4	2.8	62.4	4.6	9.7	11.2	26.6	3.5	8.5	4.8	4.4	32.3	73.1	5.7	4.2	25.3	10.8	0.7	6.0	16.2
C21orf33	"D21S2048E, ES1, GT335, HES1, KNP-I, KNP-Ia, KNPH, KNPI"	ENSG00000160221	"Chromosome 21 open reading frame 33"	P30042	21	44133605-44210114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 29.2;Melanocytes: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.8;U-266/70: 37.2;U-266/84: 31.0"									HPA018517	Supported		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA		1800000	Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (9.61e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.57e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.61e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.60e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.30e-2)"	16.0	9.6	9.1	6.1	11.4	2.2	7.2	7.9	16.6	5.1	11.7	11.6	12.4	3.0	6.6	22.8	7.6	7.3	5.2	29.2	8.4	8.7	31.6	36.8	8.5	9.9	10.9	9.2	6.7	15.7	2.0	6.5	5.6	8.3	11.0	1.9	6.6	8.8	8.0	45.9	13.4	7.7	7.6	7.3	8.9	13.7	11.8	5.1	5.8	7.1	21.0	15.2	5.1	4.7	22.5	12.3	8.9	20.7	14.7	15.6	23.9	0.4	1.6	0.9	0.2	9.5	9.1	14.2	18.5	10.4	14.6	11.1	22.2	0.2	43.8	0.3	0.1	0.6	0.2	0.1	8.7	6.5	9.6	21.3	1.2	3.6	11.9	10.6	0.6	0.3	0.1	0.9	4.0	0.7	7.4	0.7	10.6	8.3	13.8	5.0	1.6	0.5	1.2	0.4	1.6	0.6	0.4	0.1	15.5	0.9	0.3	14.6	0.2	0.2	0.5	14.2	0.3	1.0	1.5	9.0	5.6	0.3	11.0	0.1	37.2	31.0	0.9	0.6	2.9	6.7	8.9	11.3	6.8	13.0	13.3	11.3	22.5	15.5	15.6	4.6	21.6	14.8	12.8	5.1	14.7	20.7	12.3	14.6	23.9	9.1	11.4	7.9	16.6	8.4	8.7	10.9	9.2	8.3	5.1	6.0	3.5	14.3	0.4	14.5	1.9	0.0	17.8	8.1	3.4	0.0	0.0	2.1	0.0	0.0	1.9	2.9	10.6	0.0	0.0	1.6	4.3	0.5	9.2	2.4	8.1	0.0	7.5	16.5	29.2	1.4	9.2	6.0	38.8	0.0	13.3	7.8	0.0	11.5	16.3	0.0	1.5	12.9	0.0	5.2	12.4	12.7	2.2	15.4	27.5	0.1
C2CD2	"C21orf25, C21orf258, DKFZP586F0422, TMEM24L"	ENSG00000157617	"C2 calcium dependent domain containing 2"	Q9Y426	21	41885112-41953890	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 56.9"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 51.0;Cone photoreceptor cells: 78.5;Ito cells: 42.4;Rod photoreceptor cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.7;SK-BR-3: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030922, HPA030924"	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA030922: AB_2673660, HPA030924: AB_10669873"	"unprognostic (3.02e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (7.68e-5)"	"unprognostic (1.99e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.48e-1)"	23.9	56.9	5.4	6.1	8.0	1.1	21.0	2.7	7.0	5.8	5.8	7.6	10.9	3.5	6.3	6.1	5.4	4.9	7.8	3.6	5.9	5.1	5.3	4.2	9.6	9.1	12.8	4.5	11.7	10.7	19.4	3.8	4.2	10.9	8.8	4.3	11.8	8.1	9.4	2.7	10.1	4.4	5.6	11.7	20.7	5.7	2.7	9.1	5.7	4.8	3.9	5.3	7.0	23.9	1.1	1.4	0.9	1.3	1.9	2.8	0.7	6.1	2.6	1.8	4.2	38.7	10.7	7.2	4.3	6.8	2.7	2.5	4.0	7.0	0.1	2.4	8.4	6.7	0.7	6.5	4.5	3.5	0.4	2.9	1.1	3.2	3.2	5.2	0.4	0.0	6.8	4.2	14.5	5.7	6.0	12.8	0.3	3.8	0.0	7.2	0.5	0.9	1.2	10.2	2.6	8.9	0.6	2.7	3.7	4.0	13.0	3.0	1.3	4.7	21.3	3.8	3.8	5.6	2.7	4.4	6.5	0.9	2.1	3.5	2.4	3.5	0.5	19.0	3.6	1.3	0.0	1.3	0.0	1.3	0.8	0.5	0.5	1.2	0.5	1.4	1.1	2.8	1.6	0.9	1.9	0.7	0.2	1.5	0.7	5.4	8.0	2.7	7.0	5.9	5.1	12.8	4.5	10.9	9.1	3.0	13.3	6.4	6.8	3.7	51.0	2.0	5.1	4.0	5.7	3.5	78.5	9.6	0.0	5.0	0.1	12.0	2.3	0.0	7.1	3.7	6.1	12.9	0.0	4.5	3.2	1.6	4.7	42.4	7.8	0.0	3.4	2.9	1.7	0.0	7.3	3.5	7.9	6.8	2.1	2.8	35.1	12.9	15.6	0.0	2.3	2.3	7.8	1.7	7.1	12.4
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128771807	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 431.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 156.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		15000000	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.60e-5)"	33.6	20.7	10.2	30.8	13.6	6.2	27.6	7.8	13.0	33.6	35.0	13.9	34.0	8.4	57.0	29.4	29.7	27.3	24.0	60.0	10.5	9.0	23.6	38.3	31.4	17.0	14.0	9.8	28.5	21.5	18.6	19.7	104.6	14.4	29.9	21.1	18.7	26.9	40.2	26.5	12.5	16.6	78.1	17.4	26.6	25.6	14.3	10.8	8.1	25.5	16.7	13.4	57.0	27.6	14.0	19.5	13.4	22.9	13.7	18.5	16.4	16.4	13.9	32.5	10.4	90.8	88.3	17.9	113.8	99.3	41.9	55.3	18.0	25.6	8.2	20.7	156.9	48.5	9.6	16.8	22.3	63.2	5.0	11.7	9.0	20.8	19.9	41.6	12.8	16.8	59.4	16.5	57.7	22.5	57.4	37.9	8.0	15.3	11.9	81.1	9.4	9.4	7.5	21.9	15.6	14.0	7.7	23.5	12.8	17.4	9.2	3.4	19.5	36.7	33.9	45.9	62.4	7.2	10.1	50.8	116.1	15.0	96.8	50.3	19.2	23.7	15.2	120.9	16.2	118.3	11.2	21.7	13.4	18.5	22.9	17.0	14.0	12.7	13.8	18.6	10.0	11.3	13.4	2.8	13.7	18.2	19.5	13.6	16.4	10.2	13.6	7.8	13.0	10.5	9.0	14.0	9.8	14.4	10.8	20.8	32.6	29.2	53.7	72.2	27.3	197.2	22.9	49.5	37.5	24.4	17.7	103.1	14.9	67.6	7.8	81.7	12.2	0.0	52.9	431.1	239.3	93.2	58.8	48.7	119.8	27.0	18.9	138.7	55.3	4.7	92.9	49.6	114.7	20.8	39.1	30.4	58.9	7.0	111.7	16.5	11.7	58.2	119.2	21.2	38.7	67.1	203.2	20.3	23.0	60.8
CCDC85A	KIAA1912	ENSG00000055813	"Coiled-coil domain containing 85A"	Q96PX6	2	56184123-56386173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.8"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 23.8;Fibroblasts: 7.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 22.8;fHDF/TERT166: 37.2;U-266/70: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043106, HPA057020"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA043106: AB_10794770, HPA057020: AB_2683311"	"unprognostic (2.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.55e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.83e-2)"	16.0	1.4	10.5	1.3	7.5	0.4	7.8	3.4	18.8	4.2	1.6	4.9	3.0	0.9	9.3	1.6	1.4	3.5	2.1	6.5	7.9	8.5	1.9	0.7	8.1	1.1	6.6	10.2	1.2	1.4	3.0	1.0	14.4	8.8	3.4	1.4	1.0	1.9	4.5	7.2	2.7	1.3	7.3	10.6	1.4	1.3	1.0	5.2	0.0	13.5	2.2	1.3	1.8	3.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.3	0.4	0.0	5.7	0.5	5.0	0.5	0.0	0.0	22.8	0.8	37.2	0.0	1.0	0.0	0.0	2.9	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	1.7	0.1	0.0	0.6	2.8	4.9	0.0	0.0	3.1	0.6	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.0	1.1	2.7	0.0	7.5	4.0	1.1	0.0	0.4	16.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	7.5	3.4	18.8	7.9	8.5	6.6	10.2	8.8	5.2	23.8	1.1	0.0	0.5	3.0	4.4	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	5.1	0.0	0.0	0.3	0.0	7.1	0.3	0.0	0.0	1.7	0.0	1.2	5.5	0.0	5.9	0.3	0.3	5.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	1.4	0.0	2.2	0.0	0.4	1.1	0.1	0.0	0.0	0.1
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.4;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 6.9;Melanocytes: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 9.2;HDLM-2: 8.2;HUVEC TERT2: 8.9;TIME: 8.3;U-87 MG: 19.4"									HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA		170000	"Centrosome, Cytosol"	Nucleoplasm	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	5.0	1.7	1.2	19.1	1.2	0.0	2.5	0.8	1.6	1.4	9.2	0.3	1.0	5.5	1.2	8.5	1.8	1.3	2.6	3.2	1.2	1.0	1.7	1.5	2.8	14.6	1.1	0.7	1.0	1.0	0.1	1.4	6.8	3.3	1.4	15.1	2.7	2.5	1.4	1.1	1.4	18.4	1.8	1.0	31.2	2.6	4.6	0.2	9.5	1.7	6.4	12.9	4.3	1.2	0.2	0.7	0.7	0.8	0.0	0.0	0.2	0.2	0.4	0.2	0.0	1.0	0.3	0.0	0.8	1.8	0.2	0.8	0.0	1.4	0.0	0.3	0.8	9.2	0.0	0.0	1.1	1.4	8.2	0.0	0.0	0.4	1.2	0.0	0.5	0.0	0.3	0.0	0.2	3.3	0.6	8.9	0.0	0.1	4.7	5.2	0.0	0.0	6.6	0.2	0.0	0.0	1.5	1.5	1.8	0.0	0.0	1.2	5.6	4.3	6.8	0.0	0.3	0.0	5.5	8.3	3.0	2.7	0.3	0.0	0.1	0.1	0.0	19.4	0.4	5.7	0.0	0.8	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.8	1.6	1.2	1.0	1.1	0.7	3.3	0.2	0.0	0.0	0.0	0.0	1.1	2.9	0.7	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	2.2	0.7	0.0	0.0	1.2	0.3	0.5	0.1	0.0	0.4	6.9	0.0	0.0	0.0	4.1	1.1	0.0	3.3	13.5	0.0	0.0	1.0	2.0	1.1	0.0	0.0	1.7	19.4	8.0	3.4	0.7	1.1	0.2	0.0	0.0	0.1
CD177	"HNA2A, NB1, PRV1"	ENSG00000204936	"CD177 molecule"		19	43353659-43363172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 67.6;intestine: 43.5;lymphoid tissue: 33.9;vagina: 30.8"	"Cell type enhanced"	"Detected in some"	20	"Enterocytes: 90.9;Glandular cells: 37.4;Mucus-secreting cells: 26.4;Paneth cells: 43.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.6"					"Cell type enriched"	"Detected in some"	7	"neutrophil: 11.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 11.3"	"Cell line enriched"	"Detected in some"	24	"RPMI-8226: 46.0"									"HPA041820, HPA046601, HPA077640"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA041820: AB_2677691, HPA046601: AB_2679716, HPA077640: "	"unprognostic (4.32e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.24e-1)"	1.0	0.0	0.0	8.3	0.0	67.6	0.7	0.0	0.9	2.3	39.5	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	17.3	0.0		0.0	2.1	16.6	26.6	0.1	0.0	2.0	1.0	0.0	0.0	0.4	1.9	17.3	43.5	0.9	0.0	0.0	0.0	0.0	0.0	0.6	4.8	33.9	0.0	1.1	0.0	2.0	1.3	7.2	2.3	0.8	30.8	0.0	0.0	11.3	1.6	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.3	0.3	0.0	0.0	0.0	1.2	0.3	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	46.0	0.7	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	1.6	0.0	0.9	0.0											0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	1.4	5.7	0.0	0.0	0.0	0.0	0.5	0.3	0.0	90.9	0.0	0.2	0.0	0.0	37.4	0.0	0.0	0.0	0.0	8.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.2	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.1
CD24	CD24A	ENSG00000272398	"CD24 molecule"		6	106969831-106975627	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	6	"kidney: 383.7"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 1347.9;Exocrine glandular cells: 3019.5;Pancreatic endocrine cells: 1516.5"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	26	"eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0"	"Group enriched"	"Detected in many"	202	"B-cells: 23.4;granulocytes: 30.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 66.4;RPTEC TERT1: 313.7;SK-BR-3: 91.2"									"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavorable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	0.5	0.5	12.8	2.4	9.9	17.9	25.5	0.5	2.9	69.5	30.6	0.7	1.6	1.2	34.5	5.9	38.1	6.0	25.1	4.2	22.7		383.7	0.8	0.7	0.9	4.8	7.2	15.6	40.0	0.0	5.7	48.2	13.0	3.2	21.2	0.7	15.9	16.6	0.4	0.5	0.8	2.2	4.9	0.7	16.4	0.5	6.5	0.4	48.8	1.2	11.3	4.0	8.1	23.4	0.0	30.4	0.1	0.0	0.0	0.6	23.4	14.5	0.2	1.9	0.0	0.0	27.5	0.0	0.1	0.1	0.0	0.2	0.1	2.3	7.2	0.0	1.0	48.5	8.2	18.3	0.1	0.0	0.1	0.0	17.9	1.0	0.0	0.3	0.1	0.1	21.1	0.2	1.2	1.1	0.1	0.0	0.5	0.0	0.4	29.4	0.1	0.1	66.4	52.2	5.6	54.8	0.0	0.2	313.7	60.5	41.1	30.3	16.6	91.2	0.0	31.1	42.1	0.1	0.0	0.0	0.2	0.2	0.7	0.0	0.1	31.0	0.3	0.1	0.1	0.1	0.0	30.4	0.0	0.0	0.0	23.4	0.0	0.0	0.0	15.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.6											145.9	106.6	139.4	57.2	0.0	6.5	1.1	1003.8	691.9	180.9	1235.3	2.0	679.9	1347.9	1087.4	21.0	2.3	819.9	0.0	3019.5	709.4	9.3	444.2	10.4	3.8	61.3	0.0	552.5	53.4	8.9	32.3	9.5	11.8	0.0	55.9	391.5	1.1	1516.5	703.5	2.1	408.2	0.5	6.5	0.4	0.5	4.9	0.0	466.9	12.5	734.9	281.9
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711851	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.3;lymphoid tissue: 86.3"	"Group enriched"	"Detected in many"	5	"B-cells: 233.4;granulocytes: 88.9;Hofbauer cells: 87.6;Kupffer cells: 195.5;Macrophages: 131.8;T-cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 38.9;HMC-1: 43.5;U-266/70: 92.1;U-266/84: 61.5"									"CAB002497, HPA055146"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2600000	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	5.5	1.4	1.0	44.6	0.9	23.1	2.8	0.6	0.7	3.2	5.0	0.5	1.1	3.2	1.9	2.5	7.3	2.1	4.8	1.8	1.0	1.0	3.6	3.1	15.4	86.3	1.6	0.3	2.3	1.5	0.0	1.3	2.2	0.8	2.8	5.7	2.4	13.9	1.5	1.3	1.2	21.2	1.7	3.8	66.6	5.0	1.3	0.2	50.8	2.9	3.6	58.0	8.6	2.6	34.6	53.6	35.8	74.1	24.9	57.9	81.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	4.6	43.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	14.2	0.0	0.0	13.5	6.7	0.0	0.0	0.0	0.8	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	61.5	15.8	0.0	11.7	0.0	28.2	52.2	35.8	42.4	74.1	57.9	34.6	48.3	48.8	53.6	27.9	49.7	52.5	13.4	24.9	73.5	9.4	36.4	81.3	1.0	0.9	0.6	0.7	1.0	1.0	1.6	0.3	0.8	0.2	0.0	14.8	233.4	0.5	4.8	0.0	0.8	5.1	4.0	2.3	3.5	0.0	0.7	1.7	0.1	0.0	0.7	0.0	23.3	0.2	0.7	3.1	0.2	88.9	1.8	87.6	0.0	1.2	8.6	195.5	0.4	1.7	131.8	37.1	8.2	0.0	0.0	0.1	0.0	0.4	1.5	0.0	0.0	0.7	0.4	0.1	2.6	0.3	297.5	0.0	0.3
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736491	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 285.5"	"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 1502.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 217.5;U-2197: 180.1"									"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favorable (1.39e-10)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	96.7	41.0	36.7	26.3	44.3	23.8	76.0	25.9	32.7	44.8	36.9	24.0	57.9	16.5	45.4	132.8	68.4	53.2	67.6	90.5	35.6	38.4	100.0	61.0	86.4	39.8	39.7	25.8	39.3	52.3	60.6	48.0	285.5	68.7	47.4	37.7	51.4	114.8	62.6	70.6	43.4	25.0	52.4	32.9	26.2	54.7	28.1	23.1	16.1	85.9	57.7	40.0	51.2	63.4	13.5	20.5	42.8	4.8	17.7	60.4	11.1	16.8	15.8	4.7	13.8	109.9	86.2	2.7	96.0	107.2	24.1	28.2	7.3	50.7	1.3	17.2	103.4	28.7	19.0	8.6	95.8	33.8	26.8	13.1	1.7	56.0	11.0	30.0	10.1	5.8	40.0	24.2	20.4	98.3	66.8	146.8	5.9	11.8	39.0	151.5	15.4	4.7	4.2	2.6	31.1	82.5	1.8	14.6	13.5	72.7	28.8	3.2	4.4	33.4	15.5	17.6	13.9	11.8	1.0	217.5	55.4	13.3	180.1	33.3	17.3	33.8	1.6	47.6	0.0	96.2	30.5	4.8	42.8	11.3	1.6	14.4	13.5	24.0	12.7	20.5	10.6	15.7	9.3	28.4	17.7	0.9	10.5	60.4	11.1	36.7	44.3	25.9	32.7	35.6	38.4	39.7	25.8	68.7	23.1	253.1	215.4	44.4	795.7	254.1	47.4	262.5	430.6	580.9	208.1	230.3	31.4	513.5	139.3	1251.4	102.0	802.4	90.2	140.2	547.4	330.2	284.0	787.9	136.2	175.7	400.2	44.5	160.2	566.0	129.7	49.4	219.8	141.1	1204.5	272.3	85.9	184.1	823.9	122.8	192.3	162.3	45.0	271.7	576.8	86.8	27.6	248.5	699.7	62.8	98.2	1502.4
CDCP1	"CD318, SIMA135"	ENSG00000163814	"CUB domain containing protein 1"	Q9H5V8	3	45082278-45146422	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 107.6;Ductal cells: 84.9;Pancreatic endocrine cells: 100.0;Urothelial cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	5	"pons and medulla: 5.5"	"Group enriched"	"Detected in some"	5	"myeloid DC: 4.0;neutrophil: 1.8;NK-cell: 7.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.0;granulocytes: 1.8;NK-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.8;HBEC3-KT: 27.2;hTEC/SVTERT24-B: 67.5;hTERT-HME1: 45.8;PC-3: 21.1;RPTEC TERT1: 20.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010978, HPA010979, CAB025637"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401"	"unprognostic (9.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (9.98e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.34e-1)"	2.3	0.7	0.5	5.6	1.0	0.2	4.4	0.3	0.7	6.9	17.4	1.1	10.1	11.4	3.2	11.1	28.6	2.4	9.8	0.8	1.0	0.5	4.4	0.8	7.1	1.4	0.6	0.3	1.6	13.9	0.0	2.3	4.0	5.5	5.2	11.3	0.5	11.4	13.0	0.6	15.2	29.8	1.8	1.3	0.8	10.8	1.3	0.5	1.0	21.8	19.2	19.1	7.3	11.7	0.2	4.0	1.8	0.9	7.1	0.3	0.3	12.3	3.7	0.0	0.0	0.0	0.6	3.0	2.2	0.4	1.1	1.0	5.2	23.8	0.0	2.8	0.7	0.6	10.0	0.0	27.2	2.3	0.0	0.0	0.0	4.2	0.0	2.0	0.0	0.9	0.9	14.3	67.5	45.8	4.1	0.2	0.0	7.2	0.0	3.4	0.0	0.0	0.2	1.8	6.0	21.1	0.0	0.0	2.1	20.8	10.0	0.8	0.0	4.6	1.2	0.0	1.2	5.8	0.1	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.9	0.1	0.1	0.1	0.0	0.1	0.3	0.1	4.0	0.2	0.2	0.1	1.8	7.1	0.0	0.1	0.0	0.3	0.5	1.0	0.3	0.7	1.0	0.5	0.6	0.3	5.5	0.5	3.0	13.3	0.0	52.1	107.6	0.0	0.4	12.7	26.8	18.2	8.7	0.0	4.5	0.0	84.9	0.0	0.6	30.4	0.0	61.1	6.7	5.8	52.2	8.1	0.0	10.2	0.0	36.0	0.0	4.8	0.0	2.8	26.8	3.3	18.0	34.1	0.0	100.0	28.8	0.0	0.0	0.0	0.0	3.3	0.0	0.4	65.6	2.7	0.0	22.5	90.5
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"Carcinoembryonic antigen related cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 58.7;liver: 46.1;lymphoid tissue: 46.5"	"Cell type enhanced"	"Detected in many"	16	"Basal glandular cells: 234.8;Enterocytes: 131.5;Glandular cells: 256.0;Urothelial cells: 472.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"eosinophil: 20.6;neutrophil: 12.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.6"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 11.7;Hep G2: 33.3;OE19: 32.1;RT4: 21.9;SK-MEL-30: 24.6"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	NA	NA		180000000			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	5.3	5.0	0.4	30.2	0.7	15.8	5.3	0.5	0.5	7.7	58.7	0.9	2.5	11.8	3.5	1.5	35.6	1.7	4.3	3.8	0.5	0.5	24.0	46.1	5.4	8.6	1.8	0.0	2.5	1.0	0.0	3.7	16.8	1.0	8.8	35.6	1.7	20.7	5.4	0.9	1.7	54.9	3.0	1.5	5.5	3.6	1.3	0.7	1.2	2.3	18.5	46.5	7.8	12.7	1.9	0.1	20.6	1.8	0.0	1.5	0.3	0.1	2.2	0.1	0.1	0.0	0.0	5.6	0.0	0.1	0.4	0.2	0.9	11.7	0.7	4.7	0.0	1.2	0.3	0.0	3.1	0.1	0.0	0.2	0.1	0.1	33.3	0.7	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.5	0.0	0.4	0.1	0.0	0.1	32.1	0.6	0.6	0.0	0.5	0.2	21.9	0.1	0.0	0.0	0.0	24.6	3.2	0.1	0.0	0.8	0.1	0.2	0.1	0.1	0.7	0.0	1.3	0.0	0.1	0.1	0.4	0.0	20.6	0.0	0.9	0.2	1.9	0.5	0.2	0.1	0.3	0.4	0.1	12.7	0.0	1.8	0.0	1.5	0.3	0.4	0.7	0.5	0.5	0.5	0.5	1.8	0.0	1.0	0.7	6.0	10.9	15.9	234.8	1.1	5.7	1.6	7.6	4.0	7.9	0.0	3.9	0.8	0.0	16.9	2.1	7.1	131.5	0.0	13.8	7.8	1.7	256.0	9.2	32.6	1.1	4.8	16.6	51.5	6.5	0.0	0.0	3.0	6.8	1.0	22.4	1.4	43.2	84.3	0.7	10.5	6.6	0.0	1.8	4.3	2.8	0.9	0.6	4.9	9.8	472.9
CEACAM7	"CEA, CGM2"	ENSG00000007306	"Carcinoembryonic antigen related cell adhesion molecule 7"	Q14002	19	41673307-41706976	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 100.5;lymphoid tissue: 60.9"	"Group enriched"	"Detected in some"	7	"Ductal cells: 63.3;Enterocytes: 92.9;Paneth cells: 145.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 66.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.4;OE19: 3.4;U-2 OS: 1.2;U-266/84: 2.0"									"HPA069621, HPA073910"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA069621: AB_2686162, HPA073910: "	"unprognostic (5.24e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (6.03e-2)"		"unprognostic (2.07e-2)"		"unprognostic (4.30e-2)"			"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"		"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"		"unprognostic (3.14e-1)"	0.1	0.1	0.1	60.9	0.1	0.0	0.1	0.1	0.1	9.2	90.0	0.1	0.1	0.0	0.6	0.1	21.1	0.3	5.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.1	0.3	0.1	0.3	100.5	0.2	1.5	0.1	0.1	0.5	0.2	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	12.1	19.4	6.1	13.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.1	2.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	1.2	0.0	0.0	0.0	0.0	63.3	0.0	0.0	92.9	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	14.7	0.0	1.6	145.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	7.4
CEP57	"KIAA0092, Translokin, TSP57"	ENSG00000166037	"Centrosomal protein 57"	Q86XR8	11	95789965-95832693	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 393.9;Late spermatids: 289.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018315	Approved		Approved	Microtubules,Cytosol	"Intracellular and membrane"	NA	NA			Microtubules	Cytosol	"HPA018315: AB_1846537"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (7.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.25e-1)"	16.8	13.7	12.9	25.9	20.6	21.6	17.4	27.9	16.2	25.6	33.8	6.9	19.2	27.0	18.5	18.8	18.2	16.5	22.9	14.0	13.3	14.1	14.9	34.4	19.0	28.9	12.6	15.2	27.2	24.5	13.6	26.1	13.3	15.0	21.5	15.6	10.5	14.1	22.3	12.6	15.8	28.8	22.2	14.6	19.8	15.3	24.3	12.7	46.5	23.4	15.7	23.9	27.5	18.3	17.2	15.5	17.6	11.0	18.6	25.3	13.0	11.4	5.6	19.7	14.7	8.4	17.4	15.6	13.0	21.0	18.0	20.4	20.4	24.6	20.6	18.2	9.6	10.9	19.3	14.8	12.9	19.1	16.2	9.9	28.4	16.5	16.9	15.5	28.8	17.1	11.7	18.4	18.4	35.4	17.4	14.9	22.8	18.3	11.4	14.3	5.6	31.0	38.0	10.0	13.1	13.0	19.4	23.6	17.3	15.2	12.7	9.5	13.7	15.5	15.3	16.4	13.8	15.7	18.6	8.4	15.7	12.7	23.0	12.4	8.4	16.2	23.0	6.5	32.1	13.6	11.3	9.1	17.6	16.5	11.0	21.2	17.2	21.0	18.8	11.9	16.2	20.2	19.2	8.5	18.6	9.1	15.5	25.3	13.0	12.9	20.6	27.9	16.2	13.3	14.1	12.6	15.2	15.0	12.7	50.6	42.7	43.2	31.6	32.3	71.9	38.6	71.4	64.3	47.8	27.9	33.4	35.9	46.4	28.1	393.9	35.2	19.7	46.7	22.5	43.0	29.6	24.9	26.5	62.1	28.5	54.0	27.6	16.0	29.7	289.2	31.4	34.0	16.9	23.4	30.2	26.4	24.1	28.1	33.6	27.0	58.6	64.7	29.2	42.3	38.3	28.0	32.2	42.4	40.6	24.0
CFAP65	"CCDC108, DKFZp434O0527, MGC35338"	ENSG00000181378	"Cilia and flagella associated protein 65"	Q6ZU64	2	219002846-219041527	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.3;fallopian tube: 29.2;testis: 20.4"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 53.5;Early spermatids: 163.7;Late spermatids: 138.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.1"	"Region enhanced"	"Detected in many"		"pons and medulla: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.4;SCLC-21H: 1.5;SH-SY5Y: 4.0;U-87 MG: 2.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 13.1"	"HPA055156, HPA063406"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA055156: AB_2682720, HPA063406: "	"unprognostic (3.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (6.08e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.60e-2)"	0.2	0.4	1.8	0.3	6.4	0.3	0.3	0.0	2.1	2.2	0.4	5.4	0.3	0.3	0.9	6.0	0.2	29.2	0.6	0.2	2.9	3.2	0.5	0.2	3.6	0.3	0.4	1.2	4.2	0.6	0.3	6.1	0.2	16.3	0.3	0.5	2.8	0.4	0.4	0.2	0.2	0.7	0.2	0.6	0.3	0.6	20.4	2.5	0.0	1.3	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.5	0.5	0.0	1.1	0.2	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	2.4	0.1	0.0	0.0	0.0	1.2	0.0	1.5	4.0	0.0	0.1	0.7	0.6	1.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.8	6.4	0.0	2.1	2.9	3.2	0.4	1.2	16.3	2.5	0.0	3.4	0.0	0.1	0.0	0.7	0.0	7.6	53.5	12.5	0.0	11.8	0.0	0.0	0.4	163.7	0.0	0.5	0.0	1.3	0.0	0.0	1.4	0.0	0.0	0.1	0.0	28.1	0.0	0.0	138.9	0.6	0.0	0.0	0.0	25.9	0.8	1.4	0.0	0.7	0.9	20.7	0.0	0.0	15.4	4.1	0.0	0.0	0.0	3.4	0.0
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911430-5925361	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 424.9;pituitary gland: 177.5"	"Cell type enriched"	"Detected in many"	11	"Intestinal endocrine cells: 997.5"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.6;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Group enriched"	"Detected in some"	23	"SCLC-21H: 66.7;SH-SY5Y: 102.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		24000000	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	3.4	424.9	8.2	1.4	10.2	0.8	1.0	82.5	16.4	0.8	3.0	2.1	1.2	7.7	0.9	1.3	0.8	2.5	0.8	7.6	20.7	15.4	1.7	0.7	1.0	1.1	7.2	9.1	3.0	17.0	0.8	177.5	0.8	51.8	5.6	2.5	0.7	0.9	1.2	2.1	0.9	4.4	0.9	2.3	0.8	19.7	2.4	0.8	0.0	1.9	0.4	0.9	0.8	0.1	0.0	0.6	0.0	0.0	0.0	2.6	0.2	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	66.7	102.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.2	8.2	10.2	82.5	16.4	20.7	15.4	7.2	9.1	51.8	0.8	3.0	3.7	0.0	8.2	3.8	86.9	51.2	0.0	8.1	1.2	66.3	19.6	0.0	1.7	0.4	6.1	3.4	1.7	0.0	0.3	0.0	2.3	2.3	0.0	0.0	0.1	71.5	997.5	0.0	0.3	6.0	0.9	1.5	6.8	1.8	2.8	9.3	37.4	5.8	0.4	0.1	49.6	12.9	1.4	50.2	27.7	3.1	0.2	0.0	1.4	3.0
CLEC2B	"AICL, CLECSF2, HP10085"	ENSG00000110852	"C-type lectin domain family 2 member B"	Q92478	12	9852984-9870136	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 179.2;Macrophages: 186.4;Suprabasal keratinocytes: 210.5;T-cells: 224.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 58.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.2;ASC TERT1: 27.2;HSkMC: 14.9;U-937: 62.1"									HPA008194	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008194: AB_1078533"	"unprognostic (3.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (5.64e-13)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.79e-1)"	10.8	1.8	2.0	9.1	2.8	29.8	8.2	2.4	3.0	6.3	3.9	2.7	3.4	1.5	7.2	4.4	6.1	3.6	6.0	4.8	2.0	1.3	2.7	4.5	13.1	8.9	3.0	2.0	12.9	2.0	0.2	2.0	4.8	3.2	4.9	3.7	3.4	4.5	2.0	5.7	24.5	4.9	4.0	3.3	12.6	2.2	3.6	2.4	56.6	3.4	3.6	7.6	5.3	7.9	5.6	9.3	58.7	17.3	17.1	19.1	18.6	0.0	0.8	0.0	0.0	17.2	27.2	0.1	0.4	3.3	0.2	0.9	0.0	0.6	0.3	0.2	13.7	10.3	5.1	2.8	0.0	0.1	0.7	0.0	0.9	0.0	0.0	5.7	0.6	0.1	14.9	5.1	0.6	0.1	0.8	8.6	3.6	0.0	2.3	4.0	0.0	5.3	1.2	0.1	0.0	0.5	7.9	0.1	0.0	0.0	5.5	0.0	0.0	0.2	0.0	3.5	0.0	1.3	0.1	11.4	0.1	3.2	0.4	1.6	4.1	0.3	0.6	3.5	62.1	5.0	9.6	10.3	3.7	18.4	14.7	14.6	3.1	11.6	19.1	9.3	5.6	11.1	16.8	58.7	17.1	17.3	3.5	9.3	18.6	2.0	2.8	2.4	3.0	2.0	1.3	3.0	2.0	3.2	2.4	3.0	33.4	35.1	68.5	179.2	0.0	3.1	12.7	4.0	26.1	0.0	0.0	0.7	0.0	3.8	0.2	130.0	0.2	23.3	0.7	1.4	28.8	14.5	52.1	2.6	77.5	0.0	1.7	145.5	124.7	0.7	46.1	186.4	75.9	10.8	0.0	0.4	1.8	0.0	16.6	0.7	0.2	6.5	37.7	0.2	0.5	210.5	1.6	224.3	0.0	126.6
CLN5		ENSG00000102805	"CLN5, intracellular trafficking protein"	O75503	13	76990660-77019143	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 114.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA041788	Approved				"Intracellular and membrane"	NA	NA		430000			"HPA041788: AB_10962726"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.52e-9)"	"unprognostic (2.35e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.15e-2)"	15.7	17.0	10.4	11.0	11.1	8.5	18.2	9.9	9.5	15.7	11.1	12.9	12.7	7.5	13.3	26.0	12.0	15.7	16.4	14.3	10.2	10.0	34.8	21.7	12.7	13.8	16.1	6.8	21.1	15.0	17.5	20.9	22.2	14.2	14.1	10.1	16.7	13.6	15.4	11.4	10.0	13.5	14.0	13.9	12.0	12.9	10.9	13.4	13.5	45.2	7.0	10.8	13.2	11.8	8.1	6.3	24.0	14.4	0.6	13.9	8.0	11.6	5.6	8.2	6.9	36.3	23.7	10.5	11.0	20.0	8.7	15.0	6.3	11.1	5.1	8.7	15.4	10.2	12.9	5.5	12.0	9.6	9.5	11.9	6.4	7.1	5.8	16.3	8.9	9.9	21.1	13.6	4.4	8.9	18.2	15.2	6.7	4.4	9.0	20.3	3.8	5.7	6.1	5.3	22.4	5.3	4.5	7.4	4.4	20.4	6.9	3.7	5.6	7.0	8.5	12.9	11.2	9.1	12.8	14.8	6.7	5.5	7.6	6.7	12.0	14.0	5.7	17.4	6.8	14.8	24.0	8.9	20.9	2.1	12.4	1.8	8.0	10.3	3.6	6.0	8.1	13.3	8.0	6.6	0.6	14.4	6.3	13.9	8.0	10.4	11.1	9.9	9.5	10.2	10.0	16.1	6.8	14.2	13.4	14.9	25.9	17.6	25.9	10.2	19.6	6.7	30.6	33.5	42.1	64.6	9.8	44.5	8.3	32.9	1.5	20.4	16.4	0.0	33.4	114.1	33.4	28.5	21.9	30.6	41.7	6.4	13.3	26.4	21.3	3.0	46.1	26.5	23.6	33.3	12.3	47.7	21.7	13.6	44.6	40.4	24.2	19.4	28.9	19.1	39.4	10.0	38.8	9.2	9.6	18.8
CNPY2	"Cnpy2, HP10390, TMEM4, ZSIG9"	ENSG00000257727	"Canopy FGF signaling regulator 2"	Q9Y2B0	12	56309842-56316336	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 396.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038465, HPA038466"	Supported		Supported	Cytosol	"Intracellular and membrane"	NA	NA		62000	Cytosol		"HPA038465: AB_10967609, HPA038466: AB_10672646"	"unprognostic (3.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (8.37e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.32e-8)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.06e-2)"	17.8	31.4	19.0	16.1	23.8	14.0	27.3	17.3	24.1	29.9	23.7	23.3	40.1	23.0	21.1	46.4	19.1	26.1	19.9	16.9	19.0	20.4	26.7	53.2	17.3	14.9	21.2	21.8	25.7	59.9	19.9	39.3	39.7	21.6	23.4	24.2	18.9	46.2	33.4	10.9	12.3	26.4	16.8	22.5	20.2	23.6	13.7	20.4	13.0	38.0	15.5	16.2	19.7	17.4	33.1	35.3	22.2	36.4	30.1	38.7	33.7	16.2	29.3	21.0	19.3	57.3	22.4	42.5	18.5	36.9	34.5	24.6	39.0	29.1	15.1	32.0	39.9	18.0	23.7	26.2	20.7	20.1	18.3	24.5	14.5	30.9	34.3	28.5	27.3	22.3	26.0	31.5	28.4	32.0	49.5	27.9	21.2	23.2	39.1	23.7	26.7	16.7	32.3	21.5	33.0	41.8	19.7	17.2	32.0	26.8	12.5	22.6	13.3	27.2	27.2	27.2	28.3	25.7	60.1	15.0	15.1	11.5	16.4	22.1	19.2	25.5	11.4	28.0	26.7	24.1	22.2	36.4	18.3	33.4	26.1	38.7	33.1	37.2	35.2	35.3	27.6	37.9	34.3	5.2	30.1	15.9	34.3	31.2	33.7	19.0	23.8	17.3	24.1	19.0	20.4	21.2	21.8	21.6	20.4	44.7	80.8	67.3	61.3	48.7	74.0	8.5	150.3	68.3	56.9	96.0	60.9	216.3	44.7	170.3	31.1	66.5	86.5	23.3	146.9	396.1	82.6	106.0	90.0	177.6	129.7	55.6	136.3	84.7	56.3	11.1	96.1	63.5	116.4	114.6	123.9	72.9	148.7	108.7	94.0	116.9	81.3	25.8	72.2	66.7	41.7	47.0	197.7	84.1	139.6	60.7
CNPY4	"MGC40499, PRAT4B"	ENSG00000166997	"Canopy FGF signaling regulator 4"	Q8N129	7	100119613-100125511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Leydig cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014166, HPA025240"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA014166: AB_1853895, HPA025240: AB_2082630"	"unprognostic (9.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.09e-3)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.35e-2)"	12.9	18.3	10.9	13.4	9.9	5.5	11.6	16.5	13.1	22.8	13.0	14.8	8.8	6.1	23.5	15.8	6.3	16.2	20.3	13.6	9.9	9.1	11.0	6.7	9.2	15.5	9.5	9.9	26.1	7.2	17.6	17.8	20.8	10.4	14.0	10.3	18.0	6.5	17.0	4.7	8.3	9.5	21.7	11.4	14.0	8.4	9.1	13.7	16.4	11.1	9.6	9.5	13.0	16.2	2.8	5.2	8.8	9.3	8.3	15.2	4.7	3.3	5.8	14.6	26.1	34.4	16.6	7.3	12.6	13.6	6.6	12.4	3.1	3.0	7.3	14.6	22.5	4.8	3.4	5.7	6.1	6.9	6.8	5.8	3.0	9.6	4.4	9.8	5.1	5.7	15.1	1.7	6.0	2.7	14.5	22.8	3.6	2.5	4.9	9.4	9.6	10.7	6.7	7.5	2.1	8.4	3.1	11.0	3.9	6.7	0.8	3.6	7.4	12.0	9.7	6.4	9.9	4.9	2.8	18.4	21.2	12.8	8.8	5.6	4.2	6.7	6.6	12.4	7.9	8.6	8.8	3.7	5.7	11.8	8.0	15.2	2.8	12.1	14.7	5.2	2.4	9.9	14.9	1.7	8.3	9.3	3.3	9.6	4.7	10.9	9.9	16.5	13.1	9.9	9.1	9.5	9.9	10.4	13.7	6.0	1.6	0.0	2.0	3.2	6.6	3.2	5.1	4.0	4.5	12.2	2.0	29.6	1.7	5.4	0.4	11.7	2.3	23.3	2.2	8.4	26.6	0.6	9.2	0.9	11.9	7.9	2.4	19.6	1.6	0.9	32.5	3.6	15.1	5.4	1.8	25.5	2.7	2.9	29.7	2.3	13.7	12.9	12.3	1.0	3.8	3.3	15.3	6.5	1.9	0.7
CR1L		ENSG00000197721	"Complement C3b/C4b receptor 1 like"	Q2VPA4	1	207645113-207738416	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;brain: 4.3"	"Cell type enriched"	"Detected in some"	19	"Erythroid cells: 93.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 3.1;HMC-1: 7.8;K-562: 3.8"									HPA049348	Approved				"Intracellular and membrane"	NA	NA					"HPA049348: AB_2680723"	"unprognostic (2.35e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.68e-2)"	0.4	0.3	0.2	1.3	2.5	6.1	0.2	0.2	4.0	0.7	0.3	0.9	0.9	0.1	0.2	0.1	0.2	1.3	0.1	0.2	0.8	0.2	3.2	0.8	2.8	1.3	1.0	1.7	0.9	0.2	0.1	0.2	2.6	1.1	0.3	0.2	0.0	0.9	1.0	0.2	0.2	0.6	0.1	4.3	1.0	0.2	0.2	3.3	0.0	0.3	0.0	0.8	0.2	0.2	0.4	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.2	4.0	0.8	0.2	1.0	1.7	1.1	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	5.0	0.4	0.0	0.1	0.0	93.5	0.0	0.2	0.0	0.3	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1
CRB1	"LCA8, RP12"	ENSG00000134376	"Crumbs 1, cell polarity complex component"	P82279	1	197268204-197478455	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 155.1;Muller glia cells: 100.9;Rod photoreceptor cells: 136.0"	"Cancer enriched"	"Detected in single"	12	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"basophil: 9.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 9.4"	"Cell line enriched"	"Detected in some"	8	"HeLa: 17.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA061250, HPA063127"	Approved		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA061250: AB_2684458, HPA063127: AB_2684944"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-3)"		"unprognostic (2.92e-3)"	"unprognostic (1.50e-2)"	"unprognostic (5.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.96e-1)"	1.1	1.1	11.9	0.9	11.0	1.8	1.2	31.4	20.4	0.9	0.9	10.4	0.0	0.9	0.8	1.2	1.1	2.0	1.0	1.2	11.4	6.2	1.1	0.9	1.0	1.0	4.0	8.9	2.6	1.7	0.7	1.9	0.9	14.1	1.0	0.9	9.0	0.8	0.9	2.4	0.9	0.9	0.8	8.7	0.9	1.5	7.3	9.6	0.0	1.3	0.0	0.8	0.9	0.1	0.1	0.0	9.4	0.0	0.1	0.4	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	17.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.0	11.9	11.0	31.4	10.5	11.4	6.2	4.0	8.9	14.1	9.6	0.0	0.0	0.0	0.2	0.2	12.7	1.2	0.0	0.0	0.0	0.0	155.1	0.0	0.0	0.0	1.4	0.0	0.0	23.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.9	1.7	0.0	0.0	0.0	0.0	100.9	0.0	0.0	0.4	0.0	136.0	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0
CRELD1	AVSD2	ENSG00000163703	"Cysteine rich with EGF like domains 1"	Q96HD1	3	9933822-9945413	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 47.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026964	Uncertain		Approved	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA		16000000	Cytosol	Nucleoli	"HPA026964: AB_10602210"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.78e-2)"	21.8	22.9	31.6	15.3	32.4	7.3	27.3	52.2	45.1	9.9	22.4	12.0	17.1	12.5	15.1	17.8	13.1	20.1	15.8	50.2	25.6	24.9	16.6	23.5	15.8	11.0	17.2	30.7	19.7	15.2	21.9	32.4	15.1	27.2	25.4	11.4	10.0	19.4	32.2	24.4	11.6	13.1	19.5	19.4	11.9	14.8	11.1	22.3	5.9	45.7	7.4	8.2	17.8	15.6	10.5	13.7	11.5	12.5	13.4	14.3	10.4	2.8	5.2	8.5	4.4	14.4	9.4	47.1	10.4	3.1	2.6	4.9	5.0	8.5	3.4	22.9	7.2	12.1	1.8	4.1	7.5	1.8	6.7	3.9	3.1	6.7	11.8	28.8	1.1	12.0	9.6	13.9	6.4	5.9	31.4	11.8	5.2	3.7	4.1	2.5	6.8	2.0	8.4	2.3	11.6	3.5	2.1	1.2	8.1	11.0	4.9	3.4	11.0	4.8	4.5	9.3	11.7	11.5	6.8	8.2	5.0	8.1	6.6	2.5	4.7	6.0	6.3	11.1	3.5	5.3	11.5	11.4	9.4	14.2	11.6	14.3	8.9	10.5	13.7	8.2	10.5	14.2	12.7	1.8	13.4	12.5	13.7	8.0	10.4	31.6	32.4	52.2	45.1	25.6	24.9	17.2	30.7	27.2	22.3	17.9	13.7	10.7	19.5	8.7	20.8	34.7	33.1	8.1	7.9	15.7	15.7	20.0	6.6	17.7	5.8	15.0	14.7	0.0	3.9	9.2	21.7	31.7	20.7	11.5	18.5	30.2	25.9	16.0	7.8	7.9	29.7	10.2	11.8	19.0	14.9	21.0	8.8	15.0	24.8	8.2	15.0	25.8	14.1	49.7	11.9	10.8	18.5	12.1	14.1	16.3
CRIM1	S52	ENSG00000150938	"Cysteine rich transmembrane BMP regulator 1"	Q9NZV1	2	36355926-36551135	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 116.2"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 170.0;Syncytiotrophoblasts: 145.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 68.0;fHDF/TERT166: 67.0;TIME: 94.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000556	Enhanced				"Intracellular and membrane"	NA	NA		120000			"HPA000556: AB_1078567"	"unprognostic (2.15e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.51e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.67e-2)"	42.4	6.0	9.1	8.7	11.0	1.1	44.6	6.1	9.0	13.8	13.1	6.4	10.2	5.7	14.9	9.8	12.4	14.2	17.3	32.2	8.6	8.7	28.6	6.2	24.7	13.2	7.6	10.2	15.5	9.2	18.0	4.3	116.2	12.0	14.9	9.4	24.7	13.1	13.8	25.9	13.7	9.0	23.1	10.8	17.5	10.2	8.1	6.2	3.0	18.1	7.9	4.5	16.9	22.3	0.8	5.5	3.4	1.4	1.1	1.6	0.2	14.2	10.9	2.2	2.5	10.5	12.0	18.6	68.0	36.1	38.1	20.1	13.7	4.9	0.0	44.4	67.0	24.8	6.2	1.6	11.0	31.3	0.1	1.2	0.4	14.6	7.9	34.0	0.3	0.1	16.8	8.2	15.2	27.5	35.9	53.3	0.2	0.6	0.1	40.0	1.3	0.0	0.1	1.7	0.7	3.2	0.7	2.9	2.2	24.0	5.9	0.2	0.0	11.8	3.9	0.5	8.8	10.6	0.2	94.6	48.2	17.4	5.9	32.8	3.7	0.0	0.1	14.2	0.0	14.8	3.4	0.4	1.2	1.6	0.2	1.2	0.6	0.7	0.9	0.3	0.8	0.2	1.0	0.5	1.1	1.4	5.5	0.5	0.2	9.1	11.0	6.1	9.0	8.6	8.7	7.6	10.2	12.0	6.2	11.9	46.6	5.2	34.8	58.6	7.1	35.8	48.4	26.8	35.2	125.6	2.0	107.1	3.3	29.4	0.9	118.8	18.6	0.0	2.2	34.1	49.4	51.6	1.1	0.9	22.4	0.0	30.5	170.0	6.5	1.3	17.5	10.5	37.1	10.8	41.0	15.6	17.1	31.7	18.7	36.6	37.9	45.3	115.4	2.1	8.7	26.3	145.1	13.8	31.6	40.7
CTAGE5	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, MEA6, MGEA, MGEA11, MGEA6"	ENSG00000150527	"CTAGE family member 5, ER export factor"	"O15320, Q96PC5"	14	39230231-39388513	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 72.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 43.4"									"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	9.3	16.9	7.3	11.4	7.3	7.3	7.9	5.1	7.9	12.1	22.8	5.8	13.5	28.5	8.5	17.9	18.5	8.4	15.1	7.5	6.4	5.9	34.7	52.2	10.6	9.0	7.8	6.5	8.6	20.6	22.9	20.6	6.0	21.1	8.9	12.6	6.0	22.3	17.0	17.4	6.4	52.4	6.9	9.7	9.7	16.0	8.7	8.6	10.1	17.0	15.9	7.0	8.3	10.9	8.7	12.5	24.5	13.5	9.8	11.6	8.4	7.7	8.6	3.6	6.4	7.4	8.4	5.1	4.6	4.8	3.3	3.4	6.7	43.4	9.3	14.3	5.1	6.7	11.8	4.4	5.1	3.9	7.2	3.7	5.8	4.2	35.8	17.4	7.8	10.8	5.1	29.5	3.2	24.6	20.9	5.3	11.0	5.5	23.9	4.9	7.4	4.9	6.3	4.2	29.6	7.2	5.1	6.4	11.6	15.1	8.4	3.1	1.8	10.6	11.3	6.9	4.8	10.9	8.4	8.3	5.0	3.3	3.6	3.0	13.7	11.7	9.2	2.8	4.9	4.1	22.5	11.8	17.6	11.6	12.3	10.5	8.5	8.9	10.8	12.5	8.7	11.0	10.2	24.5	9.8	13.5	8.7	8.1	8.4	7.3	7.3	5.1	7.9	6.4	5.9	7.8	6.5	21.1	8.6	35.7	36.1	11.6	6.2	3.8	11.5	0.0	43.3	72.3	29.6	0.0	31.4	4.5	0.0	0.0	4.3	3.1	34.6	0.0	0.0	4.0	5.3	11.6	24.4	38.4	6.8	7.9	31.2	11.1	12.4	2.2	11.8	7.6	5.0	0.0	21.2	4.3	0.0	20.1	11.0	0.0	13.0	0.0	3.1	17.9	13.4	3.0	5.8	13.8	14.3	12.8
DLG4	"PSD-95, PSD95, SAP-90, SAP90"	ENSG00000132535	"Discs large MAGUK scaffold protein 4"	P78352	17	7189890-7219702	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 83.2"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 35.6;Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.9;hTERT-RPE1: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001999, CAB002000, HPA010122"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB001999: , CAB002000: , HPA010122: AB_1855169"	"unprognostic (7.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (8.82e-6)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.77e-3)"	5.5	16.0	58.3	7.5	73.3	4.1	4.5	47.4	83.2	9.7	4.1	5.4	4.3	4.7	13.8	5.0	5.0	9.2	10.7	8.9	58.7	24.2	3.3	3.1	6.0	4.2	14.4	53.9	12.8	4.6	11.5	15.1	8.7	14.8	7.3	3.8	3.1	6.3	12.5	3.6	4.0	4.4	10.7	11.3	7.8	5.7	10.1	17.0	1.7	5.8	0.0	3.5	7.0	4.2	0.0	1.6	0.0	0.9	0.0	1.6	0.6	0.2	7.4	18.5	6.2	7.1	10.5	0.5	9.7	8.5	7.3	7.0	0.3	3.0	1.3	4.3	8.4	0.9	0.7	1.0	3.9	3.6	9.6	1.9	5.5	13.3	0.9	6.0	0.1	30.9	11.6	0.4	6.2	6.3	28.1	8.6	7.7	2.2	4.9	10.9	0.2	4.2	3.3	2.6	0.2	0.5	7.6	0.7	0.7	5.3	0.2	7.6	6.0	0.2	0.4	1.1	3.3	4.4	3.5	10.5	17.6	8.5	3.5	5.1	0.8	0.5	0.7	13.2	3.5	5.4	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.1	1.6	0.0	0.6	58.3	73.3	47.4	71.2	58.7	24.2	14.4	53.9	14.8	17.0	0.0	1.0	3.7	1.7	2.4	35.6	3.1	2.5	1.4	2.3	3.5	96.2	0.4	0.0	0.7	1.5	5.0	0.3	0.0	0.2	0.4	6.2	1.4	6.9	1.5	3.3	19.1	14.5	5.5	10.2	0.9	6.6	5.5	3.3	1.8	0.7	6.0	0.3	0.0	9.6	0.0	58.6	0.0	2.3	6.5	1.9	1.6	0.5	0.5	0.6	0.7
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1286154-1300237	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"gallbladder: 10.0;intestine: 30.3;liver: 14.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 1.3;Cardiomyocytes: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.9;BEWO: 5.1;Hep G2: 9.5;NTERA-2: 5.5;REH: 7.3;SH-SY5Y: 17.2;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.2	0.1	1.5	3.4	2.2	0.2	0.1	1.5	2.0	0.1	10.7	2.0	0.0	12.0	0.2	0.1	0.4	0.1	10.0	0.1	1.0	1.6	0.3	14.2	0.1	0.1	1.2	0.5	0.1	0.1	0.1	0.3	0.2	1.1	0.1	2.3	1.9	0.1	0.2	0.2	0.1	30.3	0.2	0.9	0.2	0.6	0.6	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	1.7	0.0	0.0	5.1	0.2	0.0	0.0	0.0	3.6	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.1	2.2	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	5.5	2.4	0.0	7.3	0.6	0.1	0.0	0.1	0.0	17.2	0.2	0.0	0.1	0.7	0.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.2	1.5	2.0	1.0	1.6	1.2	0.5	1.1	0.7	0.0	0.0	0.0	0.0	1.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
EMCN	MUC14	ENSG00000164035	Endomucin	Q9ULC0	4	100395341-100880126	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"Endothelial cells: 203.6;Ito cells: 143.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005928	Approved				"Intracellular and membrane"	NA	NA					"HPA005928: AB_1078735"	"unprognostic (8.01e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (3.65e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.75e-2)"	26.3	10.8	3.1	6.2	7.5	0.1	24.0	3.8	6.8	26.4	9.7	1.4	13.1	3.5	28.2	19.7	16.3	10.4	16.4	31.5	4.2	3.9	45.5	4.6	25.1	5.3	5.4	3.5	12.9	3.3	8.3	10.5	0.4	6.7	17.1	4.3	19.8	5.8	16.5	16.8	6.1	5.5	20.4	9.1	1.9	5.5	7.3	3.5	1.0	28.1	20.9	2.5	23.5	21.7	0.2	0.1	1.6	0.4	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.0	26.5	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.6	0.2	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.7	1.2	0.4	0.1	0.0	0.0	3.1	7.5	3.8	6.8	4.2	3.9	5.4	3.5	6.7	3.5	6.0	8.9	0.9	0.4	14.7	0.0	9.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	203.6	0.0	0.0	0.0	0.0	6.1	0.8	0.0	0.6	0.2	0.0	0.0	143.6	8.2	0.9	1.1	1.7	15.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	13.2	0.2	0.2	12.8	0.2	0.0	0.0	0.6
EPDR1	"EPDR, MERP-1, MERP1, UCC1"	ENSG00000086289	"Ependymin related 1"	Q9UM22	7	37683843-37951941	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.6;skeletal muscle: 55.8"	"Cell type enhanced"	"Detected in many"	10	"Peritubular cells: 93.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.4;NK-cells: 1.9;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"U-937: 36.5;WM-115: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026298, HPA072321"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB026298: AB_425991, HPA072321: "	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (4.44e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.00e-4)"	11.2	23.3	21.9	2.2	16.0	2.1	4.8	30.5	30.5	21.5	4.9	7.5	1.6	7.0	22.4	7.4	4.6	15.5	5.3	13.9	20.3	34.3	8.6	6.0	13.8	2.9	25.3	18.8	18.6	5.7	5.8	4.6	2.8	57.6	18.5	4.7	8.0	7.3	22.6	55.8	1.5	6.8	16.4	13.9	8.3	3.4	6.7	5.2	5.2	16.1	7.7	1.7	4.7	8.5	0.0	5.4	0.2	0.3	1.9	1.9	0.4	0.0	23.8	2.0	0.0	18.8	6.8	0.0	1.8	0.0	0.9	2.9	2.3	1.5	0.0	27.0	26.5	28.2	0.0	0.5	0.2	0.0	0.0	3.0	10.4	3.2	14.5	0.1	8.6	0.0	11.4	0.0	6.7	0.1	6.4	0.0	10.6	0.0	7.9	15.9	1.5	3.3	7.3	7.4	0.0	3.5	10.6	6.9	9.1	14.7	5.8	2.6	9.2	0.0	1.2	8.3	5.1	0.0	6.1	0.0	5.2	8.9	14.4	11.0	10.6	4.5	0.1	24.1	36.5	35.6	0.0	0.3	0.2	1.7	0.3	0.0	0.0	0.0	1.9	1.0	0.0	0.1	1.1	0.2	1.9	0.0	5.4	0.0	0.4	21.9	16.0	30.5	30.5	20.3	34.3	25.3	18.8	57.6	5.2	29.8	37.4	1.3	9.3	1.1	5.1	16.9	7.6	5.3	20.5	1.8	0.0	0.5	14.9	8.1	0.2	1.4	6.8	0.0	7.1	0.1	8.4	9.6	2.3	11.9	3.1	11.1	3.5	6.7	1.3	0.9	26.2	2.2	27.0	24.4	4.7	10.5	13.6	5.3	93.0	11.3	5.3	6.5	12.8	0.0	0.6	0.3	0.1	0.5	4.7	2.0
EPHB6	HEP	ENSG00000106123	"EPH receptor B6"		7	142855061-142871094	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 30.1;lymphoid tissue: 26.7;skin 1: 32.1"	"Cell type enhanced"	"Detected in many"	16	"Muller glia cells: 270.3;Sertoli cells: 103.5;Suprabasal keratinocytes: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"MOLT-4: 18.2;RT4: 34.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035784			Uncertain	"Nuclear speckles"	"Intracellular and membrane"	NA	NA			"Nuclear speckles"		"HPA035784: AB_2674781"	"unprognostic (1.90e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.08e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (2.53e-3)"	"unprognostic (3.15e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (4.68e-5)"	3.3	1.7	7.4	3.0	30.1	3.3	2.6	3.1	29.3	9.0	1.5	0.8	3.4	0.9	3.0	4.5	7.5	6.4	2.8	1.4	5.4	4.2	1.7	1.3	2.4	3.6	3.3	14.4	3.9	7.8	0.8	1.1	2.9	1.7	6.8	0.9	1.5	4.7	8.1	1.8	32.1	1.6	2.0	1.4	2.6	3.3	3.8	3.6	26.7	6.6	2.5	3.3	5.1	6.5	4.1	0.9	1.0	1.3	0.0	3.1	1.4	0.1	0.0	0.0	0.4	2.0	1.0	0.0	0.2	0.4	0.1	0.0	0.6	1.3	0.0	0.0	0.1	0.0	4.5	0.2	0.0	0.0	1.0	0.1	0.3	0.0	0.2	0.6	4.3	0.2	0.3	0.0	1.2	0.0	0.0	0.2	3.0	0.6	0.0	0.0	0.0	18.2	3.3	3.1	0.7	1.3	0.4	0.0	0.0	0.0	34.6	0.0	0.0	1.2	0.9	0.0	0.4	2.9	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	1.3	0.5	0.1	1.0	0.6	4.1	2.5	1.4	0.9	1.0	3.1	1.5	1.0	0.0	0.4	0.1	1.9	1.4	7.4	30.1	3.1	29.3	5.4	4.2	3.3	14.4	1.7	3.6	3.0	1.7	4.5	25.1	48.3	4.3	2.0	38.2	6.7	10.3	7.0	2.0	0.2	5.0	25.0	0.7	1.4	0.0	0.0	5.7	0.0	12.3	11.7	0.0	1.8	4.3	0.0	1.7	1.3	11.5	4.0	27.9	5.3	11.8	0.0	0.0	270.3	19.6	0.0	9.2	0.4	5.0	103.5	18.4	0.2	8.3	103.5	0.2	8.3	0.0	23.4
EQTN	"AFAF, C9orf11, equatorin, SPACA8"	ENSG00000120160	Equatorin	Q9NQ60	9	27284659-27297139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 39.9"	"Cell type enriched"	"Detected in some"	26	"Early spermatids: 558.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;BEWO: 2.2;HaCaT: 1.2;HAP1: 1.3;HSkMC: 1.8;K-562: 1.3;RT4: 1.1"									"HPA015089, HPA015504"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA015089: AB_1845795, HPA015504: AB_2067598"	"unprognostic (7.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.34e-3)"	"unprognostic (4.41e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.67e-2)"		"unprognostic (1.14e-1)"	"unprognostic (4.59e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.1	0.1	39.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	1.3	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	1.1	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	558.1	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.8	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.1	1.9	0.3	0.1	0.0	0.2	0.1
ERLEC1	"C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB"	ENSG00000068912	"Endoplasmic reticulum lectin 1"	Q96DZ1	2	53787044-53818819	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031501, HPA031502, HPA031503"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA031501: AB_10600104, HPA031502: AB_10602174, HPA031503: AB_10670425"	"unprognostic (1.27e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.92e-2)"	21.4	30.0	20.8	15.3	27.7	14.9	26.2	16.7	40.0	38.2	23.6	18.2	48.2	19.4	26.0	52.2	16.9	21.5	21.9	28.9	22.9	30.7	20.7	40.0	24.7	22.2	23.4	26.9	23.2	69.0	26.3	48.8	42.9	29.3	40.5	27.1	19.3	31.0	53.8	20.2	14.4	19.3	20.5	24.3	21.8	28.3	21.0	15.5	17.9	39.0	13.2	20.7	26.5	19.8	21.1	22.5	32.0	17.3	24.3	27.1	21.0	12.2	13.7	13.6	8.3	38.8	35.3	19.9	30.2	33.1	15.1	16.0	9.0	16.8	8.6	28.9	31.8	26.6	8.9	8.8	12.7	19.4	19.2	11.1	10.6	9.4	27.4	26.6	17.5	19.6	22.1	21.3	15.9	26.0	30.8	17.6	8.5	11.2	35.4	22.4	10.1	7.9	14.0	10.4	19.8	8.8	7.2	16.3	23.9	17.9	11.7	8.1	14.1	10.9	24.2	18.6	16.2	11.5	13.5	18.8	16.7	14.6	13.4	17.8	52.1	34.0	4.8	27.4	10.6	19.5	32.0	14.3	16.6	24.9	15.0	27.1	21.1	21.9	23.5	15.5	16.0	20.8	23.8	5.6	24.3	17.3	22.5	19.9	21.0	20.8	27.7	16.7	40.0	22.9	30.7	23.4	26.9	29.3	15.5	83.4	94.3	32.0	36.7	22.2	76.4	75.4	61.1	111.1	68.2	62.8	29.5	89.5	28.2	65.2	121.9	56.4	29.2	23.3	101.3	87.9	88.5	101.8	71.7	82.5	53.0	90.6	52.9	71.8	37.2	85.0	81.7	39.0	75.9	68.5	97.0	72.1	77.7	45.6	79.2	35.3	50.5	51.8	53.6	120.2	65.3	29.2	153.6	48.1	48.8	43.9
ERP27	"C12orf46, ERp27, FLJ32115, PDIA8"	ENSG00000139055	"Endoplasmic reticulum protein 27"	Q96DN0	12	14914035-14939082	"Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 182.8"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 38.7;Collecting duct cells: 38.4;Distal tubular cells: 139.3;Exocrine glandular cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"RT4: 45.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039636, HPA052851"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA039636: AB_10795403, HPA052851: AB_2681972"	"unprognostic (9.02e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.45e-2)"	0.1	0.1	0.0	0.6	0.4	0.4	0.8	0.0	0.2	0.7	0.1	0.1	1.0	0.0	0.1	7.2	1.1	9.1	0.0	0.6	0.0	0.0	11.6	0.1	5.7	0.4	0.0	0.0	1.8	182.8	0.1	1.3	7.7	0.3	4.2	0.1	1.0	5.1	0.5	0.0	0.4	0.5	0.0	0.5	0.9	0.5	0.4	0.0	0.1	36.0	1.9	1.0	3.6	0.1	2.1	2.9	4.7	5.2	1.4	8.1	3.1	1.5	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	9.1	0.6	0.9	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	1.8	0.0	7.1	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.4	0.0	3.2	1.4	2.2	0.0	0.1	0.0	0.7	0.0	0.1	0.3	45.3	0.0	0.0	0.0	7.5	0.0	0.8	0.3	1.7	1.2	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	3.4	4.2	4.7	6.3	4.8	8.1	2.1	5.6	4.2	2.9	2.0	7.2	7.6	2.0	1.4	5.2	0.3	6.8	3.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	38.7	14.4	0.0	2.4	0.3	0.0	0.2	0.0	30.8	30.7	38.4	0.0	3.7	139.3	6.7	0.0	0.0	0.0	0.0	34.4	9.6	0.3	0.8	1.1	0.0	1.3	0.0	1.7	0.0	1.5	0.0	1.7	1.2	0.0	1.8	0.0	2.1	31.0	3.6	0.0	4.8	0.0	0.0	0.7	0.0	0.0	0.4	0.7	3.3	0.2	13.1
ERP29	"C12orf8, ERp28, ERp29, ERp31, PDI-DB, PDIA9"	ENSG00000089248	"Endoplasmic reticulum protein 29"	P30040	12	112013316-112023451	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039363, HPA039456"	Enhanced		Uncertain	Nucleoplasm,Microtubules	"Intracellular and membrane"	NA	NA		4900000	Microtubules	Nucleoplasm	"HPA039363: AB_10673422, HPA039456: AB_10672963"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.43e-5)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.26e-2)"	19.1	37.1	20.2	32.4	19.8	55.1	39.7	29.5	30.8	23.3	45.8	16.8	66.5	32.0	23.1	38.3	30.6	24.6	39.0	24.2	18.6	24.9	34.9	67.5	33.8	61.2	22.5	19.7	28.5	111.2	33.3	35.9	46.1	23.4	30.9	29.6	23.2	61.5	58.8	13.0	37.0	35.6	27.2	21.4	41.6	39.5	31.7	16.3	35.8	53.8	28.3	37.6	24.4	30.9	49.2	83.9	60.6	43.3	14.8	37.7	46.6	20.3	19.9	14.6	28.4	55.4	22.2	31.2	20.0	24.6	16.3	21.0	30.9	23.7	21.8	15.7	34.8	17.3	25.4	27.2	25.9	13.3	18.6	15.2	24.7	22.6	34.7	37.5	60.3	24.2	31.6	34.0	26.3	30.7	43.4	22.6	23.4	28.1	40.7	12.3	23.6	19.7	109.7	23.8	72.3	15.0	16.4	17.8	70.1	33.4	31.4	13.3	17.9	24.9	20.7	60.1	28.9	25.9	83.2	16.8	13.8	21.4	13.1	14.8	45.2	51.8	18.4	23.3	38.1	10.7	14.8	43.3	60.6	25.5	32.0	27.6	47.9	33.8	31.6	41.9	49.2	37.7	30.7	8.7	14.8	29.0	83.9	31.5	46.6	20.2	19.8	29.5	30.8	18.6	24.9	22.5	19.7	23.4	16.3	77.4	153.2	311.9	160.1	125.5	118.0	81.5	201.2	108.4	83.0	176.2	104.1	416.0	79.6	181.9	5.0	100.2	238.7	46.7	186.3	318.9	107.4	199.9	87.6	289.4	332.4	76.3	189.9	117.9	288.1	11.5	119.3	206.5	160.3	143.3	207.8	130.1	146.6	273.5	100.4	213.5	151.3	51.8	107.2	40.1	200.2	140.8	369.3	228.4	248.2	181.2
FAM19A2	"TAFA-2, TAFA2"	ENSG00000198673	"Family with sequence similarity 19 member A2, C-C motif chemokine like"	Q8N3H0	12	61708259-62279150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.7;brain: 25.8"	"Group enriched"	"Detected in many"	7	"Early spermatids: 155.9;Late spermatids: 77.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 17.7;neutrophil: 9.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 17.7"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 9.8;SCLC-21H: 3.7;WM-115: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (3.89e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.83e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.16e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.22e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.28e-1)"	1.7	1.7	16.7	1.3	10.1	3.8	1.5	1.3	25.8	3.1	1.7	1.1	0.0	1.8	1.9	1.0	0.9	1.3	1.2	0.7	13.1	7.0	0.9	0.8	0.9	1.4	5.8	12.7	4.3	1.8	0.9	5.7	4.9	9.9	2.4	1.5	0.2	1.2	11.1	0.6	1.3	1.3	1.0	2.1	1.8	1.2	5.3	0.0	0.0	1.0	0.0	0.7	1.5	2.5	0.4	0.4	17.7	1.9	0.4	2.8	0.4	0.2	0.0	1.9	0.4	1.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.3	0.8	0.1	0.0	0.3	0.3	0.3	0.7	0.4	1.3	3.0	0.0	0.3	1.4	2.2	0.1	9.8	0.0	0.0	0.3	0.0	2.7	1.9	1.1	0.0	0.0	2.5	0.5	0.8	0.3	0.0	0.5	0.0	0.0	0.0	0.0	3.7	0.3	0.8	0.0	0.6	0.7	0.4	0.4	0.1	0.4	1.1	0.2	0.5	0.8	0.9	0.5	0.0	0.6	8.1	17.7	1.9	3.8	0.3	0.6	0.1	0.4	0.8	0.4	0.2	0.2	0.7	0.2	9.2	0.4	0.2	0.4	2.8	0.4	16.7	10.1	1.3	25.8	13.1	7.0	5.8	12.7	9.9	0.0	0.0	0.0	3.7	1.0	1.6	1.7	2.5	0.0	4.0	0.0	0.0	2.0	1.3	5.0	0.5	155.9	1.6	1.5	0.0	1.0	1.1	3.2	0.6	1.1	2.4	1.6	0.0	2.4	0.6	10.4	77.3	3.7	1.2	1.7	0.0	1.5	2.5	0.9	1.9	0.4	1.3	1.7	6.5	0.8	17.3	5.6	0.5	2.2	2.5	1.7	1.4
FAM24B	"AC073585.2, MGC45962"	ENSG00000213185	"Family with sequence similarity 24 member B"	Q8N5W8	10	122849078-122879641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 24.5"	"Cell type enriched"	"Detected in many"	4	"Distal tubular cells: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"hTERT-HME1: 43.9;LHCN-M2: 55.2;TIME: 17.8"									HPA052490	Supported				"Intracellular and membrane"	NA	NA					"HPA052490: AB_2681851"	"unprognostic (4.03e-2)"	"unprognostic (4.27e-2)"	"unprognostic (3.13e-3)"	"unprognostic (8.40e-5)"	"unprognostic (2.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.42e-7)"	"unprognostic (2.99e-1)"	"unprognostic (7.06e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.81e-3)"	2.2	2.4	6.9	13.5	6.4	3.9	4.0	6.7	7.4	2.3	4.1	5.1	2.2	2.8	3.4	3.8	3.1	3.8	3.7	1.5	5.8	5.9	24.5	1.7	3.7	6.5	6.9	3.4	5.0	12.5	2.6	11.4	1.1	6.6	3.2	5.9	1.9	2.7	2.6	1.7	4.5	4.1	3.0	6.8	4.7	4.4	11.4	5.6	9.8	2.9	2.0	6.3	2.4	2.5	5.9	11.3	3.0	2.2	2.7	5.3	1.9	2.2	3.8	0.7	0.0	0.4	1.1	1.0	3.3	3.3	1.5	1.1	3.8	4.2	0.8	1.1	1.8	0.4	1.1	0.0	1.7	3.9	4.1	1.5	6.3	3.6	2.0	3.4	0.0	3.7	1.3	0.2	3.1	43.9	0.2	3.4	4.7	2.7	1.5	55.2	2.1	3.9	3.6	1.3	2.3	3.9	0.0	5.6	0.8	2.5	1.7	2.5	1.0	1.5	0.7	4.5	2.2	1.2	3.8	17.8	0.3	1.7	1.4	0.3	1.8	2.0	5.2	2.9	6.1	0.0	3.0	2.2	1.4	2.6	1.9	0.9	5.9	5.0	3.4	3.0	3.7	5.3	3.4	1.4	2.7	1.8	11.3	4.9	1.9	6.9	6.4	6.7	7.4	5.8	5.9	6.9	3.4	6.6	5.6	0.0	0.3	6.9	1.3	6.0	3.6	0.2	2.5	0.0	0.0	8.7	0.0	0.1	43.1	3.7	1.6	0.7	1.5	0.0	6.2	0.1	0.8	1.8	9.2	0.5	1.1	1.6	4.6	1.3	3.2	1.6	3.4	1.9	1.7	2.8	2.8	2.3	7.6	3.5	3.9	1.4	4.5	0.0	2.1	9.8	4.9	4.6	0.0	8.6	2.8	1.0
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276547	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.7;skeletal muscle: 32.3"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 57.8;Early spermatids: 73.4;Late spermatids: 101.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.5;HEL: 17.4;HL-60: 17.2;NB-4: 27.2;THP-1: 24.3;U-937: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	4.9	1.5	2.9	9.3	4.6	12.4	2.5	1.1	4.3	1.0	1.6	3.4	0.8	1.8	1.2	1.1	1.1	1.1	2.0	19.2	3.8	2.0	2.1	2.5	8.0	18.4	4.3	1.0	1.8	0.8	0.8	1.0	5.8	3.2	1.3	1.1	5.4	2.7	0.7	32.3	0.8	6.1	1.2	3.6	15.9	2.3	20.1	2.4	23.7	1.5	1.8	15.0	3.1	0.8	14.4	5.2	14.5	10.9	2.5	10.5	6.9	0.3	0.1	1.1	2.6	0.8	0.2	18.5	0.2	0.1	0.2	0.1	0.1	0.1	7.7	0.1	0.1	0.3	0.0	7.4	0.1	0.0	1.9	0.6	17.4	0.2	0.1	0.3	17.2	0.8	0.2	0.4	0.0	0.0	0.2	10.3	5.0	6.1	2.2	0.2	2.6	0.7	27.2	1.2	0.1	0.3	1.8	1.1	10.7	0.1	0.0	0.7	0.9	1.0	0.3	1.0	0.4	0.6	24.3	0.3	1.1	1.2	0.6	0.0	1.6	0.8	4.4	0.1	16.3	0.2	0.4	8.6	14.5	8.6	10.9	6.8	12.5	8.3	9.3	5.2	14.4	10.5	8.7	8.8	2.5	8.1	2.4	8.2	6.9	2.9	4.6	1.1	4.3	3.8	2.0	4.3	1.0	3.2	2.4	0.0	1.0	24.3	0.0	0.8	57.8	12.8	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	73.4	3.1	0.0	0.0	0.0	28.2	1.3	0.0	1.1	0.0	22.1	0.0	0.0	3.7	14.3	101.2	4.6	10.1	1.7	5.4	0.0	0.8	0.2	0.0	3.2	0.0	1.7	0.0	0.5	1.2	0.4	0.6	1.1	14.4	0.0	0.1
FCRLB	"FCRL2, FCRLM2, FCRLY, FLJ31052, FREB-2"	ENSG00000162746	"Fc receptor like B"	Q6BAA4	1	161721563-161728143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.9;lymphoid tissue: 5.0"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 6.7;Proximal tubular cells: 10.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 7.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"basophil: 8.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.1;Daudi: 7.4;fHDF/TERT166: 10.9;HMC-1: 9.4;PC-3: 5.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB026139	Uncertain		Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"CAB026139: "	"unprognostic (1.87e-1)"	"unprognostic (1.20e-4)"	"unprognostic (5.77e-3)"	"unprognostic (7.49e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.14e-2)"	0.5	0.2	0.2	3.4	0.3	0.0	0.3	1.0	0.8	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	1.4	0.6	0.3	2.4	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	1.2	0.0	0.2	0.7	2.7	0.2	0.3	0.8	0.2	0.4	1.5	0.2	0.2	0.2	0.2	0.3	0.2	5.0	0.8	0.2	4.9	0.6	8.9	0.2	5.3	2.7	0.6	0.7	0.1	0.0	0.3	0.5	0.8	0.0	4.6	6.1	1.5	1.5	0.1	0.2	7.4	0.2	10.9	0.3	0.1	0.2	0.4	4.0	0.1	0.3	0.2	0.1	0.2	0.2	0.0	9.4	1.4	0.0	2.7	0.2	0.5	1.3	0.0	0.4	0.3	0.2	0.4	0.0	2.6	0.2	0.0	5.5	0.0	0.5	0.3	0.2	0.2	0.0	0.0	0.0	0.2	2.3	0.3	0.0	0.0	0.8	1.6	0.7	1.7	0.8	0.0	0.0	2.9	3.3	0.4	0.8	8.9	0.1	2.4	2.7	0.1	1.0	4.6	1.6	1.5	0.6	4.9	0.8	1.2	1.5	5.3	0.2	0.0	0.0	0.6	0.2	0.3	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	2.2	1.0	1.0	0.0	1.6	0.0	0.0	0.0	3.5	0.0	1.8	5.0	1.1	0.1	1.1	0.0	0.0	1.0	4.6	0.7	0.4	0.0	0.8	1.3	0.0	1.2	6.7	2.4	0.0	0.0	2.3	1.7	0.0	0.0	3.1	0.9	0.0	0.4	10.5	0.4	0.0	1.4	2.7	1.2	0.4	0.7	2.2	0.0	0.7
FIBIN	MGC24932	ENSG00000176971	"Fin bud initiation factor homolog (zebrafish)"	Q8TAL6	11	26994184-26996121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 58.9"	"Cell type enhanced"	"Detected in many"	15	"Fibroblasts: 70.5;Leydig cells: 35.1;Muller glia cells: 22.1;Peritubular cells: 32.9"	"Cancer enhanced"	"Detected in all"		"glioma: 48.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 32.7;ASC TERT1: 20.8;fHDF/TERT166: 10.1;HHSteC: 42.4;HSkMC: 43.9;hTCEpi: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040120	Uncertain				"Intracellular and membrane"	NA	NA					"HPA040120: AB_10795243"	"unprognostic (1.72e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (1.93e-5)"	"prognostic unfavorable (6.72e-4)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (1.02e-2)"	17.1	4.9	7.5	6.7	6.2	0.3	14.9	2.1	12.0	22.4	11.0	8.4	3.3	2.3	11.6	8.7	17.9	13.2	7.4	17.2	8.2	3.8	11.7	1.9	15.6	2.6	8.3	6.1	15.7	3.7	0.4	1.1	11.7	8.0	16.8	2.8	16.5	8.4	58.9	10.5	7.6	5.0	15.6	7.9	12.0	9.9	5.0	5.5	0.3	12.6	7.6	1.9	9.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	32.7	20.8	0.0	1.0	2.7	0.1	0.4	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.4	0.0	0.0	43.9	11.5	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	6.2	2.1	6.4	8.2	3.8	8.3	6.1	8.0	5.5	0.0	0.0	0.0	2.0	6.0	0.4	1.2	5.1	0.0	0.0	10.4	0.0	0.7	10.0	0.6	0.0	0.3	0.0	0.0	0.0	0.6	70.5	0.1	0.0	0.6	1.6	0.0	0.0	10.4	0.0	0.0	35.1	1.5	6.8	0.0	0.0	22.1	0.1	0.0	32.9	3.8	0.3	0.0	4.4	0.0	0.2	4.4	1.6	0.0	0.0	0.0
FJX1	"FLJ22416, FLJ25593"	ENSG00000179431	"Four jointed box 1"	Q86VR8	11	35618419-35620868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 15.5;Cytotrophoblasts: 18.7;Extravillous trophoblasts: 14.0;Ito cells: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059220	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA059220: AB_2683950"	"unprognostic (8.99e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (9.56e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.39e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (9.24e-9)"	"unprognostic (1.64e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.35e-2)"	"prognostic unfavorable (6.56e-4)"	6.0	3.5	7.8	3.5	10.3	0.7	3.6	6.6	25.4	8.8	1.4	7.9	0.0	1.1	10.1	3.4	3.1	6.1	4.5	2.4	8.0	4.9	3.8	4.9	2.2	2.3	5.7	5.7	12.2	17.0	1.7	1.8	6.6	7.7	4.1	1.1	2.7	2.6	4.7	1.1	10.3	1.1	3.4	5.1	7.8	1.7	1.2	3.3	1.7	2.2	3.0	3.4	3.7	2.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	9.8	4.9	5.2	1.6	1.8	5.8	1.6	11.1	7.5	10.6	7.7	6.2	3.1	0.0	2.5	4.3	22.0	10.5	1.8	18.3	9.1	0.1	14.5	0.9	1.9	0.2	4.4	1.1	0.0	2.1	14.0	5.5	16.9	1.7	4.8	0.5	5.2	0.0	10.2	2.3	0.3	0.0	7.2	0.0	14.7	0.6	11.7	2.2	8.1	12.2	5.0	2.8	1.2	0.9	3.1	4.0	21.1	0.2	9.4	8.5	15.7	1.6	26.1	0.0	0.0	0.0	15.2	0.4	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	10.3	6.6	12.3	8.0	4.9	5.7	5.7	7.7	3.3	0.0	0.0	0.0	9.3	15.5	0.4	1.0	0.0	4.0	3.4	0.0	11.8	18.7	1.7	7.9	0.0	5.6	0.0	0.0	0.2	14.0	4.5	1.5	0.0	0.0	3.1	0.0	0.0	16.0	0.6	0.0	0.6	1.5	0.0	0.0	0.0	10.3	1.1	0.0	0.7	6.7	0.3	0.0	5.3	0.4	1.1	8.3	10.0	0.0	0.0	2.6
FNDC4	"FLJ22362, FRCP1"	ENSG00000115226	"Fibronectin type III domain containing 4"	Q9H6D8	2	27491883-27495245	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.9;liver: 57.6"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 165.4;Hepatocytes: 113.4;Late spermatids: 388.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.0;ASC diff: 17.4;HUVEC TERT2: 20.9;SH-SY5Y: 16.3;TIME: 19.0;U-87 MG: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051804, HPA063581"	Uncertain		Approved	Nucleoplasm,Aggresome,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Aggresome, Cytosol"	"HPA051804: AB_2681617, HPA063581: AB_2685048"	"unprognostic (2.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (6.11e-4)"	18.5	45.9	13.4	2.7	13.7	0.7	9.1	10.8	29.5	3.8	2.0	4.0	0.5	1.5	2.8	2.8	11.8	1.5	10.0	3.1	15.6	8.5	2.3	57.6	2.0	1.4	12.0	8.6	16.5	4.6	18.6	2.8	2.5	22.2	6.3	2.1	1.9	2.1	3.3	1.3	2.4	1.4	4.7	5.4	3.5	3.2	10.2	3.8	0.0	1.8	0.7	2.7	4.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	17.0	17.4	10.7	0.1	3.9	7.8	2.8	2.5	0.7	0.2	0.0	0.4	12.3	3.7	0.0	6.5	2.3	2.5	0.0	1.0	0.8	0.0	8.7	6.5	0.0	0.1	9.1	1.1	4.9	1.0	12.9	20.9	0.0	0.9	0.0	10.3	0.0	0.0	0.0	6.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.1	16.3	0.1	0.0	0.1	1.3	0.0	0.0	19.0	2.7	1.2	1.0	3.0	0.0	0.0	0.0	14.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.7	10.8	29.5	15.6	8.5	12.0	8.6	22.2	3.8	0.0	0.3	0.0	2.8	3.1	8.2	2.5	10.2	0.0	0.0	0.0	3.9	0.1	3.3	68.5	165.4	5.8	0.0	0.0	41.6	0.1	8.1	14.7	5.7	113.4	0.5	0.0	0.0	6.2	1.3	388.8	14.4	0.6	3.3	1.8	0.0	12.3	60.5	0.0	11.0	0.2	11.8	0.0	11.3	4.9	3.6	2.0	0.0	0.0	0.0	1.0
FP565260.6		ENSG00000280071			21	5079294-5128425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 47.1"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 3.4;Collecting duct cells: 3.5;Hofbauer cells: 7.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA018517	Uncertain		Approved	Centrosome,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Centrosome	"HPA018517: AB_2669899"	"unprognostic (4.87e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.67e-4)"	"unprognostic (1.88e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.25e-1)"	"unprognostic (2.84e-2)"	3.9	6.7	2.8	2.0	6.6	1.3	3.4	8.2	7.0	3.0	5.7	5.2	2.5	5.7	2.2	5.0	3.9	3.3	2.8	15.5	3.2		12.9	14.4	4.8	10.5	6.7	4.7	5.6	2.7	4.0	0.9	6.4	4.2	3.0	4.7	4.4	4.9	2.3	17.1	1.3	3.6	2.4	3.0	2.6	2.2	1.4	3.9	1.1	4.2	11.1	2.4	3.9	2.0	47.1	43.8	19.9	46.4	37.1	41.4	46.1	13.2	12.5	13.9	24.4	13.3	12.7	6.8	0.0	2.6	0.8	1.2	2.0	13.6	1.2	15.4	16.3	13.8	9.5	20.0	10.4	1.2	9.1	8.9	51.5	13.3	12.7	12.1	22.1	9.8	20.3	17.6	8.0	14.7	11.9	16.1	17.5	20.2	15.3	9.6	27.8	22.0	24.2	27.2	37.2	20.4	45.2	10.5	48.2	18.2	12.3	14.1	23.7	18.4	34.7	12.9	7.5	35.7	31.1	5.7	8.0	9.9	0.8	8.0	20.7	21.1	8.7	16.4	45.8	6.7	19.9	33.6	16.9	31.6	36.0	31.6	43.9	41.4	32.9	43.8	47.1	39.7	30.2	6.8	37.1	46.4	28.9	40.0	46.1											0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	3.5	0.0	2.8	0.0	1.4	0.0	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
FRAS1	"FLJ14927, FLJ22031, KIAA1500"	ENSG00000138759	"Fraser extracellular matrix complex subunit 1"	Q86XX4	4	78057570-78544269	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 17.9"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 29.8;Cholangiocytes: 22.9;Collecting duct cells: 27.9;Cytotrophoblasts: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 23.4;Hep G2: 14.1;RH-30: 13.5;SiHa: 14.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051601	Approved				"Intracellular and membrane"	NA	NA					"HPA051601: AB_2681547"	"unprognostic (1.33e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (4.69e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.09e-2)"	2.0	1.2	6.2	5.0	10.1	0.1	1.3	0.9	6.4	3.6	2.7	0.7	0.1	0.6	3.3	3.1	2.0	1.5	4.1	2.6	2.3	2.3	11.6	0.8	5.2	0.3	1.2	1.8	0.9	7.9	0.7	5.5	8.3	3.8	3.2	2.2	1.3	1.8	1.3	3.7	2.1	1.4	2.2	0.9	1.1	1.6	1.4	1.0	2.1	17.9	1.9	0.4	1.3	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.9	4.4	1.8	0.0	4.8	2.0	3.2	0.7	2.7	0.4	0.2	3.5	6.5	0.0	5.5	23.4	0.0	0.9	2.5	1.4	0.1	0.0	2.5	2.7	5.3	14.1	0.5	0.0	0.0	9.7	1.5	0.0	3.5	3.7	0.1	0.2	0.0	0.0	2.7	0.1	0.1	0.0	5.7	2.3	0.9	0.0	13.5	0.0	5.9	6.4	3.3	6.5	14.1	4.5	0.8	8.6	0.0	0.0	0.0	0.0	3.1	1.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	10.1	0.9	6.4	2.3	2.3	1.2	1.8	3.8	1.0	29.8	0.0	0.0	2.3	1.6	9.0	6.9	22.9	1.4	14.8	27.9	0.0	22.8	3.3	4.7	1.9	2.1	0.4	0.0	1.6	1.0	5.4	1.4	0.0	0.0	3.9	0.0	1.2	0.6	0.0	2.0	0.6	0.3	1.7	0.0	1.1	0.3	1.9	0.0	0.0	3.9	2.6	0.0	3.2	0.0	1.3	1.1	13.0	0.0	1.0	0.2
GCSH		ENSG00000140905	"Glycine cleavage system protein H"	P23434	16	81081938-81096425	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.9"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 501.6;Extravillous trophoblasts: 1237.6;Proximal tubular cells: 489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041368, HPA057079"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA041368: AB_10804001, HPA057079: "	"unprognostic (4.09e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.55e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (6.26e-6)"	"unprognostic (1.12e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.47e-2)"	10.9	10.0	28.9	3.7	26.8	3.0	11.4	8.1	21.8	9.9	6.4	15.0	14.2	3.8	9.4	35.9	6.0	10.4	6.3	11.7	23.5	20.6	37.3	55.9	4.0	5.8	30.8	15.8	8.9	10.2	19.4	7.2	12.9	18.7	9.9	7.0	10.4	9.4	9.3	18.1	4.3	3.1	6.9	27.6	2.6	5.2	3.5	17.9	6.7	48.7	5.9	4.8	6.6	4.9	4.4	12.2	2.8	2.6	7.9	7.3	2.9	18.1	8.0	25.3	11.0	12.4	9.6	51.7	10.6	7.9	12.9	6.3	10.7	17.0	4.8	9.6	4.6	9.8	9.3	19.3	10.7	21.6	1.3	25.2	6.2	10.7	33.0	14.1	20.0	7.2	9.8	14.4	8.0	16.5	4.0	6.5	13.5	24.0	1.0	12.8	19.2	13.0	40.6	33.4	14.6	16.8	20.4	13.3	7.2	29.2	16.7	13.1	13.6	15.2	9.9	20.0	20.4	14.5	9.6	5.7	8.4	14.7	13.3	10.9	4.1	8.7	29.0	5.6	12.0	6.7	2.8	1.7	1.7	3.4	2.6	5.7	4.4	3.3	4.9	4.5	3.3	5.8	7.3	2.2	7.9	2.0	12.2	2.6	2.9	28.9	26.8	8.1	21.8	23.5	20.6	30.8	15.8	18.7	17.9	3.0	5.1	31.8	74.7	25.8	44.4	11.8	33.1	20.1	13.6	76.8	35.3	501.6	250.4	57.2	25.7	29.8	9.8	0.0	37.0	1237.6	66.3	92.3	36.8	317.5	102.2	36.5	25.3	31.3	17.6	15.2	130.3	25.7	81.0	24.4	29.9	130.3	38.6	14.0	132.6	489.6	42.3	32.3	58.7	20.0	68.6	23.7	191.3	21.0	48.6	56.2
GHDC	LGP1	ENSG00000167925	"GH3 domain containing"	Q8N2G8	17	42188799-42194532	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031650	Uncertain				"Intracellular and membrane"	NA	NA					"HPA031650: AB_10601014"	"unprognostic (2.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.21e-4)"	"prognostic unfavorable (6.81e-5)"	"unprognostic (5.13e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (2.08e-1)"	"unprognostic (7.93e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-2)"	14.8	22.4	6.6	10.3	8.3	9.8	10.2	11.5	12.2	12.6	13.7	13.0	28.4	15.1	10.5	11.7	10.2	10.8	15.5	9.2	6.5	9.4	21.5	20.0	10.3	14.8	11.8	5.9	15.7	17.2	10.9	11.5	10.1	10.0	14.5	5.2	15.9	22.4	17.2	5.5	6.1	17.2	8.8	8.4	21.6	13.3	8.4	8.0	8.5	30.0	6.5	12.7	10.6	8.8	7.7	5.3	3.3	7.3	2.1	4.7	4.0	3.2	11.6	0.8	9.2	3.1	2.8	7.3	4.4	3.5	2.3	2.9	3.7	15.8	5.0	15.9	4.0	2.7	0.3	2.6	0.1	0.5	8.1	9.4	7.5	5.1	7.7	8.2	6.0	32.2	4.2	2.4	6.2	1.9	2.8	3.5	3.1	7.2	22.6	1.1	4.0	3.8	11.8	2.0	12.3	0.0	3.8	4.3	21.4	6.1	2.6	1.8	6.3	0.1	20.8	14.8	0.2	14.3	9.6	3.0	10.7	4.3	9.3	2.0	17.0	13.2	3.3	9.0	7.6	4.3	1.4	5.9	3.3	4.7	5.9	2.2	5.3	3.2	4.7	5.3	7.7	3.3	3.6	3.3	2.1	7.3	4.7	2.8	4.0	6.6	8.3	11.5	12.2	6.5	9.4	11.8	5.9	10.0	8.0	0.0	8.1	7.5	6.8	2.6	7.5	1.6	17.8	10.7	4.5	15.7	5.9	11.0	3.3	11.0	0.8	9.0	7.4	0.0	16.6	9.9	8.7	8.4	12.7	14.8	23.9	7.9	13.2	25.8	21.3	1.1	10.6	7.6	8.5	1.8	8.3	17.3	10.0	3.5	13.1	15.0	4.0	0.0	3.9	0.6	0.7	1.6	6.1	9.2	8.1	5.0
GLIPR1	"GliPR, RTVP1"	ENSG00000139278	"GLI pathogenesis related 1"	P48060	12	75480680-75503853	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.8"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 303.3;Hofbauer cells: 220.1;Kupffer cells: 261.5;Macrophages: 237.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 40.8;U-138 MG: 79.5;U-87 MG: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011014	Approved				"Intracellular and membrane"	NA	NA					"HPA011014: AB_1849714"	"unprognostic (2.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.09e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.69e-9)"	"unprognostic (9.06e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	32.0	12.5	6.7	30.4	7.5	10.9	11.8	2.5	10.2	14.7	13.1	5.2	6.0	4.5	28.8	19.2	8.0	20.2	23.1	12.7	6.3	5.4	10.3	8.2	18.6	45.4	9.3	6.6	18.3	4.5	1.4	5.6	24.2	11.1	12.3	9.0	7.2	13.7	12.5	3.3	3.7	16.2	27.0	19.6	32.0	15.4	7.2	8.1	8.9	7.3	4.3	20.9	20.6	8.9	15.2	39.7	76.8	55.1	3.0	20.0	34.7	1.4	1.5	1.2	0.1	4.8	10.3	0.2	19.7	20.8	16.6	12.1	0.8	0.6	4.9	4.1	21.3	14.7	0.2	0.0	8.1	27.2	7.9	0.3	0.2	1.8	1.2	5.5	1.7	0.2	9.5	3.0	40.8	9.0	26.8	13.4	0.3	0.3	6.2	31.0	0.0	0.8	4.1	0.1	0.0	0.6	0.2	0.9	0.1	1.7	0.3	0.0	0.0	8.1	0.0	0.0	2.8	0.2	1.4	21.6	79.5	7.5	8.4	30.0	1.1	0.1	0.4	31.5	2.0	1.1	2.8	55.1	6.3	20.0	38.0	13.5	12.0	14.3	15.7	39.7	15.2	4.3	9.1	76.8	3.0	40.6	33.4	14.6	34.7	6.7	7.5	2.5	10.2	6.3	5.4	9.3	6.6	11.1	8.1	11.9	16.5	78.6	66.6	12.0	2.5	0.7	7.6	12.0	4.5	3.5	3.9	3.6	0.0	94.4	10.2	6.3	0.0	0.0	71.1	303.3	25.7	70.6	9.3	3.4	220.1	6.4	3.4	13.5	261.5	4.5	13.3	237.2	15.1	13.6	0.3	2.0	65.0	2.9	50.5	1.4	2.8	12.9	27.4	1.9	1.1	8.5	14.1	117.9	0.1	23.7
GML	LY6DL	ENSG00000104499	"Glycosylphosphatidylinositol anchored molecule like"	Q99445	8	142834247-142916506	"Predicted intracellular proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"adrenal gland: 68.3"	"Cell type enhanced"	"Detected in some"	28	"granulocytes: 4.6;Sertoli cells: 6.5;Spermatocytes: 24.7;Spermatogonia: 7.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Group enriched"	"Detected in some"	19	"HMC-1: 1.2;JURKAT: 2.1;SK-MEL-30: 1.6;U-937: 2.5"														"Intracellular and membrane"	NA	NA																							0.0	68.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.4	0.0	2.2	0.0	0.8	1.4	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	24.7	7.2	0.0	0.0	0.0	0.0	0.0
GNPTG	"C16orf27, c316G12.3, CAB56184, GNPTAG"	ENSG00000090581	"N-acetylglucosamine-1-phosphate transferase gamma subunit"	Q9UJJ9	16	1351923-1364113	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004055	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		420000000	"Endoplasmic reticulum"	Cytosol	"HPA004055: AB_1079006"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.07e-2)"	23.1	67.3	38.0	16.9	35.7	19.9	20.2	22.0	38.8	19.6	23.5	41.7	22.2	16.5	18.9	28.4	17.3	19.1	22.2	17.8	38.5	31.7	29.9	41.1	21.7	22.6	39.3	28.6	22.3	34.6	33.7	25.1	27.2	28.9	21.1	15.6	20.5	37.8	22.2	28.1	33.4	19.5	15.1	43.3	26.3	21.2	18.0	31.0	11.1	24.0	13.2	13.2	20.0	17.8	15.5	29.3	25.8	37.1	14.6	21.7	20.9	4.7	7.8	5.7	10.0	52.5	19.6	7.3	14.1	18.5	5.6	10.8	6.9	13.6	3.0	16.3	19.0	8.5	8.8	3.4	8.2	2.9	9.7	7.6	4.0	24.1	11.8	22.3	6.5	16.3	26.0	14.4	5.4	7.7	15.8	10.3	5.6	4.8	18.2	9.2	11.0	3.0	6.6	5.3	12.3	4.4	11.0	4.8	13.9	14.0	6.3	4.4	5.9	14.2	14.7	10.1	3.3	13.6	9.9	10.0	11.3	9.7	9.2	6.8	19.2	13.9	6.3	9.3	5.6	7.4	25.8	37.1	22.2	21.7	34.0	19.9	15.5	18.7	20.5	29.3	14.6	17.3	15.8	15.0	14.6	31.9	24.7	21.3	20.9	38.0	35.7	22.0	38.8	38.5	31.7	39.3	28.6	28.9	31.0	38.7	42.0	23.2	23.3	18.5	13.9	7.7	40.8	38.8	58.0	19.2	23.6	22.0	8.3	22.9	2.3	20.2	23.2	0.0	12.6	16.8	30.5	22.2	23.2	26.0	44.9	7.9	8.7	36.2	34.5	2.7	27.9	37.0	32.1	18.0	18.4	24.7	14.7	28.8	16.6	37.7	23.3	19.4	18.4	24.7	27.2	17.8	26.0	20.3	20.0	22.0
GOLM1	"bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73"	ENSG00000135052	"Golgi membrane protein 1"	Q8NBJ4	9	86026146-86100173	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 83.7;stomach 1: 114.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 319.9;Paneth cells: 285.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 343.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010638, HPA011929, CAB015341"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		70000000	"Golgi apparatus"		"CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (8.14e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.40e-3)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.89e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.23e-1)"	6.1	53.6	23.3	15.6	18.2	1.9	11.6	23.1	27.7	21.0	53.1	16.5	6.0	62.8	11.9	9.3	4.2	11.1	83.7	4.0	24.7	26.3	22.0	6.6	4.4	2.8	17.4	20.4	11.1	19.5	7.8	15.1	5.3	22.3	39.9	45.5	10.9	43.0	3.5	2.6	4.6	16.5	8.4	25.5	11.3	114.2	5.0	16.4	5.0	19.5	7.9	36.6	11.6	11.0	1.2	2.2	7.2	5.9	1.2	5.7	2.5	29.5	29.0	21.8	24.6	28.1	16.3	23.0	13.5	9.8	21.3	17.3	14.2	59.3	0.6	13.4	26.1	20.6	22.9	13.3	13.3	15.5	1.0	21.2	9.2	19.3	0.7	16.7	13.6	7.4	24.7	7.2	20.0	7.3	26.8	36.3	4.4	5.7	0.9	12.0	13.9	1.6	10.2	34.3	38.7	21.0	8.7	24.9	4.5	35.5	12.7	24.6	15.4	18.4	40.0	15.1	14.7	22.5	14.0	23.1	5.6	15.7	16.8	16.0	79.6	7.5	0.2	24.1	6.1	12.1	2.1	5.5	0.8	5.7	3.9	0.7	1.1	0.5	0.8	0.7	1.2	0.7	1.3	7.2	1.2	5.9	2.2	0.3	2.5	23.3	18.2	23.1	20.8	24.7	26.3	17.4	20.4	22.3	16.4	8.9	11.7	0.0	9.8	2.1	16.9	4.3	71.4	69.6	61.4	33.2	7.9	5.4	21.6	148.1	319.9	21.5	193.3	0.0	197.4	30.2	20.6	130.5	1.1	12.5	9.8	63.5	70.2	9.8	7.5	196.5	17.0	3.3	21.9	1.0	76.8	15.7	203.7	285.1	12.4	11.5	6.1	0.0	10.3	8.9	34.3	0.9	5.4	4.3	129.2	17.6
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532129-170553446	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027208, HPA027250, HPA027746"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	7.7	14.7	8.4	9.4	9.2	0.5	10.6	8.7	9.5	10.7	9.4	4.8	7.0	4.8	8.8	10.5	6.3	6.8	6.7	8.2	7.4	7.8	7.2	11.1	6.8	9.6	6.3	8.1	12.6	9.7	6.5	20.6	9.4	8.7	11.1	10.4	6.3	8.8	13.1	3.3	6.5	7.0	6.4	11.1	10.4	5.6	8.6	7.3	8.7	10.5	4.2	9.7	10.4	10.0	6.2	7.3	1.2	7.4	7.9	9.4	5.5	5.1	5.0	9.6	3.6	12.9	9.6	6.3	7.8	12.1	6.9	7.2	3.2	8.8	7.5	9.0	7.9	4.5	6.5	9.5	4.6	9.2	8.0	2.9	5.0	6.5	4.0	8.7	6.6	5.1	8.3	4.5	7.4	6.9	8.6	5.4	4.3	6.8	3.7	7.3	1.2	9.5	6.0	8.5	11.6	6.3	5.7	6.4	10.0	6.2	3.8	2.5	5.3	6.5	7.9	18.2	6.4	5.0	11.7	6.9	11.0	5.8	4.3	10.8	6.7	7.3	6.6	9.2	6.0	9.8	1.0	7.4	0.0	4.7	7.4	7.4	6.1	8.3	7.2	7.3	6.2	7.3	6.2	1.2	7.9	5.7	4.6	9.4	5.5	8.4	9.2	8.7	9.5	7.4	7.8	6.3	8.1	8.7	7.3	0.0	10.7	6.0	2.9	2.5	3.9	6.7	7.6	1.4	6.8	5.2	2.0	5.2	3.3	9.4	1.6	7.4	5.1	0.0	5.3	5.6	10.4	4.1	12.8	5.8	6.3	4.8	0.0	3.7	6.3	2.6	13.0	3.9	3.3	10.0	6.4	3.4	5.8	7.0	6.0	4.4	7.2	6.5	8.5	13.1	7.7	1.4	4.7	5.7	6.0	2.7
GP2	ZAP75	ENSG00000169347	"Glycoprotein 2"	P55259	16	20309572-20327808	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	354	"pancreas: 1812.8"	"Cell type enhanced"	"Detected in some"	30	"Cholangiocytes: 117.2;Exocrine glandular cells: 424.3;Glandular cells: 76.3"	"Cancer enriched"	"Detected in many"	14	"pancreatic cancer: 320.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015739, HPA016668"	Enhanced				"Intracellular and membrane"	NA	NA		27000			"HPA015739: AB_1849905, HPA016668: AB_1849907"	"unprognostic (2.14e-2)"		"unprognostic (1.97e-2)"	"unprognostic (5.68e-2)"			"unprognostic (4.29e-2)"	"unprognostic (1.63e-1)"			"unprognostic (2.84e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.1	0.0	5.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.4	1812.8	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.4	1.4	2.3	0.9	0.6	0.8	0.3	0.5	0.3	0.6	1.0	0.0	0.2	1.3	0.3	0.0	0.5	0.2	1.3	0.7	1.3	1.4	0.4	0.6	0.7	0.1	0.4	0.7	0.3	0.2	0.4	1.3	0.2	0.0	0.4	0.9	0.0	0.3	0.2	0.0	0.5	0.0	0.5	0.8	0.8	0.5	0.0	0.5	0.6	0.1	0.1	1.2	0.8	0.8	1.8	0.1	0.2	0.7	0.5	0.6	1.4	0.2	0.7	0.5	0.5	0.0	1.1	2.2	0.8	1.0	0.7	0.8	0.3	0.3	0.6	0.3	2.0	0.9	0.7	0.8	0.3	0.5	0.6	0.7	0.7	0.1	1.4	0.7	0.7	2.3	0.6	0.2	1.4	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	117.2	0.0	0.0	0.0	0.0	0.0	8.3	0.8	6.1	0.0	0.6	0.0	424.3	0.0	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.0	7.2	2.0	0.2	32.3	13.9	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	1.4
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435671-240468078	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 142.6"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 181.5;Syncytiotrophoblasts: 85.9;Urothelial cells: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030571, HPA070449"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		6500000	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322, HPA070449: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.78e-5)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	13.6	22.8	32.4	7.2	21.0	1.9	8.1	42.7	33.6	11.5	8.1	10.1	9.5	5.4	9.6	9.8	26.3	7.8	7.1	40.7	26.5	11.9	8.5	11.0	7.4	4.0	8.8	22.5	14.1	18.1	5.8	14.4	20.2	13.6	29.5	4.0	6.3	16.3	17.6	62.9	142.6	4.9	12.0	8.3	5.2	6.5	20.0	10.5	1.7	4.5	24.3	10.7	10.5	15.2	0.9	0.1	0.0	0.0	0.1	0.8	0.3	16.2	22.4	5.3	13.9	16.2	15.6	21.6	39.0	19.4	4.5	5.3	7.9	18.2	0.4	5.4	41.3	24.7	44.9	2.8	27.7	0.9	7.8	2.4	0.0	20.6	9.8	23.3	0.3	1.5	13.7	18.1	10.1	5.3	9.5	2.3	0.8	0.1	0.8	11.5	8.5	0.3	0.1	8.3	1.8	5.0	2.9	24.2	3.7	3.6	26.3	5.3	3.5	25.5	22.5	2.3	5.0	7.1	1.6	10.9	24.3	41.2	11.5	16.1	0.1	0.1	0.1	17.3	0.4	27.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.3	32.4	21.0	42.7	33.6	26.5	11.9	8.8	22.5	13.6	10.5	14.9	6.7	0.0	52.5	40.8	12.0	50.2	22.9	8.1	23.9	24.4	2.0	58.0	6.6	25.6	0.6	3.7	0.9	0.0	9.3	181.5	28.8	15.7	4.6	19.2	8.0	23.8	0.0	15.4	0.0	2.1	17.5	2.7	33.7	2.8	4.3	27.8	13.4	0.0	7.1	2.2	4.9	25.8	16.5	0.5	4.9	40.4	85.9	0.7	2.7	90.8
GPC2	"cerebroglycan, DKFZp547M109, FLJ38962"	ENSG00000213420	"Glypican 2"	Q8N158	7	100169606-100177372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 34.3;skin 1: 9.4;testis: 16.7"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 30.9;Intestinal endocrine cells: 10.3;Spermatocytes: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.2;AN3-CA: 9.7;BEWO: 8.6;SH-SY5Y: 26.7"					"Low region specificity"	"Detected in all"			CAB025423	Uncertain				"Intracellular and membrane"	NA	NA					"CAB025423: "	"unprognostic (4.33e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-4)"	"unprognostic (3.42e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-4)"	"unprognostic (7.25e-4)"	"unprognostic (1.67e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.94e-4)"	0.5	0.5	3.2	3.5	1.9	1.9	0.6	2.2	4.3	0.8	0.9	2.1	0.0	0.5	2.6	0.3	0.2	0.4	0.4	0.3	2.9	1.6	0.2	0.1	0.5	2.2	2.0	0.9	0.8	0.3	0.5	0.7	0.3	1.5	0.5	0.8	0.5	1.7	0.4	0.8	9.4	0.7	0.8	3.3	1.4	0.3	16.7	2.0	34.3	0.3	0.7	2.0	0.6	1.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.1	24.2	9.7	0.0	0.0	8.6	0.8	0.0	0.1	0.2	0.0	0.3	2.0	0.5	0.2	1.4	0.8	0.8	0.3	0.0	0.0	0.7	0.2	0.3	0.0	0.4	0.5	3.7	0.8	0.4	0.5	0.0	0.4	1.1	5.4	0.9	0.0	0.6	0.3	5.5	0.7	4.2	0.4	1.4	6.3	1.7	0.0	0.1	0.4	6.4	26.7	0.5	0.6	0.8	3.5	0.4	0.4	0.9	0.2	3.9	0.5	0.1	0.8	0.3	2.8	0.2	1.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.3	3.2	1.9	2.2	1.7	2.9	1.6	2.0	0.9	1.5	2.0	0.0	0.0	0.0	0.9	1.5	0.1	1.4	0.0	0.0	0.0	1.8	3.9	0.3	0.0	1.1	30.9	0.6	0.0	0.0	0.8	0.6	0.6	0.7	0.0	0.0	0.3	0.0	10.3	0.0	0.3	4.1	0.9	0.6	0.0	0.0	0.8	1.7	1.2	0.0	1.1	0.0	1.8	0.0	0.9	12.5	5.5	3.3	0.3	0.0	1.2	0.6
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415490	"Plasma proteins, Predicted membrane proteins"			"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 47.6;Extravillous trophoblasts: 33.8;Proximal tubular cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 47.7;HAP1: 27.3;NTERA-2: 25.0;RPTEC TERT1: 63.0;SuSa: 57.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		170000	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	39.7	9.9	16.3	10.7	5.3	0.3	6.8	3.7	4.9	14.6	21.6	8.2	3.4	10.0	11.7	16.3	18.6	11.2	23.7	9.6	9.5	5.0	39.6	2.4	25.6	7.1	5.1	6.6	12.4	12.5	9.4	20.4	26.9	9.5	10.3	10.7	9.3	12.2	11.6	20.3	4.3	11.3	16.9	7.9	6.5	19.8	7.2	6.4	5.2	12.4	11.6	2.0	17.1	11.7	0.9	0.6	0.1	0.7	0.0	0.0	0.2	0.0	0.0	47.7	1.8	2.0	0.3	5.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	16.4	0.2	0.0	0.0	27.3	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	25.0	0.0	0.7	0.1	4.3	0.0	63.0	1.8	0.0	0.3	0.2	0.0	0.0	57.9	0.7	0.7	0.0	4.9	5.8	0.0	3.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	16.3	5.3	3.7	4.9	9.5	5.0	5.1	6.6	9.5	6.4	47.6	20.3	0.0	3.3	1.3	0.0	3.4	5.1	9.4	9.1	22.7	0.0	0.3	3.3	6.4	0.4	0.6	2.9	0.0	10.9	33.8	6.9	1.1	0.0	0.0	2.5	0.0	2.4	0.0	0.8	0.9	2.0	2.4	1.7	1.8	9.3	0.8	12.6	3.5	0.4	34.9	0.0	0.0	14.4	1.2	21.2	0.4	2.6	0.0	10.2	0.6
GPC5		ENSG00000179399	"Glypican 5"	P78333	13	91398607-92873682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;kidney: 14.8;testis: 11.3"	"Cell type enriched"	"Detected in some"	23	"Distal tubular cells: 54.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"CACO-2: 31.4;HeLa: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040152, HPA044081"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA040152: AB_2676863, HPA044081: AB_2678801"	"unprognostic (4.99e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-5)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-5)"	"unprognostic (2.19e-2)"	"unprognostic (1.82e-6)"	"unprognostic (3.03e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.69e-3)"	0.8	3.8	11.8	1.1	18.3	0.8	0.7	3.1	18.9	0.6	1.5	2.9	0.1	0.7	0.6	0.9	0.6	0.8	1.6	2.3	11.8	6.0	14.8	2.9	6.5	1.0	7.3	5.6	1.5	0.8	0.6	7.7	1.4	19.4	0.9	1.5	0.0	0.8	1.5	0.6	0.7	0.8	0.8	4.4	0.7	0.9	11.3	6.6	0.0	2.7	0.0	0.7	0.6	0.3	0.5	0.4	0.3	1.8	2.0	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	18.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	2.2	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.5	0.1	1.2	0.4	0.2	0.0	0.5	0.3	2.0	1.8	0.0	0.0	0.2	11.8	18.3	3.1	8.6	11.8	6.0	7.3	5.6	19.4	6.6	0.0	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.1	54.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0
GPC6		ENSG00000183098	"Glypican 6"	Q9Y625	13	93226842-94407401	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 47.6;Hepatocytes: 39.9;Rod photoreceptor cells: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"NK-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"NK-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.2;HHSteC: 17.5;HSkMC: 29.7;hTERT-RPE1: 26.6;SuSa: 17.0;U-87 MG: 21.9"	"Low region specificity"	"Detected in all"							HPA017671	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		360000	"Golgi apparatus, Vesicles"		"HPA017671: AB_1849833"	"unprognostic (5.24e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.21e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.35e-3)"	11.0	3.2	3.7	9.7	6.8	0.4	6.5	3.2	7.3	7.6	10.6	3.7	2.6	3.1	5.7	9.9	6.3	6.9	19.9	7.9	3.0	3.0	9.5	21.3	6.6	4.9	2.5	4.7	11.1	2.3	1.2	7.5	1.8	5.1	12.8	8.2	20.8	3.6	19.2	1.8	3.0	7.1	13.7	19.8	3.4	8.1	2.4	2.1	0.2	4.4	1.5	1.4	14.3	15.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	1.9	4.2	1.8	26.2	8.9	0.0	2.9	0.0	2.0	2.7	0.0	0.0	0.1	0.0	6.3	0.0	0.0	2.3	0.5	3.8	0.0	1.7	0.0	0.0	7.9	17.5	0.0	0.0	29.7	0.2	4.8	3.3	26.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.7	0.0	1.4	0.0	0.6	0.0	2.3	0.0	1.7	7.0	0.0	0.8	0.0	17.0	5.7	0.0	0.0	11.1	9.5	10.4	4.8	6.5	0.0	0.0	21.9	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	3.7	6.8	3.2	7.3	3.0	3.0	2.5	4.7	5.1	2.1	0.0	0.3	0.0	0.6	0.6	47.6	1.6	5.1	0.0	1.2	7.0	9.8	0.2	0.0	0.2	4.9	0.5	0.0	0.0	0.0	0.1	6.1	2.0	0.0	39.9	0.4	0.0	0.0	8.0	1.0	3.1	4.4	0.4	1.7	0.0	0.0	2.3	0.1	0.0	1.8	14.3	84.5	0.0	16.1	2.6	0.7	0.4	0.1	0.0	0.0	0.1
GPNMB	"HGFIN, NMB"	ENSG00000136235	"Glycoprotein nmb"	Q14956	7	23235967-23275108	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 137.7"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 290.6;Hofbauer cells: 788.7;Melanocytes: 566.8;Suprabasal keratinocytes: 314.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 354.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.8;intermediate monocyte: 7.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.1"	"Cell line enriched"	"Detected in many"	5	"ASC diff: 329.4"	"Region enhanced"	"Detected in some"		"olfactory region: 12.1"	"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA		41000000				"unprognostic (3.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.82e-1)"	"unprognostic (6.95e-2)"	137.7	4.3	7.7	9.5	5.9	0.7	33.8	1.0	5.5	56.0	20.7	7.9	9.2	3.5	56.5	34.6	32.6	17.3	45.8	50.0	5.5	2.8	10.8	8.9	58.7	24.1	4.4	5.0	39.7	4.0	0.3	3.7	52.7	18.2	24.8	15.7	115.7	18.1	9.8	11.3	97.2	12.1	26.2	15.7	8.4	11.2	19.8	1.5	20.6	14.0	31.7	26.7	33.4	41.9	0.4	0.8	1.2	7.1	0.3	0.2	0.8	1.1	0.0	0.0	0.0	329.4	60.0	0.0	2.1	35.7	1.7	7.6	0.0	0.0	0.0	0.0	6.8	3.2	7.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	41.3	8.6	2.9	0.3	47.8	0.0	0.0	0.0	0.0	9.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	27.8	0.1	0.0	0.0	11.1	51.4	0.0	0.1	0.1	0.0	10.5	1.2	19.1	0.3	0.3	0.5	0.0	3.6	0.1	10.5	0.9	3.8	0.1	0.2	7.1	0.1	0.2	0.0	0.0	0.8	0.4	0.2	0.1	1.2	0.3	0.3	0.8	0.1	0.8	7.7	5.9	1.0	5.5	5.5	2.8	4.4	5.0	18.2	1.5	17.9	28.2	2.7	6.4	290.6	0.4	176.6	2.5	2.7	14.8	71.5	0.0	5.9	3.3	0.4	2.4	9.6	0.0	0.0	0.7	2.7	76.6	1.8	20.9	3.8	788.7	1.6	0.0	6.2	136.5	2.1	120.3	119.7	566.8	4.6	0.0	0.2	0.7	0.0	101.5	0.7	0.5	0.0	64.0	3.8	1.2	314.4	24.1	0.0	0.0	10.9
GSG1	MGC3146	ENSG00000111305	"Germ cell associated 1"	Q2KHT4	12	13083560-13103683	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"testis: 156.4"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 9027.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 9.6;LHCN-M2: 11.0;RPTEC TERT1: 13.7;U-2 OS: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.50e-1)"	"unprognostic (2.21e-2)"		"unprognostic (6.33e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.23e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.32e-3)"	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.2	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	156.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	2.6	0.7	0.5	1.2	0.1	0.1	0.5	0.3	0.1	2.3	1.4	0.5	0.2	0.4	0.4	0.5	0.2	0.1	0.2	0.2	9.6	0.8	0.1	0.2	0.0	0.9	0.2	0.0	0.2	0.6	0.3	0.0	0.2	0.1	0.9	0.0	1.8	0.1	0.1	0.0	0.1	0.1	1.8	11.0	0.3	0.1	1.1	2.3	0.1	0.2	0.1	4.0	0.2	13.7	0.2	0.6	0.3	0.2	0.0	0.1	0.3	0.1	1.6	0.1	0.6	6.9	0.3	0.3	0.6	0.4	0.1	3.0	0.3	0.2	1.3	0.5	0.9	1.2	0.4	0.6	0.8	0.6	1.0	0.4	1.3	0.8	0.9	2.6	0.5	0.7	0.7	0.5	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.0	3.0	1.4	0.0	0.1	0.1	9.4	0.4	0.0	0.0	0.0	0.0	5.9	0.1	1.7	0.4	1969.0	0.0	0.0	23.3	0.0	0.1	0.0	0.1	0.0	0.0	0.7	1.6	26.4	2.5	0.0	9027.4	49.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	37.4	0.0	14.7	6.5	0.0	51.2	19.7	0.0	0.0	0.0	0.0	0.0
HDHD5	CECR5	ENSG00000069998	"Haloacid dehalogenase like hydrolase domain containing 5"	Q9BXW7	22	17137511-17165287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 36.5;Ductal cells: 28.6;Exocrine glandular cells: 24.8;Extravillous trophoblasts: 35.3;Hofbauer cells: 38.3;Proximal tubular cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005548	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA005548: AB_1078497"	"unprognostic (4.04e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.54e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.21e-3)"	12.2	22.2	10.3	11.3	13.3	12.8	14.7	13.2	13.2	10.6	23.7	11.3	8.8	23.7	12.6	10.1	15.3	11.9	16.0	29.5	9.9	8.4	14.7	29.8	12.5	12.4	16.4	10.4	13.6	25.3	8.9	9.6	7.4	13.2	12.7	13.1	7.7	17.3	10.0	37.2	15.7	16.5	12.0	9.9	14.6	13.6	12.4	13.7	15.1	9.4	25.9	11.6	11.9	10.7	10.1	29.3	2.9	34.6	11.1	15.0	17.5	22.7	15.1	11.3	15.3	6.7	4.1	14.5	6.5	7.2	17.6	19.0	22.1	8.5	37.4	11.0	7.8	8.6	16.1	14.3	15.3	8.2	11.3	20.9	0.0	10.9	0.0	11.2	16.8	8.8	10.0	19.1	7.8	8.7	9.9	12.3	24.8	10.9	9.7	9.2	22.2	29.5	34.6	17.3	35.2	13.5	16.9	17.1	9.4	12.0	12.6	23.0	17.4	12.7	18.5	19.5	9.4	18.5	21.1	10.6	15.0	11.1	10.5	11.2	15.5	16.8	27.5	12.0	0.0	12.5	2.9	34.6	1.6	11.8	21.4	14.7	10.1	11.2	10.7	29.3	9.6	15.0	12.5	1.7	11.1	11.6	12.1	11.3	17.5	10.3	13.3	13.2	13.2	9.9	8.4	16.4	10.4	13.2	13.7	6.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	9.1	5.2	0.0	21.4	36.5	28.6	0.0	0.0	0.0	0.0	24.8	35.3	0.0	0.0	4.7	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	9.0	0.0	0.0	21.7	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0
HRC	MGC133236	ENSG00000130528	"Histidine rich calcium binding protein"	P23327	19	49151198-49155424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 155.8;skeletal muscle: 82.1"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 1159.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 6.4;HSkMC: 6.6;K-562: 8.7;THP-1: 15.6;U-266/84: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004833	Enhanced				"Intracellular and membrane"	NA	NA		23000			"HPA004833: AB_1079083"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.75e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.41e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.04e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-1)"	2.4	0.8	0.2	0.1	0.5	0.0	0.8	0.0	0.6	1.6	0.3	0.3	0.3	0.2	1.8	4.3	1.3	1.0	0.5	155.8	0.2	0.2	0.7	0.4	0.3	0.4	0.4	0.3	0.7	0.3	0.4	0.2	0.4	0.3	1.4	0.2	1.3	1.4	0.6	82.1	0.3	0.3	0.5	0.2	0.1	0.2	0.7	0.1	0.0	1.7	25.9	2.0	0.4	0.6	0.5	0.1	0.9	0.5	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.5	6.4	0.0	0.0	1.3	6.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.1	0.0	0.0	0.3	0.7	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	15.6	0.2	0.0	0.0	0.3	0.0	0.1	4.7	0.0	0.0	0.0	0.3	0.9	0.0	0.3	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.2	0.4	0.1	0.2	0.0	0.2	0.5	0.0	0.6	0.2	0.2	0.4	0.3	0.3	0.1	0.0	0.0	0.0	0.2	0.2	0.0	1159.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.3	0.0	0.2	0.0	0.7	0.1	0.0	0.4	0.1	3.2	1.2	0.6	0.0	0.0	7.8	0.0	3.3	0.0	2.8	1.0	0.1	0.0	7.8	0.0	0.1	64.7	36.8	0.0	0.1	0.1	0.1	0.0	1.2	0.1
HSPA13	STCH	ENSG00000155304	"Heat shock protein family A (Hsp70) member 13"	P48723	21	14371115-14383484	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014797	Approved				"Intracellular and membrane"	NA	NA		2200000			"HPA014797: AB_1857567"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	10.2	19.1	18.2	12.8	35.8	15.2	12.0	17.5	27.5	16.1	9.2	8.5	10.9	7.4	17.3	21.3	7.0	8.9	9.6	10.9	18.1	28.2	13.0	23.2	10.2	10.7	17.5	15.8	13.2	11.6	14.8	31.5	18.3	21.8	12.4	9.9	8.1	12.4	14.0	4.7	4.1	7.3	14.9	18.8	10.8	9.3	16.3	13.8	13.4	21.4	5.6	12.7	12.1	7.4	6.7	7.4	18.4	4.8	10.8	10.8	5.3	5.9	4.8	19.2	11.0	13.9	11.2	12.2	16.8	19.8	14.0	16.1	4.5	6.5	10.3	11.8	12.0	20.9	2.6	8.8	5.7	23.5	10.7	6.9	10.0	5.2	8.5	35.8	16.3	12.9	10.0	18.9	20.0	34.6	17.8	11.7	9.4	8.4	67.3	15.2	5.9	10.8	5.0	14.2	2.8	6.7	10.2	16.9	22.4	7.3	2.3	4.4	10.8	12.4	6.5	23.7	10.2	9.0	10.9	11.6	18.4	15.4	14.4	12.2	25.6	19.1	8.3	20.6	10.5	22.9	18.4	4.2	4.2	6.3	4.8	10.8	6.7	6.8	6.7	4.9	3.8	7.6	7.2	1.8	10.8	4.1	7.4	5.3	5.3	18.2	35.8	17.5	26.3	18.1	28.2	17.5	15.8	21.8	13.8	8.9	13.1	15.7	12.6	11.3	37.7	13.3	5.1	6.7	5.7	3.5	13.7	19.8	0.0	7.2	5.2	12.1	3.5	0.0	8.8	20.9	19.5	18.0	18.5	10.5	12.4	57.2	14.3	14.1	13.7	1.8	9.2	12.6	21.9	6.4	6.8	37.1	8.7	2.9	18.0	6.3	17.4	12.9	16.9	30.9	5.3	8.9	53.7	12.8	3.8	11.5
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936748-203961577	"CD markers, Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8"	"Cell type enriched"	"Detected in some"	4	"T-cells: 23.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 18.4"	"Lineage enriched"	"Detected in single"	58	"T-cells: 18.4"	"Group enriched"	"Detected in some"	7	"HEL: 6.0;MOLT-4: 15.7"	"Low region specificity"	"Detected in single"							"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	1.5	0.3	0.2	15.6	0.2	13.8	0.7	0.2	0.2	0.8	1.2	0.0	0.2	0.5	1.2	0.5	1.1	1.2	1.6	0.5	0.2	0.2	1.0	0.8	4.0	19.4	0.3	0.0	0.6	0.3	0.0	0.4	0.1	0.1	0.7	1.1	0.7	2.9	0.0	0.2	0.6	6.2	0.3	0.4	6.1	1.0	0.6	0.0	51.8	1.4	2.4	28.9	3.0	0.9	0.0	0.0	0.0	0.0	0.3	18.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	2.9	0.0	10.5	4.6	0.0	0.0	11.0	5.0	0.0	0.3	0.0	0.0	18.4	3.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	5.8	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.6	0.1	23.5	0.0	0.0
IGF2		ENSG00000284779	"Insulin like growth factor 2"		11	2129112-2158658	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	8	"liver: 24.1"	"Cell type enriched"	"Detected in many"	5	"Leydig cells: 2784.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;RH-30: 3.3"														"Intracellular and membrane"	NA	NA																							1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	1.9	0.0	0.6	4.7	0.0	0.0	2.5	1.4	1.2	3.5	0.0	0.0	0.0	0.0	9.1	11.3	0.0	0.0	0.0	0.0	3.9	0.3	0.0	350.3	0.0	0.0	0.0	38.1	8.5	19.9	2784.7	1.7	3.3	0.0	0.0	0.1	0.0	0.0	605.3	0.0	0.3	64.7	7.3	3.2	4.3	3.6	0.0	0.0	0.0	0.1
IGSF21	"MGC15730, RP11-121A23.1"	ENSG00000117154	"Immunoglobin superfamily member 21"	Q96ID5	1	18107746-18378483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.5;lymphoid tissue: 16.5"	"Cell type enriched"	"Detected in some"	17	"Bipolar cells: 179.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		7900				"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.85e-4)"	"unprognostic (3.76e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-2)"	3.1	9.0	14.1	1.7	12.3	1.6	6.0	48.5	32.7	3.0	1.8	7.2	0.0	0.9	1.9	1.8	2.6	1.8	2.4	1.8	21.1	10.4	1.7	1.7	2.5	1.3	10.9	13.9	2.0	4.1	1.8	1.1	3.3	10.1	4.5	1.5	5.5	1.9	3.0	1.4	1.5	1.2	2.7	6.5	16.5	1.6	1.8	4.5	0.0	1.4	0.0	2.1	4.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	12.3	48.5	27.4	21.1	10.4	10.9	13.9	10.1	4.5	0.0	0.0	0.9	0.0	0.2	179.6	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	1.6	2.9	0.0	10.5	8.3	0.6	1.6	0.0	0.0	0.0	3.7	0.2	0.6	0.0	0.0	10.8	6.5	0.3	0.2	0.4	0.1	0.0	0.0	0.0	0.1
ITFG1	"CDA08, LNKN-1, TIP"	ENSG00000129636	"Integrin alpha FG-GAP repeat containing 1"	Q8TB96	16	47154387-47464149	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015590, HPA019728"	Approved		Approved	"Intermediate filaments,Aggresome"	"Intracellular and membrane"	NA	NA		21000	"Intermediate filaments"	Aggresome	"HPA015590: AB_1846347, HPA019728: AB_1846348"	"unprognostic (6.53e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-3)"	14.0	26.6	19.9	8.8	52.4	6.4	15.0	31.2	34.6	18.3	20.0	14.8	9.8	17.3	17.5	19.0	11.5	15.8	17.1	26.0	20.7	26.6	28.7	26.5	15.8	11.0	17.0	19.0	17.4	20.2	43.0	22.9	30.7	28.7	17.9	19.9	13.8	15.1	18.1	14.6	10.8	19.4	17.4	17.6	12.4	16.0	20.7	15.7	13.4	25.8	7.6	11.5	15.3	11.6	12.8	18.7	23.4	24.4	16.6	18.3	17.7	8.0	9.4	17.1	11.9	33.5	25.9	20.5	19.5	27.8	17.7	9.5	5.3	19.7	9.8	26.6	24.0	12.0	12.0	8.3	12.4	17.7	4.2	5.7	5.1	9.0	12.4	15.7	12.1	22.8	19.0	21.7	9.0	11.8	37.6	17.0	9.2	14.6	12.9	22.2	7.8	7.5	5.6	5.5	10.2	9.2	11.5	16.9	24.2	23.5	6.0	8.4	11.9	17.7	20.6	8.6	17.8	9.0	11.1	16.4	18.9	9.2	10.0	7.4	18.2	23.9	18.2	18.9	7.7	14.7	13.5	24.4	23.4	12.4	23.8	12.0	12.8	15.4	13.7	18.7	11.4	16.9	14.1	15.4	16.6	21.9	13.0	18.3	17.7	19.9	52.4	31.2	34.6	20.7	26.6	17.0	19.0	28.7	15.7	47.6	29.1	31.2	36.5	34.1	48.8	52.0	33.1	21.4	20.5	78.5	45.2	90.9	8.3	48.2	66.3	35.8	59.3	46.7	46.4	73.7	50.5	38.7	8.1	58.9	45.3	38.1	59.5	36.8	54.3	25.1	32.5	33.8	27.0	41.5	40.4	43.5	41.4	31.7	57.7	48.2	40.9	77.6	42.2	46.1	97.5	26.5	95.3	20.6	32.4	30.2
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48233158-48270357	"Disease related genes, Predicted membrane proteins"			"Amyloidosis, Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 346.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 236.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 236.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 109.5;RPTEC TERT1: 155.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2600000	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	89.3	79.6	60.6	41.3	61.6	25.0	79.6	87.2	65.8	72.6	58.3	64.9	93.4	83.4	61.2	346.2	71.5	53.2	59.4	86.9	75.9	61.4	198.7	65.1	80.2	75.9	71.7	49.8	100.7	48.5	27.0	63.1	132.0	50.2	66.5	36.0	80.8	75.1	99.8	30.9	73.5	81.0	53.1	90.0	78.5	64.5	44.7	48.3	35.0	73.1	63.0	47.7	63.3	74.5	13.3	23.3	236.4	46.6	17.2	31.7	73.7	8.6	7.6	12.8	23.9	48.8	29.7	19.0	23.0	29.2	11.6	14.7	5.4	41.8	2.3	19.6	16.8	9.2	35.6	6.9	16.7	9.8	6.8	16.2	16.5	6.2	14.7	21.0	16.2	109.5	17.8	14.9	6.8	7.5	58.9	14.9	11.6	4.2	20.1	14.1	5.9	26.1	35.8	35.0	25.1	10.3	11.8	12.7	11.8	155.7	41.2	4.4	17.2	20.4	16.8	11.9	44.8	10.9	17.3	24.0	9.7	9.7	12.5	11.2	7.8	7.3	0.3	14.1	9.4	21.6	136.9	46.6	141.3	21.3	35.7	28.1	12.0	29.8	26.5	23.3	13.3	31.7	26.5	236.4	17.2	35.5	10.3	28.7	73.7	60.6	61.6	87.2	58.0	75.9	61.4	71.7	49.8	50.2	48.3	646.2	271.8	308.5	1451.5	766.1	652.6	328.8	715.9	234.2	337.8	1889.5	176.7	1011.0	462.6	652.8	18.2	997.4	807.3	186.9	609.1	1937.1	842.6	824.8	565.6	490.5	1723.2	333.7	272.1	1299.4	1392.0	32.7	1728.8	1023.4	646.2	1577.2	438.3	1662.7	462.4	719.8	1890.9	2151.3	195.5	1203.0	551.5	116.1	261.4	1004.9	1230.6	638.1	376.8	1464.7
JMJD8	C16orf20	ENSG00000161999	"Jumonji domain containing 8"	Q96S16	16	681671-684528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (2.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.04e-2)"	21.3	29.8	11.3	12.4	14.0	11.8	18.4	10.2	21.8	28.7	22.8	16.1	26.3	13.9	27.1	28.9	28.2	24.8	28.6	30.3	11.4	9.4	36.8	48.0	17.3	20.0	9.2	9.5	34.3	33.8	32.0	20.7	24.3	11.4	27.9	9.1	22.5	33.1	30.0	13.9	18.1	19.0	29.9	8.2	21.6	22.3	27.8	10.7	18.5	32.8	14.0	17.0	23.5	18.2	5.1	9.0	0.3	7.3	3.6	7.9	3.1	8.3	22.2	5.8	26.4	25.1	10.1	3.7	10.4	21.0	11.4	13.4	12.5	21.2	2.9	11.6	15.8	0.0	15.8	7.2	14.2	4.4	11.6	9.1	6.3	11.9	1.4	11.6	14.3	11.7	12.0	9.6	7.5	9.1	8.2	17.6	5.4	7.6	17.5	6.8	19.0	7.6	9.8	14.9	14.4	9.0	8.5	1.4	31.7	22.6	5.2	10.5	11.0	16.1	18.4	3.4	3.4	19.0	14.2	9.0	0.3	9.4	5.2	5.2	10.0	5.2	3.5	3.1	6.3	9.3	0.3	7.3	0.1	6.2	5.6	7.9	4.3	6.7	6.2	9.0	5.1	6.0	5.9	0.3	3.6	4.7	5.4	7.1	3.1	11.3	14.0	10.2	21.8	11.4	9.4	9.2	9.5	11.4	10.7	8.9	17.6	11.9	18.7	12.2	15.2	10.3	22.9	6.7	13.6	22.7	13.7	30.1	24.9	35.3	16.9	15.8	15.8	0.0	36.7	33.3	22.7	18.5	2.3	23.2	18.2	15.9	20.7	14.1	13.6	37.9	21.6	11.5	16.9	19.0	16.4	25.2	29.2	8.6	27.6	25.8	19.7	0.0	25.8	24.5	13.0	16.9	25.4	10.2	17.8	12.9
KIRREL2	"DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1"	ENSG00000126259	"Kirre like nephrin family adhesion molecule 2"	Q6UWL6	19	35855861-35867109	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"pancreas: 38.5"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 27.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.1;HMC-1: 24.4;JURKAT: 14.1;U-937: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA071587, HPA074326"	Enhanced		Supported	"Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Centriolar satellite"		"HPA071587: AB_2732182, HPA074326: AB_2732251"	"unprognostic (1.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-6)"	"unprognostic (1.72e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.62e-2)"	0.2	0.0	0.4	0.3	0.8	0.0	0.0	0.2	1.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.5	0.2	0.4	0.0	38.5	0.0	0.9	0.1	0.5	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.1	0.0	2.6	0.1	2.1	0.0	0.0	15.1	0.0	0.0	0.0	0.2	0.0	0.0	24.4	0.1	0.0	0.0	0.0	0.0	0.0	14.1	0.1	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	3.0	0.9	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.6	1.0	0.2	0.0	0.0	0.0	0.2	0.0	5.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.8	0.2	1.2	0.7	0.0	0.2	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	27.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	5.3	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.8	0.0	0.0	0.0	2.9	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0
KIRREL3	"KIAA1867, KIRRE, NEPH2"	ENSG00000149571	"Kirre like nephrin family adhesion molecule 3"	Q8IZU9	11	126423359-127003460	"Disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 10.9;brain: 28.2"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 7.4;Early spermatids: 2.6;Late spermatids: 10.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 10.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 10.9"	"Cell line enhanced"	"Detected in some"		"BJ: 19.0;BJ hTERT+: 11.2;BJ hTERT+ SV40 Large T+: 7.2;BJ hTERT+ SV40 Large T+ RasG12V: 7.5;fHDF/TERT166: 13.7;U-138 MG: 8.8;U-251 MG: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053324	Enhanced				"Intracellular and membrane"	NA	NA					"HPA053324: "	"unprognostic (1.92e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.23e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.06e-6)"	"unprognostic (9.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.92e-1)"	1.2	4.0	12.3	1.9	20.0	1.4	1.0	13.2	28.2	1.5	2.2	23.6	0.0	1.7	1.1	1.0	1.7	1.1	1.4	2.3	9.1	7.2	1.1	1.0	1.0	2.1	7.2	11.7	1.3	1.4	0.9	0.1	1.6	9.9	1.0	1.8	0.6	3.5	3.4	1.0	1.1	1.7	1.9	8.9	2.6	1.5	1.2	12.1	0.0	1.0	0.0	1.9	1.1	0.2	0.0	10.9	0.9	0.0	0.0	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.1	0.1	19.0	11.2	7.2	7.5	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.5	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	4.5	0.1	0.3	0.3	0.0	0.0	0.9	0.0	0.1	2.1	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	8.8	6.1	3.4	10.4	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	12.3	20.0	13.2	17.4	9.1	7.2	7.2	11.7	9.9	12.1	0.0	0.0	0.0	0.0	0.0	7.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	10.7	0.0	0.0	1.7	0.0	0.1	0.3	0.1	0.3	0.0	0.0	1.5	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.1
KRBA2		ENSG00000184619	"KRAB-A domain containing 2"	Q6ZNG9	17	8368637-8376711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 28.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA022849	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA022849: AB_1852996"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.98e-2)"	"unprognostic (8.35e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.61e-4)"	"unprognostic (6.14e-2)"	"unprognostic (5.02e-7)"	"unprognostic (1.82e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.08e-1)"	10.2	6.5	7.2	3.9	9.7	1.6	6.1	7.8	7.6	6.4	4.5	9.9	4.1	3.7	6.6	5.1	3.9	5.0	3.9	27.5	8.2	4.4	9.6	2.7	4.0	4.0	9.9	6.4	7.1	5.0	11.2	8.8	4.7	7.6	6.9	4.0	11.0	7.7	4.9	11.0	6.4	4.2	4.6	9.1	3.9	4.5	6.2	8.7	6.3	7.5	6.0	3.4	7.5	5.7	5.0	2.8	12.7	3.8	1.8	6.0	0.7	0.6	6.2	7.1	6.6	3.9	5.8	3.9	0.9	2.6	3.1	3.8	0.1	2.4	0.6	4.5	1.0	1.8	1.5	2.6	1.0	4.1	3.1	2.2	1.0	4.0	2.8	1.4	0.4	1.8	4.5	0.0	2.6	1.3	2.1	4.8	4.0	0.0	0.8	2.3	1.0	2.7	0.3	0.7	0.2	2.2	5.0	4.5	0.6	2.0	4.3	2.4	4.9	6.3	2.1	1.6	5.8	3.1	0.4	2.9	2.2	3.8	0.9	0.9	2.6	1.5	0.4	2.8	0.0	5.1	12.7	2.3	3.5	3.4	1.8	3.2	2.9	3.4	2.6	1.2	5.0	6.0	3.3	2.2	1.8	3.8	2.8	3.2	0.7	7.2	9.7	7.8	7.6	8.2	4.4	9.9	6.4	7.6	8.7	0.0	0.6	0.0	1.2	0.2	2.0	0.4	0.0	4.0	0.0	1.8	15.7	2.0	3.3	2.4	0.3	1.5	1.0	0.0	1.0	0.5	0.9	0.5	4.7	0.0	0.8	3.2	4.1	2.5	1.0	0.0	1.4	1.1	1.7	0.0	1.0	2.4	1.6	0.0	2.8	0.9	28.5	0.0	1.2	1.8	1.5	0.6	1.0	1.3	1.2	0.3
KRT10	"CK10, K10, KPP"	ENSG00000186395	"Keratin 10"	P13645	17	40818117-40822595	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	20	"skin 1: 1236.8"	"Cell type enriched"	"Detected in all"	5	"Suprabasal keratinocytes: 10939.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 562.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 131.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000132, HPA012014"	Enhanced				"Intracellular and membrane"	NA	NA		34000000000			"CAB000132: , HPA012014: AB_1852195"	"unprognostic (3.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.10e-2)"	4.1	4.4	5.3	3.7	6.0	3.9	41.4	7.2	6.4	37.3	3.7	1.4	8.2	4.0	14.9	5.4	7.4	3.0	3.7	9.3	6.4	2.9	5.9	7.6	3.0	5.3	5.2	3.2	3.3	9.2	2.6	8.1	5.7	4.9	5.6	2.9	2.4	17.4	8.3	12.2	1236.8	4.9	3.0	4.0	3.7	4.3	9.6	6.1	11.6	5.5	21.7	5.8	3.3	62.7	17.5	15.4	21.7	5.7	13.2	13.4	3.4	17.9	22.9	6.7	7.2	8.3	7.4	6.2	16.2	10.0	6.7	6.1	8.7	6.8	5.0	24.4	7.1	8.8	36.3	2.8	6.1	8.6	11.9	18.0	4.7	29.9	15.9	9.6	10.0	13.9	5.8	131.9	4.4	9.6	8.7	4.6	5.9	25.3	9.6	7.7	13.5	13.0	9.7	8.6	12.4	14.6	9.7	9.8	10.6	6.8	19.5	5.9	6.9	11.5	27.7	21.1	10.0	21.5	13.6	5.2	11.3	16.7	13.9	20.0	0.2	12.1	14.1	15.3	6.5	14.1	21.7	4.7	19.1	9.8	4.2	11.1	17.5	10.8	13.4	7.7	10.1	12.1	11.8	1.6	13.2	5.7	15.4	10.3	3.4	5.3	6.0	7.2	6.4	6.4	2.9	5.2	3.2	4.9	6.1	32.8	40.2	140.7	245.9	1989.5	42.2	180.5	168.2	18.7	37.5	106.4	19.6	108.0	258.6	178.2	67.5	155.9	127.9	70.0	325.5	259.5	164.5	278.2	74.8	191.4	95.0	20.6	173.9	148.0	93.7	31.5	200.5	149.2	372.8	55.1	172.8	131.5	192.1	133.3	164.4	188.8	57.0	103.5	208.9	225.9	128.5	10939.8	133.9	135.5	151.3	432.6
LILRB1	"CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7, PIR-B, PIRB"	ENSG00000104972	"Leukocyte immunoglobulin like receptor B1"		19	54617158-54637528	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"blood: 26.7;lymphoid tissue: 52.5"	"Group enriched"	"Detected in some"	7	"B-cells: 16.2;Hofbauer cells: 16.3;Kupffer cells: 58.9;Macrophages: 35.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"intermediate monocyte: 19.1;non-classical monocyte: 26.7"	"Lineage enriched"	"Detected in many"	10	"monocytes: 26.7"	"Group enriched"	"Detected in some"	19	"Daudi: 10.6;THP-1: 5.5"														"Intracellular and membrane"	NA	NA						"unprognostic (9.23e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (6.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.03e-2)"	2.6	1.5	2.5	11.9	4.5	2.5	0.9	0.4	2.5	1.1	1.8	3.1	0.5	0.6	0.5	1.8	0.8	1.4	0.7	2.5	2.2	1.6	1.5	3.2	5.6	18.7	4.7	0.9	1.7	0.7	0.3	1.1	2.7	3.7	1.4	1.1	0.8	1.2	0.8	0.3	0.3	4.8	5.4	5.8	52.5	1.0	0.5	4.6	0.8	0.8	0.1	3.0	4.9	0.6	1.2	2.5	0.1	26.7	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	3.1	0.0	0.6	19.1	0.0	1.2	0.0	0.5	2.5	1.1	0.0	0.4	0.1	0.0	26.7	1.0	0.0	1.7	2.5	4.5	0.4	2.5	2.2	1.6	4.7	0.9	3.7	4.6	0.0	2.1	16.2	0.3	0.2	0.0	0.6	2.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.2	2.3	0.4	16.3	0.0	0.0	3.7	58.9	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	1.4
LLCFC1	"C7orf34, CTM-1"	ENSG00000165131	"LLLL and CFNLAS motif containing 1"	Q96L11	7	142939343-142940868	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	21	"testis: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Group enriched"	"Detected in some"	5	"K-562: 3.2;RT4: 3.4;SiHa: 1.5"														"Intracellular and membrane"	NA	NA						"unprognostic (5.05e-2)"	"unprognostic (9.94e-2)"			"unprognostic (5.49e-3)"			"unprognostic (2.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.02e-1)"			0.1	0.0	0.1	0.1	0.1	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.5	0.0	31.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	3.2	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRFN5	"C14orf146, FIGLER8, SALM5"	ENSG00000165379	"Leucine rich repeat and fibronectin type III domain containing 5"	Q96NI6	14	41607570-41904549	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.1;parathyroid gland: 38.4"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 4.1;Fibroblasts: 3.3;Leydig cells: 7.8;Peritubular cells: 3.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 17.7;HSkMC: 3.6;RPTEC TERT1: 6.0;SCLC-21H: 9.3;U-138 MG: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001177	Uncertain				"Intracellular and membrane"	NA	NA					"HPA001177: AB_1079274"	"unprognostic (5.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.61e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.02e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.92e-3)"	1.5	3.3	7.9	1.7	9.3	0.5	2.4	3.1	19.1	13.7	2.2	0.8	1.3	0.8	3.8	1.5	1.2	5.0	1.9	0.9	12.2	9.5	0.9	0.6	1.2	0.6	4.3	11.9	2.7	0.9	38.4	1.0	1.8	8.7	3.7	1.9	0.9	0.8	9.3	0.8	1.0	0.9	9.3	1.6	1.2	1.0	1.7	1.2	0.0	1.0	0.0	0.8	7.8	6.3	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	9.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.5	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	9.3	3.1	19.1	12.2	9.5	4.3	11.9	8.7	1.2	0.0	0.0	0.0	0.0	0.2	4.1	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.3	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.8	7.8	0.0	1.7	0.0	0.0	0.2	0.2	0.0	3.9	0.0	1.0	0.0	1.0	0.0	1.5	0.3	0.1	0.0	0.0	0.0
LY6E	"RIG-E, SCA-2, TSA-1"	ENSG00000160932	"Lymphocyte antigen 6 family member E"	Q16553	8	143017982-143023832	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 1253.6;Extravillous trophoblasts: 3995.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 91.0;MCF7: 95.8"	"Low region specificity"	"Detected in all"												"Intracellular and membrane"	NA	NA						"unprognostic (1.05e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.94e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (6.74e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.12e-2)"	29.6	35.1	24.8	16.7	33.0	40.4	30.2	22.6	53.4	42.1	10.4	10.1	9.0	11.3	26.6	38.6	30.3	30.8	42.9	19.3	34.8	15.8	39.9	127.1	50.6	27.8	13.0	20.9	41.2	13.1	5.2	13.8	72.6	13.0	20.7	6.7	23.3	57.8	25.4	7.7	17.8	10.2	23.3	8.6	45.9	19.5	16.4	4.7	23.2	19.2	22.6	27.3	18.5	22.6	34.8	19.2	4.9	79.3	50.7	47.6	44.1	12.6	21.5	0.2	10.6	16.8	31.0	28.2	26.9	50.1	64.5	91.0	0.4	22.9	8.9	18.3	22.1	9.0	26.4	6.5	14.5	7.7	6.0	9.0	27.8	10.4	9.0	16.5	2.2	6.9	31.9	5.5	11.4	4.8	6.7	5.3	8.6	7.5	24.3	4.3	95.8	7.0	9.7	6.6	40.8	14.8	6.2	0.0	22.4	14.2	9.4	16.2	5.7	31.3	19.8	28.4	9.9	25.9	4.5	3.5	4.0	22.6	10.5	0.1	0.2	1.1	0.2	8.7	7.8	12.0	2.6	23.2	2.0	47.6	70.4	29.1	33.4	38.0	38.4	19.2	34.8	25.9	34.6	4.9	50.7	79.3	3.5	30.3	44.1	24.8	33.0	22.6	53.4	34.8	15.8	13.0	20.9	13.0	4.7	20.8	12.0	124.3	378.0	155.9	9.6	2.0	188.5	24.1	45.5	43.6	0.0	1253.6	19.9	233.6	2.8	206.7	1.1	0.0	19.5	3995.5	396.8	163.3	53.0	298.0	333.3	44.5	28.2	108.6	68.1	5.4	268.4	147.6	150.1	29.7	10.8	11.8	122.7	0.0	208.9	188.8	2.4	142.3	89.3	1.4	29.4	102.6	446.8	262.9	12.0	497.8
LY6G6D	"C6orf23, G6D, Ly6-D, MEGT1, NG25"	ENSG00000244355	"Lymphocyte antigen 6 family member G6D"	O95868	6	31715356-31717804	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"seminal vesicle: 7.4;skin 1: 21.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	22	"colorectal cancer: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 6.2"	"Region enhanced"	"Detected in some"		"cerebellum: 6.8"					HPA054412	Uncertain				"Intracellular and membrane"	NA	NA					"HPA054412: AB_2682480"			"unprognostic (5.48e-2)"		"unprognostic (1.25e-1)"					"unprognostic (2.81e-2)"		"unprognostic (2.13e-1)"						0.6	0.2	0.1	0.0	0.7	0.2	0.1	0.0	0.6	5.1	2.7	0.3	1.7	0.1	0.5	0.0	0.3	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	5.6	0.6	0.3	0.3	7.4	0.1	21.4	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.7	0.0	0.6	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	111	"HEL: 23.1"									HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.3	0.0	2.9	0.0	0.5	4.3	0.0	0.0	5.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.3	0.2	1.7	0.1	0.0	0.3	3.9	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.6	2.2	0.0	0.1	0.2	0.4	0.4	0.8	1.1	0.4	0.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.4	0.4	0.4	0.7	0.4	0.0	0.2	0.3	0.4	1.1	0.1	0.3	0.8	0.7	1.0	2.9	0.5	0.0	5.2	1.7	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6H	NMLY6	ENSG00000176956	"Lymphocyte antigen 6 family member H"	O94772	8	143157914-143160711	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 58.2"	"Group enriched"	"Detected in some"	8	"Intestinal endocrine cells: 52.7;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 6.8;NTERA-2: 1.3;SCLC-21H: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077218	Enhanced				"Intracellular and membrane"	NA	NA					"HPA077218: "	"unprognostic (8.76e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.45e-4)"	"unprognostic (3.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.76e-3)"	"unprognostic (5.97e-2)"	"unprognostic (2.20e-5)"	"unprognostic (6.43e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.89e-3)"	1.4	1.4	46.7	1.6	26.3	1.3	1.3	0.0	42.8	1.3	2.8	3.2	0.0	5.6	1.5	1.4	1.5	2.6	1.4	1.2	58.2	53.4	1.3	1.2	1.4	1.4	10.9	32.5	1.2	1.3	1.2	8.4	1.3	7.1	1.3	1.3	0.0	1.3	1.4	1.4	1.2	2.2	1.8	4.0	1.2	4.3	2.3	1.9	0.0	1.3	0.0	1.2	1.4	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.8	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	46.7	26.3	0.0	36.9	58.2	53.4	10.9	32.5	7.1	1.9	0.0	0.0	0.0	0.1	0.6	1.3	4.2	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.1	0.0	52.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	0.0	3.4	0.0	0.0	1.1	16.2	0.0	0.0	0.0	0.0	0.5
LYNX1-SLURP2		ENSG00000284505	"LYNX1-SLURP2 readthrough"		8	142764334-142778224	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 13.1;esophagus: 13.6"	"Cell type enriched"	"Detected in single"	9	"Pancreatic endocrine cells: 5.9"									"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.7;non-classical monocyte: 4.1"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"A549: 2.3;BJ: 3.6;EFO-21: 3.0;HaCaT: 2.6;SH-SY5Y: 1.7;TIME: 1.7"														"Intracellular and membrane"	NA	NA																							3.8	2.4	3.7	0.8	4.1	0.3	1.1	1.2	13.1	1.1	1.4	2.1	0.0	1.1	1.9	1.4	13.6	2.1	1.2	7.0	3.0		1.6	6.5	1.1	0.6	2.3	4.2	1.6	1.0	1.2	0.0	0.7	6.7	3.6	0.9	1.9	2.0	5.0	2.0	8.6	1.5	3.5	1.2	1.5	1.2	0.8	1.4	0.0	0.5	0.5	1.1	4.2	0.8	0.0	0.2	0.0	4.1	0.0	0.6	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.1	0.4	0.3	0.0	0.0	3.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.4	0.2	0.0	0.1	1.1	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.7	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.2	0.0	0.0	4.1	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LYPD1	"LYPDC1, MGC29643"	ENSG00000150551	"LY6/PLAUR domain containing 1"	Q8N2G4	2	132644853-132671579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;fallopian tube: 74.6"	"Group enriched"	"Detected in many"	5	"Ductal cells: 49.4;Exocrine glandular cells: 65.7;monocytes: 108.2;Pancreatic endocrine cells: 67.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 57.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 10.9"	"Lineage enriched"	"Detected in single"	36	"granulocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 17.4;HUVEC TERT2: 14.8;SK-MEL-30: 15.2;SuSa: 13.7;U-251 MG: 31.7;WM-115: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068333			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA068333: "	"unprognostic (9.25e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.40e-3)"	"unprognostic (5.60e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	1.5	2.5	16.4	1.7	27.8	1.2	1.4	3.8	16.8	1.3	2.5	4.6	0.0	1.4	2.5	1.8	1.4	74.6	3.6	1.8	18.9	19.0	3.2	1.6	1.4	3.5	16.9	5.4	8.4	3.5	2.0	12.4	1.2	11.8	1.4	1.4	5.4	21.7	1.4	1.2	1.5	1.4	1.8	7.0	1.3	1.4	1.5	3.4	1.2	1.3	1.1	2.5	1.4	0.0	0.3	0.0	10.9	0.0	0.0	0.0	0.0	0.2	4.8	5.4	0.0	0.0	0.0	0.0	1.1	0.6	2.4	0.5	0.4	0.6	0.0	10.1	2.0	1.6	5.2	0.0	0.0	1.2	0.0	1.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	1.0	14.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.3	0.1	2.1	0.0	0.0	0.0	7.1	0.1	0.7	1.3	0.6	0.0	15.2	13.7	0.0	0.1	0.7	0.3	7.6	3.2	31.7	0.0	0.0	0.0	6.2	0.0	63.9	1.3	0.0	10.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	27.8	3.8	11.0	18.9	19.0	16.9	5.4	11.8	3.4	0.0	0.0	0.0	0.0	0.1	0.8	0.2	5.1	0.0	0.0	5.2	0.0	0.0	1.7	49.4	4.4	0.0	0.0	0.0	65.7	0.0	0.1	0.1	0.0	0.0	0.1	14.3	1.7	0.6	0.3	6.3	3.7	0.0	0.0	108.2	0.0	1.5	67.6	0.0	0.0	2.2	0.8	0.0	5.3	1.1	1.8	0.0	0.0	0.0	0.0	0.0
LYPD2	"LYPDC2, RGTR430, UNQ430"	ENSG00000197353	"LY6/PLAUR domain containing 2"	Q6UXB3	8	142750150-142752534	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"blood: 76.5;esophagus: 77.5;lymphoid tissue: 69.2;tongue: 37.9"	"Cell type enriched"	"Detected in single"	13	"Ito cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"non-classical monocyte: 76.5"	"Lineage enriched"	"Detected in many"	20	"monocytes: 76.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 15.1;HaCaT: 4.1;OE19: 2.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028599	Uncertain				"Intracellular and membrane"	NA	NA					"HPA028599: AB_10603777"		"prognostic favorable (2.00e-4)"		"unprognostic (3.10e-2)"		"prognostic favorable (2.63e-4)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.11e-3)"		"unprognostic (1.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.3	0.0	77.5	0.2	0.1	1.2	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	7.7	0.0	0.5	6.5	0.0	0.0	0.0	0.1	11.6	0.0	0.0	5.7	0.0	37.9	69.2	0.0	10.1	0.2	3.7	0.0	76.5	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	76.5	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0
LYPD4	MGC42718	ENSG00000273111	"LY6/PLAUR domain containing 4"	Q6UWN0	19	41837074-41844697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"testis: 120.3"	"Group enriched"	"Detected in some"	55	"Early spermatids: 232.6;Late spermatids: 649.6;Spermatocytes: 177.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"BEWO: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"	NA	NA						"unprognostic (4.07e-2)"			"unprognostic (2.92e-1)"										"unprognostic (3.21e-1)"	"unprognostic (1.00e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.8	1.2	1.7	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.3	1.8	0.3	0.5	0.6	0.4	0.9	0.6	0.5	0.5	0.5	0.5	0.6	0.8	1.5	1.7	1.2	0.7	0.5	0.5											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	649.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.5	0.0	177.4	5.0	0.0	0.0	0.0	0.0	0.0
LYPD6B	"CT116, LYPD7"	ENSG00000150556	"LY6/PLAUR domain containing 6B"	Q8NI32	2	149038107-149215262	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.9"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 202.8;Late spermatids: 80.2;Suprabasal keratinocytes: 60.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 14.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.0;LHCN-M2: 41.7;NB-4: 13.6;RT4: 22.0;SK-BR-3: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049239	Uncertain				"Intracellular and membrane"	NA	NA					"HPA049239: AB_2680688"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.59e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-3)"	0.2	0.2	1.4	0.1	1.5	0.0	8.9	0.7	2.4	1.4	2.3	0.6	21.8	1.1	1.1	0.5	2.1	12.2	27.3	0.1	5.0	2.4	4.0	0.4	2.7	2.4	0.7	0.6	1.7	13.2	9.8	0.6	0.6	0.9	5.0	1.5	2.5	11.9	26.6	0.1	38.9	2.9	1.8	0.6	1.3	20.3	16.9	0.7	0.2	0.2	0.6	2.3	9.1	3.7	2.8	0.0	14.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.6	2.7	1.0	0.3	0.0	0.0	0.0	26.0	0.0	5.6	0.6	0.6	8.6	0.0	3.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	9.4	0.0	13.6	0.8	5.8	0.1	0.0	0.1	1.7	1.3	22.0	1.5	0.0	0.1	13.2	0.0	2.7	1.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	14.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.5	0.7	2.4	5.0	2.4	0.7	0.6	0.9	0.7	0.0	1.3	2.0	20.2	26.6	0.0	1.1	50.9	22.7	6.8	43.6	0.0	0.0	6.6	10.6	202.8	0.8	3.6	0.0	16.3	0.5	0.8	26.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	80.2	2.0	1.1	5.0	1.0	3.1	0.0	23.2	6.5	0.0	0.0	0.0	0.0	0.9	1.5	1.5	60.3	0.2	0.0	2.5	35.1
MCCD1		ENSG00000204511	"Mitochondrial coiled-coil domain 1"	P59942	6	31528717-31530232	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	188	"kidney: 63.6"	"Group enriched"	"Detected in some"	34	"Distal tubular cells: 339.8;Proximal tubular cells: 251.4"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.4;renal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.34e-1)"			"unprognostic (2.39e-2)"			"unprognostic (2.71e-1)"			"unprognostic (3.22e-2)"			"prognostic favorable (1.73e-4)"					0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	63.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	339.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	251.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MFAP3		ENSG00000037749	"Microfibril associated protein 3"	P55082	5	154038906-154220478	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015883, HPA049198"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA015883: AB_1853840, HPA049198: AB_2680672"	"unprognostic (6.02e-2)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (9.35e-3)"	21.3	7.6	5.8	8.0	12.2	7.9	11.3	12.6	11.4	11.1	8.3	6.3	7.8	7.2	14.1	7.3	11.6	7.5	8.9	9.2	7.2	6.8	9.5	9.4	10.9	6.8	6.4	7.1	9.4	6.3	27.2	9.6	15.0	8.8	7.8	8.4	9.5	8.8	6.4	13.2	6.4	9.5	11.7	8.9	7.9	7.4	8.3	7.0	9.1	11.3	6.3	9.2	12.2	10.1	3.0	10.6	14.6	10.3	7.7	9.6	5.4	9.7	12.7	21.6	22.7	19.5	18.3	21.2	17.6	18.9	18.4	23.8	19.1	22.2	14.0	20.5	16.6	18.3	22.0	20.3	22.0	29.5	6.3	13.3	9.2	19.5	6.9	18.6	16.4	10.8	19.7	21.9	22.0	18.7	15.2	25.7	12.7	10.4	15.2	16.0	6.4	9.1	3.7	11.2	10.4	7.5	8.7	25.6	12.8	11.9	13.8	22.3	24.9	19.3	21.8	17.4	20.0	22.9	8.1	23.3	24.0	16.8	13.2	17.9	15.3	19.6	13.2	12.2	11.3	18.8	8.1	10.3	14.6	6.5	9.8	9.6	3.0	5.6	4.9	10.6	3.0	7.4	5.4	8.4	7.7	7.0	3.8	4.9	5.4	5.8	12.2	12.6	11.4	7.2	6.8	6.4	7.1	8.8	7.0	0.0	0.3	0.0	0.9	5.4	3.3	2.0	0.0	0.0	0.0	5.2	5.9	3.5	1.7	0.9	4.5	4.8	2.0	0.0	1.0	2.4	2.7	1.1	4.6	1.6	1.6	3.2	0.0	0.0	1.2	3.3	1.7	2.5	8.5	1.0	0.6	7.8	0.9	0.0	0.0	1.1	4.3	0.0	3.0	2.1	2.1	4.8	5.0	1.3	0.6	1.4
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.9"	"Group enriched"	"Detected in many"	20	"Early spermatids: 409.5;Late spermatids: 1347.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 14.4;RT4: 23.5;SK-BR-3: 21.6;SuSa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.1	3.4	15.0	1.3	19.6	2.7	10.2	4.9	19.4	11.4	2.1	21.1	4.2	1.0	4.9	32.9	1.2	4.0	2.6	1.9	15.4	11.1	25.6	29.5	2.7	1.2	21.8	10.0	1.1	1.6	5.7	3.3	5.5	21.1	2.9	2.2	17.5	2.0	11.7	4.2	19.7	1.1	3.9	16.4	1.7	1.3	30.6	20.8	0.0	2.8	0.2	1.0	11.9	1.5	0.0	0.7	7.9	0.8	0.0	0.8	6.9	0.2	3.5	1.9	2.0	1.6	0.8	0.7	3.8	0.5	1.8	1.6	1.2	0.2	0.0	0.1	5.9	3.4	1.8	6.9	0.8	0.8	0.0	2.6	0.0	3.7	1.4	0.9	0.0	14.4	1.2	2.1	0.2	0.6	1.0	0.2	2.2	0.5	0.7	3.6	2.0	0.6	0.5	2.0	0.4	3.0	0.0	1.1	0.0	5.2	23.5	1.6	3.5	3.2	21.6	6.9	12.8	1.2	0.0	0.1	1.9	7.1	3.5	7.3	0.3	0.0	0.0	4.8	0.7	7.1	7.9	0.2	2.1	0.8	0.8	0.4	0.0	0.7	0.2	0.3	0.0	0.3	0.1	4.9	0.0	0.0	0.7	0.1	6.9	15.0	19.6	4.9	15.4	15.4	11.1	21.8	10.0	21.1	20.8	0.0	6.4	0.0	0.2	2.3	9.2	2.5	0.0	0.0	0.0	34.9	19.6	2.9	5.0	0.4	409.5	2.3	0.4	23.3	1.0	0.9	0.5	0.5	4.6	43.3	0.9	3.2	2.4	4.9	1.0	1347.3	4.9	0.6	6.8	0.0	0.1	2.3	1.3	0.0	8.5	17.3	14.7	19.4	3.4	18.0	13.6	7.3	7.9	0.0	0.4	2.1
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666731-56668065	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"intestine: 101.1;kidney: 210.7;liver: 396.4;pancreas: 217.1;thyroid gland: 278.4"	"Cell type enhanced"	"Detected in many"	22	"Distal tubular cells: 5804.3;Hepatocytes: 13716.6;Paneth cells: 6754.7;Proximal tubular cells: 31723.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"U-937: 156.0"														"Intracellular and membrane"	NA	NA						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	10.1	1.0	11.7	10.4	50.7	0.7	2.8	1.1	27.4	1.0	78.1	3.1	1.9	49.6	1.5	15.9	21.7	4.6	23.2	0.9	25.1	7.6	210.7	396.4	2.4	7.0	23.6	11.3	0.6	217.1	0.4	1.0	0.6	46.9	21.6	48.9	22.4	2.4	1.0	0.6	2.9	101.1	7.9	7.7	0.5	47.4	0.6	3.6	0.0	278.4	1.9	1.8	2.4	1.2	0.1	1.1	0.7	1.1	0.3	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.5	0.6	0.1	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	35.6	0.0	0.0	0.0	0.0	0.1	10.2	6.0	0.0	3.2	0.4	0.0	0.2	0.1	1.6	0.0	15.3	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	156.0	0.0	0.7	1.1	0.3	1.5	1.1	1.4	0.1	1.7	2.6	1.1	0.0	1.6	2.9	0.1	0.3	0.5	0.3	2.8	1.5	11.7	50.7	1.1	27.4	25.1	7.6	23.6	11.3	46.9	3.6	26.8	5.4	164.5	23.0	51.4	0.0	9.4	145.2	6.7	15.9	2184.4	0.0	2.9	5804.3	77.4	0.3	3.5	4202.6	140.2	238.0	320.8	7.8	355.3	17.3	13716.6	22.8	0.0	237.6	129.5	169.9	0.2	21.6	83.6	28.7	18.0	3803.0	0.0	432.8	6754.7	2.1	31723.3	0.0	0.0	18.1	0.3	0.9	68.1	111.0	37.1	2367.7	10.9
MUC15		ENSG00000169550	"Mucin 15, cell surface associated"	Q8N387	11	26559033-26572233	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8"	"Cell type enhanced"	"Detected in many"	25	"Alveolar cells type 1: 101.3;Ciliated cells: 164.6;Syncytiotrophoblasts: 556.9"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 56.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;K-562: 9.7;SK-BR-3: 16.6;SuSa: 11.3;U-266/70: 6.5;U-266/84: 17.4"	"Group enriched"	"Detected in some"	4	"cerebellum: 1.3;thalamus: 1.5"	"Low region specificity"	"Detected in many"			"HPA026110, HPA073304"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA026110: AB_1854200, HPA073304: "	"unprognostic (1.49e-1)"	"unprognostic (2.08e-3)"		"unprognostic (7.71e-5)"		"unprognostic (5.09e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.54e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	3.9	0.0	0.0	9.3	0.0	0.1	265.1	11.0	1.0	0.1	0.1	0.0	0.0	5.2	0.1	4.8	0.1	0.0	0.0	0.1	1.8	0.0	2.1	56.8	0.0	0.8	0.0	0.0	14.4	1.0	0.0	12.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	1.1	77.8	8.1	1.7	3.0	6.5	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.6	0.0	16.6	0.0	11.3	0.1	0.0	0.0	0.0	2.5	0.0	0.0	6.5	17.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	20.9	0.0	12.3	3.1	0.0	0.0	0.0	164.6	64.8	47.1	0.0	52.1	26.6	3.0	0.4	0.0	0.0	0.0	0.0	15.5	0.5	0.6	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	26.0	556.9	0.0	0.0	10.5
MUC17		ENSG00000169876	"Mucin 17, cell surface associated"	Q685J3	7	101020072-101058745	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	299	"intestine: 125.2"	"Cell type enriched"	"Detected in some"	5	"Enterocytes: 59.0"	"Group enriched"	"Detected in some"	29	"colorectal cancer: 6.1;pancreatic cancer: 4.9;stomach cancer: 22.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;OE19: 1.0"									HPA031634	Enhanced				"Intracellular and membrane"	NA	NA					"HPA031634: AB_10603021"			"unprognostic (2.37e-2)"	"unprognostic (2.41e-1)"		"unprognostic (8.17e-3)"					"unprognostic (5.57e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.79e-8)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-2)"			0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	64.7	0.0	0.0	15.8	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	2.5	0.0	0.1	0.0	0.1	0.1	125.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	3.5	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0
MUC19	FLJ35746	ENSG00000205592	"Mucin 19, oligomeric"		12	40393395-40570832	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	4	"salivary gland: 22.6"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-937: 8.9"														"Intracellular and membrane"	NA	NA						"unprognostic (7.80e-3)"	"unprognostic (2.84e-1)"		"unprognostic (1.69e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.25e-3)"		"unprognostic (8.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.63e-2)"	"unprognostic (6.99e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.35e-3)"	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUC2		ENSG00000198788	"Mucin 2, oligomeric mucus/gel-forming"		11	1074875-1110511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	20	"intestine: 28.1"	"Group enriched"	"Detected in some"	38	"Cardiomyocytes: 14.8;granulocytes: 9.2;Intestinal endocrine cells: 13.6"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 93.2;pancreatic cancer: 27.7;stomach cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.0;RPMI-8226: 1.0;RT4: 2.6;U-2197: 1.0"									CAB016275	Enhanced				"Intracellular and membrane"	NA	NA					"CAB016275: AB_627970"	"unprognostic (6.37e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.09e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.37e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.10e-2)"	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUC3A	MUC3	ENSG00000169894	"Mucin 3A, cell surface associated"	Q02505	7	100949555-100968346	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"gallbladder: 84.4;intestine: 138.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 181.0;Mucus-secreting cells: 104.0;Paneth cells: 136.8;Undifferentiated cells: 104.3"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 29.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 11.8;CAPAN-2: 3.9;MCF7: 2.6;OE19: 5.9"									HPA010871	Uncertain				"Intracellular and membrane"	NA	NA					"HPA010871: AB_1854201"	"unprognostic (1.12e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.50e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.51e-2)"	0.1	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	31.4	0.0	0.0	23.3	0.0	0.0	0.0	0.0	84.4	0.8	0.0		0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.5	6.7	0.0	0.0	0.0	2.4	0.0	138.0	0.1	0.0	0.0	1.4	0.0	0.0	19.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	11.8	3.9	0.0	0.1	0.0	0.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	2.6	0.0	0.0	1.7	5.9	0.0	0.0	0.0	0.3	0.6	0.0	0.9	0.0	0.0	1.2	0.0	1.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	21.4	0.0	0.0	1.2	33.1	0.0	0.0	1.8	0.0	0.3	0.0	12.0	0.4	0.0	181.0	0.0	25.0	0.6	0.0	42.1	0.0	5.1	0.2	0.0	9.9	0.6	1.5	0.0	0.3	0.0	0.0	1.8	104.0	0.0	34.7	136.8	0.0	0.1	0.0	0.0	1.3	0.5	3.4	0.1	0.2	0.0	104.3	12.8
NAA38	"LSMD1, MGC14151, PFAAP2"	ENSG00000183011	"N(alpha)-acetyltransferase 38, NatC auxiliary subunit"	Q9BRA0	17	7856685-7885238	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 1093.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059189			Supported	Nucleoplasm	"Intracellular and membrane"	No	No			Nucleoplasm		"HPA059189: "	"unprognostic (6.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.28e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.75e-2)"	24.4	38.7	55.9	20.5	51.0	41.8	23.8	25.1	60.7	22.1	27.0	18.7	16.2	20.1	17.2	22.9	19.8	30.1	28.1	34.2	41.4	37.2	26.1	27.6	18.4	26.3	45.9	36.2	15.8	33.3	17.9	21.3	15.0	32.1	26.7	18.1	19.7	37.5	33.2	74.5	16.5	18.2	23.8	34.2	22.3	22.2	26.6	25.6	14.6	18.7	39.8	20.0	18.0	15.9	66.0	84.4	68.7	71.8	35.5	52.1	70.5	27.7	51.1	28.7	29.3	16.0	17.9	9.9	13.0	15.1	24.1	20.2	19.2	11.9	19.2	22.0	13.7	15.4	22.9	15.3	24.0	6.0	28.4	69.8	29.2	57.9	27.7	15.6	8.1	22.7	25.9	13.4	15.7	10.3	16.7	23.3	44.1	6.0	21.0	13.9	33.5	29.3	19.4	6.4	21.1	59.6	30.2	13.2	12.7	22.0	15.7	12.8	24.6	10.1	24.5	18.4	4.3	15.1	21.5	12.5	16.2	11.7	13.1	36.3	8.7	8.8	7.0	27.3	33.9	15.8	68.7	71.8	47.6	47.7	59.1	43.6	66.0	50.9	48.6	84.4	57.1	46.1	47.8	51.7	35.5	56.4	76.8	52.1	70.5	55.9	51.0	25.1	60.7	41.4	37.2	45.9	36.2	32.1	25.6	71.5	116.4	99.9	74.2	83.6	100.6	294.9	109.5	131.2	75.1	240.8	47.1	142.9	439.3	87.9	575.0	132.2	186.5	70.0	137.1	98.8	70.4	99.2	97.1	325.3	181.0	38.1	217.8	193.3	210.1	1093.0	108.1	113.0	72.6	165.1	179.4	108.6	125.9	144.0	106.4	289.2	88.8	109.9	82.5	94.0	121.8	86.9	76.9	96.9	261.5	96.2
NDFIP1	"MGC10924, N4WBP5"	ENSG00000131507	"Nedd4 family interacting protein 1"	Q9BT67	5	142108505-142154443	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009682	Approved				"Intracellular and membrane"	NA	NA					"HPA009682: AB_1079455"	"unprognostic (2.78e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.74e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (6.95e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (2.39e-7)"	"unprognostic (9.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.76e-2)"	23.3	34.2	43.8	12.9	48.8	9.0	23.4	47.5	68.3	24.0	16.2	21.3	21.6	19.7	18.9	57.4	12.6	19.5	18.6	21.7	42.6	55.0	38.9	47.7	20.0	21.5	36.8	44.0	26.4	25.8	64.6	25.8	18.1	46.2	28.4	16.0	24.3	36.8	31.6	16.5	12.3	18.8	16.9	26.7	21.3	20.0	16.2	18.4	11.7	42.4	8.8	13.7	18.7	14.7	4.9	14.0	21.0	14.8	8.7	34.0	21.8	16.4	11.1	20.0	26.9	42.6	24.3	13.4	18.0	18.9	15.6	17.9	12.4	27.9	1.5	37.7	19.6	21.7	16.6	12.7	18.9	18.5	18.9	15.6	21.8	10.9	8.9	18.6	11.8	7.8	18.5	17.9	10.9	14.3	22.4	17.9	17.2	7.1	26.9	19.3	8.5	13.1	3.7	10.7	16.3	10.7	5.0	11.1	37.7	38.4	17.7	21.2	22.0	19.7	29.6	26.5	15.6	20.8	11.8	20.5	19.3	7.2	15.5	17.7	17.4	19.9	6.8	20.4	7.8	14.6	21.0	12.4	9.6	9.3	14.8	11.8	4.9	16.7	11.4	14.0	3.8	34.0	26.1	7.5	8.7	14.2	4.2	18.6	21.8	43.8	48.8	47.5	68.3	42.6	55.0	36.8	44.0	46.2	18.4	53.6	60.0	62.4	137.2	99.1	191.3	61.8	109.5	28.1	37.5	146.5	133.5	129.0	119.3	174.5	17.1	98.8	109.7	163.5	126.9	230.0	162.0	235.1	58.9	149.5	139.2	300.3	132.1	108.1	191.1	10.1	107.9	128.4	161.9	202.0	70.9	284.2	150.5	92.1	147.4	149.1	267.3	129.4	117.6	20.0	28.7	88.5	160.2	97.0	70.7	226.5
NECAB3	"APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51"	ENSG00000125967	"N-terminal EF-hand calcium binding protein 3"	Q96P71	20	33657087-33674463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 49.7"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044785, HPA070595, HPA071786"	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186"	"unprognostic (8.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.44e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.19e-5)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (6.13e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-1)"	7.7	29.1	13.9	5.6	10.5	2.3	6.4	3.8	30.0	5.7	8.1	7.1	9.4	14.6	4.9	8.4	6.5	6.9	5.5	30.5	13.2	10.0	6.4	6.3	11.9	2.9	11.3	15.0	22.4	13.6	10.9	5.5	4.9	15.5	23.8	5.4	6.9	13.7	9.7	49.7	3.3	8.3	7.4	6.8	3.4	13.6	6.5	5.5	0.4	10.6	10.8	3.3	7.7	7.8	1.2	2.6	3.5	6.5	2.4	3.0	1.2	4.4	3.9	2.9	5.9	2.3	4.6	14.2	6.3	2.4	4.1	3.6	18.4	3.0	5.0	15.1	3.7	9.6	5.4	3.0	1.8	1.5	1.7	4.4	4.7	16.6	21.4	6.2	1.1	4.6	5.8	2.7	3.8	1.2	4.4	2.7	2.7	6.8	2.7	5.2	6.9	1.7	4.7	1.2	4.8	10.0	5.3	7.6	8.6	3.7	3.4	18.6	5.2	14.6	16.3	6.4	3.3	20.7	5.7	2.2	5.0	7.1	6.5	7.0	10.2	4.2	9.1	9.8	2.2	2.1	0.0	2.7	3.5	0.8	2.5	1.9	0.5	1.3	0.7	2.6	1.2	1.0	0.3	0.1	2.4	6.5	0.1	3.0	1.2	13.9	10.5	3.8	30.0	13.2	10.0	11.3	15.0	15.5	5.5	14.9	39.2	3.4	5.1	2.7	16.0	27.9	5.1	4.0	5.7	5.2	7.9	16.1	28.2	3.2	75.4	2.9	30.8	0.0	6.5	21.8	7.5	16.3	3.5	6.6	7.6	7.9	19.1	2.5	4.0	41.0	24.5	5.4	11.8	1.8	16.2	17.7	5.0	13.3	22.3	9.2	15.9	6.5	14.7	14.0	14.7	2.8	17.3	5.1	19.1	8.2
NLRP5	"CLR19.8, MATER, NALP5, PAN11, PYPAF8"	ENSG00000171487	"NLR family pyrin domain containing 5"	P59047	19	55999726-56061813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"parathyroid gland: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"Karpas-707: 3.1;U-2 OS: 9.2"									HPA056271	Uncertain				"Intracellular and membrane"	NA	NA					"HPA056271: AB_2683083"	"unprognostic (9.67e-2)"			"unprognostic (2.22e-2)"								"unprognostic (5.03e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		3.1	0.0	19.3	0.6	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPIPB15	"LOC440348, NPIPL2"	ENSG00000196436	"Nuclear pore complex interacting protein family member B15"	A6NHN6	16	74377878-74392080	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 18.6"	"Group enriched"	"Detected in many"	8	"Early spermatids: 335.7;Late spermatids: 195.5"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	5	"memory B-cell: 4.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"T-47d: 13.5"									"HPA011188, HPA053611"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (2.23e-2)"	"unprognostic (3.48e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.14e-3)"	1.8	1.2	0.8	0.5	1.3	2.9	3.8	4.5	1.5	2.1	6.2			4.1	1.1	0.0	3.0	2.1	2.1	1.1	1.1	0.8	3.1	8.4	2.4	2.6	0.8		1.8	6.1	4.4	5.2	2.7		7.1	11.2		6.1	1.1	3.0	4.1	5.3	1.5	0.9	3.1	4.3	18.6			4.4		2.2	1.4	1.8	4.0	0.2	0.8	0.3	0.6	0.6	0.5	2.8	0.1	2.7	1.6	3.3	2.3	0.6	1.9	2.6	2.1	5.9	1.6	0.1	4.7	0.0	3.7	0.0	5.3	0.0	2.2	1.7	0.0	3.0	0.1	6.2	2.7	1.5	1.9	9.5	3.2	4.8	4.3	3.3	3.2	0.0	0.1	0.4	1.9	1.8	4.3	1.0	0.0	0.6	1.4	0.0	1.0	2.7	3.1	0.0	1.8	3.8	0.0	7.0	0.0	4.5	0.0	13.5	2.2	0.2	2.0	5.6	0.0	1.0	6.5	1.8	1.1	2.7	1.3	1.4	0.0	0.3	0.2	0.6	0.0	0.0	4.0	0.2	0.6	0.2	0.7	0.2	0.0	0.8	0.6	0.1	0.1	0.0	0.5											3.0	5.1	3.7	1.6	1.8	2.8	1.1	7.6	4.0	7.9	7.0	7.9	1.0	0.0	1.2	335.7	2.9	12.4	0.0	3.3	0.9	3.4	5.9	0.0	2.1	1.0	0.0	16.8	3.1	4.0	195.5	10.6	1.2	3.3	1.0	35.4	1.1	2.1	28.1	7.1	0.5	1.7	0.0	2.8	7.2	5.3	2.4	2.1	4.5	15.8	5.5
NPIPB7	"LOC440350, NPIPL1"	ENSG00000233232	"Nuclear pore complex interacting protein family member B7"	O75200	16	28456372-28471175	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 14.9"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 117.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.2;hTCEpi: 2.5;U-266/70: 1.6"									"HPA011188, HPA053611"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA011188: AB_2668455, HPA053611: AB_2682206"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-1)"		"unprognostic (7.43e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.03e-2)"	0.0	0.0	0.5	0.2	0.9	0.1	0.1	2.3	0.5	0.1	0.3			0.3	0.3	0.3	0.0	0.2	0.1	0.1	0.5	0.8	0.0	0.0	0.2	0.4	0.3		0.5	0.4	0.0	0.0	0.0		0.1	0.5		0.0	0.1	0.0	0.8	0.2	0.1	0.2	0.1	0.1	14.9			0.4		0.1	0.1	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	6.2	0.0	0.2	0.0	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.5	0.4	0.2	0.1	0.0	1.2	0.0	0.1	0.0	0.9	0.1	1.0	0.6	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.4	0.1	0.0	1.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	117.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0
NUBPL	"C14orf127, FLJ12660, huInd1, IND1"	ENSG00000151413	"Nucleotide binding protein like"	Q8TB37	14	31489956-31861224	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029203	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA029203: AB_10602810"	"unprognostic (1.49e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.21e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.64e-8)"	"unprognostic (2.82e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.56e-2)"	12.0	16.0	11.4	11.6	10.7	2.1	12.1	5.7	11.5	7.5	10.1	10.6	9.1	6.6	14.7	13.3	7.6	9.0	7.4	22.5	11.5	9.2	16.5	16.2	10.2	6.9	11.0	8.9	11.3	7.8	14.1	19.0	7.4	12.7	8.9	10.7	10.0	15.4	9.0	16.7	8.1	7.7	11.3	13.5	8.5	8.0	19.2	12.2	6.2	10.8	6.3	8.7	9.7	7.5	4.9	7.5	0.7	2.0	4.1	5.4	1.5	10.5	6.7	5.1	2.5	7.3	13.5	8.9	5.4	6.5	6.9	8.4	4.6	12.2	7.5	7.2	7.1	5.9	9.4	6.8	11.7	12.4	5.4	8.7	2.7	5.0	23.6	7.2	7.9	2.4	8.8	13.8	4.8	10.5	5.9	4.0	5.4	4.9	4.0	7.8	5.8	5.8	5.5	4.2	8.4	10.2	6.6	10.6	4.1	8.3	7.9	4.9	5.0	9.2	8.7	11.3	6.1	17.0	4.2	3.8	7.0	4.8	4.5	5.3	6.4	6.4	7.4	4.7	5.7	6.3	0.0	2.0	0.6	3.9	2.0	3.1	4.9	4.5	4.2	7.5	2.9	5.4	4.2	0.7	4.1	1.1	3.6	2.5	1.5	11.4	10.7	5.7	11.5	11.5	9.2	11.0	8.9	12.7	12.2	11.9	9.8	3.9	7.4	8.5	14.6	31.5	15.3	22.7	14.8	8.7	19.6	9.4	6.6	5.5	15.6	8.0	6.3	0.0	5.0	8.4	9.8	4.9	13.9	11.6	4.4	9.5	6.9	4.9	3.3	5.3	6.1	7.2	11.8	1.0	10.0	15.8	4.2	2.9	11.0	14.6	27.1	12.9	6.5	13.7	5.2	10.2	4.8	4.4	16.8	5.5
NXPE1	"FAM55A, MGC34290"	ENSG00000095110	"Neurexophilin and PC-esterase domain family member 1"	Q8N323	11	114521645-114559895	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 44.0;lymphoid tissue: 20.4"	"Cell type enhanced"	"Detected in some"	13	"Early spermatids: 50.2;Late spermatids: 47.7;Mucus-secreting cells: 34.2;Undifferentiated cells: 40.5"	"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;U-138 MG: 1.1;WM-115: 1.0"									HPA049133	Enhanced				"Intracellular and membrane"	NA	NA					"HPA049133: AB_2680647"	"unprognostic (2.81e-1)"		"unprognostic (2.19e-3)"		"unprognostic (3.40e-3)"			"unprognostic (4.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.76e-1)"				0.1	0.0	0.1	20.4	0.1	0.0	0.1	0.1	0.1	0.1	44.0	0.1	0.1	0.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	36.9	0.1	0.3	0.1	0.1	0.0	4.4	1.0	0.1	0.1	0.0	2.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	12.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.0	0.0	47.7	0.3	0.0	0.0	0.0	34.2	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	40.5	0.0
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 101.3;Urothelial cells: 183.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;CAPAN-2: 28.4;HaCaT: 22.9;MCF7: 22.6;RPTEC TERT1: 17.7;RT4: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.8	3.4	3.8	3.7	0.5	7.6	3.9	2.9	4.3	15.5	3.2	21.9	10.2	1.7	7.4	10.6	7.9	17.1	1.1	4.0	2.9	15.3	31.7	29.2	0.4	4.0	1.7	2.3	33.2	12.0	3.2	9.0	6.7	5.7	10.9	7.7	7.1	25.0	0.5	8.7	24.5	1.2	3.8	2.1	15.1	2.0	1.5	0.4	58.1	9.8	8.6	5.0	6.5	1.2	1.2	1.8	0.3	2.0	0.9	0.1	15.4	6.2	0.1	0.5	0.2	0.4	12.5	0.0	1.5	2.1	3.1	21.3	28.4	0.1	5.4	0.3	7.8	22.9	6.3	3.0	5.8	0.1	11.1	1.2	0.2	6.5	0.1	0.5	1.6	0.0	3.2	4.8	0.2	1.1	1.2	2.1	0.0	0.1	0.0	22.6	0.6	0.4	2.4	6.8	2.6	0.0	4.7	0.5	17.7	19.3	2.1	1.0	0.1	16.9	0.2	4.4	9.5	1.9	0.2	0.1	6.4	1.3	1.5	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.7	0.8	0.2	0.2	0.8	0.9	0.3	0.1	1.2	0.7	0.9	1.8	2.0	0.2	1.2	0.4	0.1	3.4	3.7	3.9	2.9	4.0	2.9	4.0	1.7	6.7	1.5	101.3	47.6	3.2	51.5	3.3	6.0	1.3	56.0	48.2	55.7	24.4	13.7	26.5	8.3	49.2	2.0	5.3	55.1	0.0	52.8	1.2	3.2	76.5	2.3	42.9	2.6	6.4	25.2	16.0	25.3	1.1	2.8	2.6	1.7	5.4	35.4	3.5	63.1	47.2	1.4	11.3	6.2	12.9	2.7	4.2	7.8	13.6	13.7	4.9	33.9	183.7
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9, endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 291.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	39.3	32.9	24.4	28.1	27.6	32.2	38.0	27.0	34.9	37.4	39.1	27.6	34.5	37.2	36.2	37.7	35.2	32.0	33.0	39.2	23.2	23.1	42.9	94.4	40.2	34.2	27.7	22.0	44.2	110.7	49.5	29.2	47.0	28.2	34.7	34.1	42.0	53.2	28.5	19.0	36.9	47.4	28.1	18.6	37.5	35.7	21.4	24.0	23.8	47.6	23.2	34.4	33.3	35.1	11.5	35.8	54.1	48.7	11.4	16.1	36.7	6.7	13.8	7.0	17.4	36.7	24.9	15.6	17.0	21.7	12.6	12.8	14.3	22.1	8.7	28.4	20.3	9.7	12.3	6.5	11.0	10.0	11.1	7.9	9.8	9.8	12.9	24.0	15.3	25.2	22.8	17.7	12.3	12.6	43.4	20.9	5.8	7.4	34.7	13.1	11.7	4.1	18.6	7.9	13.5	9.8	5.4	291.6	21.8	9.6	16.8	7.2	9.6	24.2	16.7	13.7	13.4	19.9	30.2	19.1	17.0	10.2	11.5	10.7	20.7	17.8	9.0	14.4	11.2	23.4	30.6	48.7	54.1	16.1	44.4	15.2	10.9	13.7	14.2	35.8	11.5	10.7	12.3	52.0	11.4	35.0	31.1	15.0	36.7	24.4	27.6	27.0	34.9	23.2	23.1	27.7	22.0	28.2	24.0	80.4	110.4	55.1	75.1	51.3	42.6	12.6	91.7	93.7	103.5	69.8	72.6	122.4	8.3	114.5	4.8	76.5	142.5	46.7	96.4	106.6	99.6	64.6	86.8	139.4	128.9	47.7	99.5	76.7	105.2	9.1	105.0	115.3	113.1	158.7	107.2	85.8	84.7	129.8	74.3	44.0	34.1	90.5	57.7	33.4	54.8	45.0	165.3	69.2	78.8	57.0
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380879	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0"	"Cell type enhanced"	"Detected in some"	24	"Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	4	"amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 5.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.4	0.2	3.5	0.2	4.3	0.1	0.4	0.2	5.8	0.4	2.7	0.0	0.0	0.2	0.5	3.1	0.5	0.5	0.4	9.8	1.0	0.4	13.3	0.1	0.3	0.5	0.5	3.6	0.2	0.7	0.2	21.0	1.4	0.3	0.5	0.3	1.4	0.3	0.5	1.0	0.3	0.6	0.6	0.3	0.4	0.4	0.8	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.5	3.9	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.4	0.5	2.5	0.0	0.2	0.9	0.0	0.1	7.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	0.2	5.8	1.0	0.4	0.5	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
P3H4	"LEPREL4, NO55, SC65"	ENSG00000141696	"Prolyl 3-hydroxylase family member 4 (non-enzymatic)"	Q92791	17	41801947-41812604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 4.4;MAIT T-cell: 5.9;memory CD4 T-cell: 2.9;memory CD8 T-cell: 2.8;naive CD4 T-cell: 3.5;naive CD8 T-cell: 4.2;NK-cell: 9.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 9.5;T-cells: 5.9"	"Cell line enriched"	"Detected in many"	12	"OE19: 144.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA022520			Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA022520: "	"unprognostic (9.11e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.69e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (4.48e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.96e-3)"	5.0	13.6	5.4	6.0	5.0	0.5	12.7	7.8	6.2	11.5	8.9	2.9	17.9	8.6	11.9	10.4	5.3	8.3	11.2	9.7	4.3	5.0	7.9	2.7	6.4	6.7	5.5	6.0	12.2	34.5	11.5	11.8	12.8	4.4	10.0	4.3	7.3	10.9	9.5	3.9	7.7	7.6	10.5	3.7	4.4	5.4	3.5	5.9	0.9	20.9	4.5	4.4	7.6	7.1	0.8	0.3	0.0	0.2	9.5	5.9	1.5	1.2	6.6	4.0	10.4	4.3	4.2	3.9	9.7	4.9	3.8	5.2	3.2	1.8	0.2	4.1	8.4	2.9	2.2	3.4	4.7	1.3	2.6	5.4	1.6	6.4	4.3	5.3	0.3	0.5	4.4	1.3	3.3	2.9	8.9	4.7	0.4	0.2	1.6	2.3	4.4	0.0	0.8	2.5	144.7	3.6	3.3	4.4	4.3	2.3	0.3	2.0	4.1	1.8	11.8	4.0	2.6	6.8	1.1	4.9	3.7	5.4	6.7	4.8	1.5	0.3	0.0	5.6	1.5	5.6	0.0	0.2	0.0	4.4	0.0	5.9	0.6	2.9	2.8	0.3	0.8	3.5	4.2	0.0	9.5	0.0	0.0	0.7	1.5	5.4	5.0	7.8	6.2	4.3	5.0	5.5	6.0	4.4	5.9	0.0	8.5	0.0	4.7	0.0	3.4	8.3	7.6	1.4	3.4	5.2	7.9	8.8	6.6	19.2	0.4	6.0	9.1	23.3	5.8	23.2	10.0	7.7	1.1	2.4	2.5	25.4	2.4	12.3	0.6	0.4	19.5	1.0	0.0	1.0	13.6	11.6	8.0	10.5	19.4	4.8	2.5	19.4	3.4	2.5	8.3	0.0	4.5	2.9	11.8	1.8
PDZD11	PDZK11	ENSG00000120509	"PDZ domain containing 11"	Q5EBL8	X	70286595-70290514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003972	Approved				"Intracellular and membrane"	NA	NA					"HPA003972: AB_1855165"	"unprognostic (1.51e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.52e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.72e-3)"	16.5	22.0	40.1	11.2	32.1	5.8	21.3	14.4	36.0	20.3	24.2	23.5	12.4	20.7	18.4	28.7	26.1	19.9	17.2	30.7	34.5	39.6	27.5	21.7	13.1	15.1	40.6	25.1	17.5	21.9	23.5	18.4	13.7	35.8	20.2	28.5	26.0	22.1	21.9	12.9	20.0	26.7	22.1	29.2	14.6	17.1	8.1	13.4	17.8	24.0	22.0	21.3	21.7	16.6	16.9	17.3	7.8	25.8	16.0	33.4	14.8	20.0	22.7	15.7	17.5	25.9	30.9	13.4	21.8	24.3	32.5	30.2	21.6	25.6	10.8	26.9	38.3	36.7	15.4	25.6	29.3	36.8	15.1	20.7	7.0	23.3	16.6	23.2	9.6	9.8	31.7	20.4	36.1	22.5	30.8	26.1	13.6	11.1	39.2	51.9	29.9	15.5	13.0	12.3	45.1	40.7	11.0	31.7	21.3	27.5	18.2	16.9	17.1	24.1	18.7	22.8	19.6	17.2	8.6	20.5	23.6	19.9	35.7	21.2	8.7	15.3	11.2	34.1	13.9	27.4	5.4	11.6	7.8	19.4	20.8	21.4	16.9	20.0	21.7	17.3	13.8	12.4	17.8	4.8	16.0	25.8	13.1	33.4	14.8	40.1	32.1	14.4	36.0	34.5	39.6	40.6	25.1	35.8	13.4	11.9	10.2	11.9	25.9	21.9	22.1	41.1	25.5	16.0	18.2	31.4	3.9	36.3	99.5	41.7	0.3	23.3	40.0	0.0	36.0	51.5	33.8	19.1	26.5	19.4	54.2	30.2	17.7	24.5	24.5	0.4	28.1	22.2	28.7	36.9	40.5	45.2	44.5	48.0	35.7	68.9	15.6	38.8	27.8	3.8	16.0	24.6	22.4	20.2	39.4	27.7
PET117	CSRP2BP	ENSG00000232838	"PET117 homolog"	Q6UWS5	20	18137873-18143169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA047716	Approved				"Intracellular and membrane"	NA	NA					"HPA047716: AB_2680128"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (7.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (4.15e-4)"	"unprognostic (3.73e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	10.9	19.0	19.9	9.1	23.5	9.3	13.3	16.0	28.6	11.8	15.4	14.4	13.2	23.4	12.9	15.6	10.6	12.2	12.2	13.8	18.5	16.4	21.8	16.1	10.8	12.7	18.8	17.7	14.0	18.9	19.4	17.5	11.4	15.2	16.4	15.7	11.5	12.0	12.1	25.3	11.2	17.7	13.2	18.3	10.1	26.3	13.6	10.2	12.2	13.8	10.3	10.2	10.6	8.6	16.5	24.5	6.5	17.1	12.8	22.3	10.7	18.7	17.5	7.8	8.7	10.2	8.7	20.2	11.2	10.4	12.2	11.7	15.9	16.3	14.7	15.8	9.9	22.0	10.9	12.5	19.5	13.0	4.1	11.9	14.1	10.2	33.6	15.1	18.6	14.1	11.5	12.7	11.8	12.6	10.4	10.5	15.1	10.8	11.0	10.8	16.5	14.7	18.7	11.5	21.1	18.2	9.9	22.7	20.1	13.2	11.2	13.5	12.0	14.8	26.3	26.0	17.6	16.1	13.6	9.6	11.9	8.7	11.8	16.5	13.9	23.5	18.8	5.5	5.8	10.9	2.0	16.1	6.5	13.5	13.9	15.7	15.8	15.8	15.9	14.4	16.5	22.3	17.1	1.0	12.8	17.1	24.5	12.4	10.7	19.9	23.5	16.0	28.6	18.5	16.4	18.8	17.7	15.2	10.2	17.9	8.8	8.2	14.3	3.4	16.6	11.2	33.1	8.1	13.6	15.7	3.9	25.7	28.2	16.4	0.8	7.1	18.1	0.0	23.0	29.0	10.0	16.9	8.1	23.7	13.1	22.3	15.1	4.9	11.9	3.3	15.0	7.7	6.8	11.8	16.6	10.5	25.4	10.5	6.3	42.0	11.9	6.5	8.1	10.4	30.7	5.5	10.9	8.7	20.3	10.5
PIANP	"C12orf53, DKFZp547D2210, PANP"	ENSG00000139200	"PILR alpha associated neural protein"	Q8IYJ0	12	6693792-6700800	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.7"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 13.9;Horizontal cells: 17.5;Peritubular cells: 13.1"	"Cancer enhanced"	"Detected in many"		"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.9;HAP1: 7.8;hTERT-RPE1: 13.1;NTERA-2: 16.5;SH-SY5Y: 15.6;U-2 OS: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010631	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA010631: AB_10603680"	"unprognostic (1.82e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.30e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	1.5	8.3	28.0	2.2	55.7	1.2	1.5	27.4	52.8	7.2	2.7	2.6	0.5	1.9	11.6	4.1	1.8	2.2	3.3	1.5	19.5	26.2	1.5	1.1	1.5	2.4	11.0	20.9	1.8	1.7	1.2	4.0	1.5	9.0	3.4	2.0	1.7	2.2	8.7	1.3	1.7	2.2	8.1	4.6	1.6	2.1	4.4	8.3	0.0	1.4	0.0	1.7	1.8	2.5	0.3	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.4	5.9	1.1	0.2	0.3	0.2	1.5	7.9	4.1	3.7	0.1	0.2	0.1	0.0	2.8	0.6	0.2	7.8	0.2	2.0	0.2	1.0	0.3	0.2	0.0	0.2	0.3	0.2	1.0	0.0	1.6	0.0	13.1	0.0	2.4	0.0	0.2	0.3	0.2	0.2	0.2	16.5	0.0	0.0	1.1	0.0	0.1	0.1	0.1	2.1	15.6	0.0	0.1	0.0	1.1	0.0	0.0	0.0	4.3	8.7	4.4	1.1	0.2	0.0	0.3	5.8	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.7	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.0	55.7	27.4	27.8	19.5	26.2	11.0	20.9	9.0	8.3	0.0	0.0	0.0	0.0	0.2	13.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	17.5	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	13.1	0.0	3.0	0.0	1.4	0.1	4.5	0.1	0.1	0.0	0.0	0.0
PIGBOS1		ENSG00000225973	"PIGB opposite strand 1"	A0A0B4J2F0	15	55317184-55319161	"Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 35.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																"Intracellular and membrane"	NA	NA						"prognostic favorable (4.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.58e-3)"	"unprognostic (4.62e-3)"	"unprognostic (7.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.96e-1)"	6.7	5.8	3.9	7.3	6.4	11.0	7.1	4.1	10.6	4.4	6.2	7.4	6.4	6.9	7.3	7.4	5.1	6.6	8.2	6.6	4.0		9.7	9.2	7.4	11.5	7.9	4.9	6.8	13.4	4.5	9.1	8.3	6.4	5.8	5.6	7.3	6.2	4.3	5.5	4.6	8.0	6.0	5.5	7.8	7.1	5.2	7.1	9.1	12.6	4.4	5.8	7.1	7.3	20.3	26.7	35.9	27.1	19.5	27.7	16.6	7.6	7.6	6.7	4.6	9.1	10.6	8.7	8.7	7.8	6.3	4.5	4.1	5.3	9.9	10.0	5.2	11.2	6.8	2.4	4.3	4.2	12.8	3.7	16.8	7.0	8.0	7.5	11.4	14.4	8.6	7.8	4.4	4.5	9.1	7.3	9.3	20.1	9.4	5.8	6.4	5.8	23.3	3.8	8.5	4.3	8.2	6.2	18.1	5.7	5.0	5.0	8.4	5.2	7.8	25.0	9.1	8.0	27.4	7.4	10.3	12.4	6.0	11.9	10.1	26.6	8.4	9.2	25.8	10.9	28.1	27.0	35.9	16.7	19.9	15.4	18.8	20.3	17.7	20.8	20.3	27.7	20.2	27.5	19.5	27.1	26.7	24.9	16.6											26.8	16.3	25.8	12.8	0.0	13.5	6.0	10.2	34.8	18.2	17.4	5.9	29.2	33.2	21.7	15.6	15.8	17.3	46.7	34.1	29.3	12.4	16.7	6.9	29.7	33.5	17.5	28.9	25.8	24.3	3.4	27.6	29.1	0.0	32.5	16.3	17.9	24.2	17.6	18.4	37.3	19.5	32.3	13.0	14.6	16.4	0.0	19.9	23.0	15.5	7.8
PIGR		ENSG00000162896	"Polymeric immunoglobulin receptor"	P01833	1	206928518-206946466	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 139.0;intestine: 320.1;salivary gland: 398.1"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 2375.7;Mucus-secreting cells: 2056.5;Paneth cells: 2331.9;Undifferentiated cells: 3429.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 731.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"EFO-21: 28.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006154, CAB009454, HPA012012"	Enhanced				"Intracellular and membrane"	NA	NA		1900000000			"CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371"	"prognostic favorable (1.22e-5)"	"unprognostic (7.42e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (5.08e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-2)"	0.3	0.3	0.3	74.2	0.3	0.0	6.9	0.3	0.3	35.1	232.8	0.6	0.4	158.9	2.6	0.5	2.6	0.7	139.0	0.3	0.3	0.3	52.5	5.0	25.1	0.3	0.3	0.3	0.6	4.2	0.0	0.9	0.4	0.3	3.0	75.6	0.4	398.1	0.6	0.4	0.4	320.1	2.0	0.3	0.4	25.3	0.6	0.3	0.4	0.4	23.9	22.5	4.9	0.6	3.4	1.1	1.4	0.5	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	1.4	0.2	0.0	0.0	0.2	0.0	5.0	0.1	1.3	0.6	2.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.2	0.3	1.0	0.0	0.1	0.0	1.4	0.5	0.3	0.4	0.2	0.5	3.4	0.3	0.3	1.1	3.4	0.5	0.5	1.4	0.5	0.3	0.9	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	86.4	488.0	21.0	2.7	0.2	0.0	0.8	662.5	127.2	379.9	102.9	0.0	0.0	14.9	60.9	0.0	0.5	2375.7	0.0	58.6	0.0	0.0	57.7	51.8	26.7	0.3	0.0	410.4	1.8	1.5	0.0	0.0	3.2	1.7	1.0	2056.5	0.0	144.1	2331.9	0.0	262.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3429.8	34.0
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593312-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 66.5;Kupffer cells: 114.3;Macrophages: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9"	"Group enriched"	"Detected in all"	6	"B-cells: 17.5;monocytes: 38.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.7;NB-4: 17.8;REH: 52.8;THP-1: 26.9;U-698: 33.7;U-937: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	5.8	2.2	2.9	16.8	7.1	14.7	4.8	1.0	3.0	1.4	2.2	3.2	0.0	1.9	1.3	2.3	1.3	2.0	8.5	3.3	3.1	2.4	6.2	38.4	6.0	19.5	5.3	0.5	3.3	16.1	0.3	3.0	10.9	5.1	1.8	2.7	1.6	29.7	0.8	1.1	1.5	6.6	2.4	7.3	32.0	1.9	1.7	4.3	2.0	2.4	0.6	19.2	4.1	2.2	17.5	4.4	4.7	38.9	4.5	4.8	4.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.4	24.7	2.5	0.0	0.4	0.0	5.2	0.0	0.2	13.7	0.9	3.7	0.0	0.4	0.0	10.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.3	17.8	0.2	7.0	0.3	52.8	1.2	5.8	0.0	0.0	1.1	0.6	0.0	0.0	0.3	0.1	0.0	26.9	0.0	0.0	0.8	0.0	0.2	0.2	0.0	33.7	0.0	27.7	0.0	1.7	5.4	3.3	4.8	15.5	1.7	17.5	0.1	1.5	4.4	16.2	0.0	1.2	4.7	4.5	38.9	3.9	0.1	4.2	2.9	7.1	1.0	3.0	3.1	2.4	5.3	0.5	5.1	4.3	3.0	3.8	29.6	0.0	1.3	0.2	2.2	28.1	1.4	3.4	1.8	2.0	0.4	1.7	26.1	3.3	1.4	2.6	0.0	25.2	0.7	1.0	0.5	13.9	66.5	41.2	0.0	1.7	8.0	114.3	0.4	1.1	53.7	5.0	2.8	2.5	0.2	22.8	18.4	2.1	12.8	3.3	0.0	1.7	0.2	0.2	1.0	1.9	27.7	2.9	0.1
PLXDC1	"TEM3, TEM7"	ENSG00000161381	"Plexin domain containing 1"	Q8IUK5	17	39063303-39154394	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 313.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.2;MOLT-4: 4.1;U-87 MG: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012805	Approved				"Intracellular and membrane"	NA	NA		6000000			"HPA012805: AB_1857893"	"unprognostic (4.28e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.07e-3)"	"unprognostic (6.07e-3)"	"unprognostic (4.62e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (9.15e-8)"	"unprognostic (9.37e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.33e-2)"	6.1	3.5	6.6	5.7	13.8	1.4	10.0	13.3	13.8	6.9	5.1	5.0	5.9	2.4	15.1	7.8	14.6	10.4	17.1	18.4	7.6	6.3	3.7	1.0	5.0	6.0	7.8	6.3	18.2	4.3	1.3	3.1	2.7	7.5	5.2	3.7	19.7	4.0	6.6	8.4	5.1	5.0	13.2	3.7	2.3	4.5	6.0	4.8	27.8	3.4	10.5	10.8	5.9	5.2	0.3	2.0	1.0	0.3	2.2	4.9	1.6	0.1	0.0	0.2	2.1	0.4	0.0	0.3	0.2	13.2	1.0	0.6	0.2	3.1	0.2	0.3	0.4	0.1	0.3	0.3	0.2	0.7	0.1	1.1	0.4	1.0	0.1	0.3	0.5	0.1	0.5	0.2	0.5	0.1	0.2	0.0	1.3	0.1	0.9	0.1	1.5	4.1	0.4	0.5	0.1	0.0	0.5	0.7	0.5	0.0	0.1	2.1	0.2	0.1	0.3	0.0	0.3	0.3	0.3	0.0	1.6	0.9	0.6	0.3	0.2	0.1	0.2	8.6	0.6	0.2	0.5	0.3	0.2	3.8	0.1	3.3	0.2	1.3	1.4	0.0	0.3	4.9	4.9	1.0	2.2	0.1	2.0	0.1	1.6	6.6	13.8	13.3	13.8	7.6	6.3	7.8	6.3	7.5	4.8	0.0	12.2	0.0	0.8	4.6	313.9	3.2	0.0	2.7	3.4	0.0	19.6	0.1	0.0	0.0	1.8	3.4	0.0	0.0	0.2	0.1	12.1	0.8	1.1	0.0	0.1	6.4	0.0	0.6	1.0	5.5	0.6	3.5	6.8	8.2	0.0	12.0	0.1	0.0	1.1	0.0	23.0	45.3	22.1	0.5	0.6	3.9	0.0	4.3	0.0	0.4
PRAC2	"C17orf93, HOXB-AS5, HOXB13-AS1, NCRNA00253"	ENSG00000229637	"Prostate cancer susceptibility candidate 2"	D3DTV9	17	48723168-48724758	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"intestine: 11.2;prostate: 12.8;urinary bladder: 3.4"	"Cell type enhanced"	"Detected in some"	8	"Basal glandular cells: 28.5;Early spermatids: 35.3;Glandular cells: 28.1;Intestinal endocrine cells: 30.7;Late spermatids: 33.5;Undifferentiated cells: 22.4;Urothelial cells: 19.2"	"Cancer enriched"	"Detected in many"	8	"prostate cancer: 26.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"PC-3: 32.0;REH: 12.5"														"Intracellular and membrane"	NA	NA						"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"			"unprognostic (9.98e-2)"	"unprognostic (3.27e-2)"		"unprognostic (9.77e-2)"	"unprognostic (8.97e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.82e-1)"	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.8	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.8	32.0	12.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	5.9	0.0	0.0	0.0	0.4	28.1	0.0	0.0	0.1	0.0	30.7	0.0	0.0	33.5	0.3	0.0	0.0	0.0	17.4	0.0	0.0	8.6	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	22.4	19.2
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435288-11450968	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		62000000	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: AB_2677758, HPA043560: AB_2678553"	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	46.9	37.4	26.9	32.5	28.5	50.9	45.0	37.8	39.4	46.8	42.6	36.3	50.1	43.6	50.1	48.4	41.2	50.2	50.2	31.5	27.7	27.3	41.2	85.6	39.9	53.2	29.6	32.1	72.6	77.7	52.9	40.3	72.7	27.0	48.8	38.4	43.9	58.8	53.1	31.3	43.8	41.8	40.1	38.6	42.5	37.9	42.8	29.8	51.6	60.1	32.7	41.9	44.6	44.9	26.2	44.1	32.8	29.8	19.5	28.5	19.4	48.4	34.0	37.8	63.3	64.8	84.0	39.3	52.2	71.3	61.2	57.8	49.6	54.6	31.2	84.6	71.8	30.6	48.2	38.9	56.8	49.6	33.4	25.0	27.1	42.7	43.0	48.5	42.2	39.8	76.7	42.5	57.5	45.4	75.7	41.9	35.1	31.3	70.7	52.9	71.5	32.9	48.8	79.5	23.1	44.0	35.2	34.5	79.3	42.6	42.5	24.0	47.3	45.6	47.5	42.7	36.1	48.8	46.8	42.2	74.4	35.1	70.5	61.1	87.0	103.5	21.7	56.9	44.4	50.7	15.9	29.8	23.8	24.9	22.2	28.5	23.9	21.0	23.8	22.6	26.2	20.3	21.3	32.8	19.5	24.4	44.1	22.0	19.4	26.9	28.5	37.8	39.4	27.7	27.3	29.6	32.1	27.0	29.8	11.9	16.3	75.4	50.7	37.2	17.1	7.8	66.2	16.0	11.4	61.1	31.4	147.4	28.2	75.5	15.3	39.1	147.7	0.0	111.1	158.0	54.4	53.8	41.5	78.4	82.6	9.5	56.6	52.2	73.7	39.6	72.8	59.1	50.6	87.4	103.8	61.8	88.9	99.5	68.2	54.0	21.2	38.8	46.2	36.5	51.7	33.1	120.0	55.4	107.3	50.1
PRRT3	FLJ33674	ENSG00000163704	"Proline rich transmembrane protein 3"	Q5FWE3	3	9945542-9952394	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 23.6;Rod photoreceptor cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;MCF7: 16.1;SK-BR-3: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035127, HPA035128, HPA069859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		18000	"Plasma membrane"	Nucleoplasm	"HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: "	"unprognostic (1.55e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.15e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.09e-1)"	1.4	2.9	8.4	1.8	11.9	2.1	2.0	13.4	26.0	2.4	1.4	4.2	0.0	1.0	2.0	2.2	1.7	10.8	1.9	1.6	5.9	3.2	1.5	0.9	1.4	1.8	2.7	8.3	2.9	2.9	24.7	6.9	0.8	11.4	4.0	0.8	1.8	2.0	2.9	1.5	2.5	1.2	1.7	2.3	1.5	1.5	3.9	3.2	1.2	3.4	0.0	2.0	2.1	1.8	1.8	1.5	0.9	0.6	1.7	3.8	1.0	0.2	0.7	2.6	3.4	12.7	1.7	0.8	1.2	2.4	1.5	3.3	0.2	2.4	1.3	0.3	3.0	1.5	0.2	0.9	3.2	0.6	6.8	1.4	0.5	1.3	0.0	1.3	0.3	1.2	3.2	0.2	1.2	0.5	7.1	0.6	4.3	0.7	3.4	1.8	16.1	3.0	0.2	6.2	0.1	1.5	1.8	0.3	1.3	0.7	0.2	4.9	3.2	1.2	24.2	0.4	1.0	6.5	0.3	0.6	0.3	3.5	0.6	0.9	4.4	4.5	0.4	8.0	0.2	0.9	0.9	0.6	0.5	3.3	0.3	3.7	1.6	3.4	3.3	0.2	1.8	3.8	3.5	0.8	1.7	0.4	1.5	0.6	1.0	8.4	11.9	13.4	26.0	5.9	3.2	2.7	8.3	11.4	3.2	0.0	1.3	3.0	3.6	2.4	23.6	2.5	7.6	8.1	1.2	10.4	13.7	0.6	3.3	2.6	3.1	2.8	4.2	0.0	4.4	0.4	4.8	3.6	1.1	2.4	3.1	14.3	10.9	1.8	1.3	2.7	5.2	2.1	1.7	17.2	4.7	9.8	3.2	0.0	2.5	6.2	22.5	0.0	4.7	9.7	5.7	1.9	0.3	4.6	3.6	2.0
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 49.0"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 72.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Peroxisomes, Plasma membrane"	"HPA046373: AB_2679642, HPA052681: AB_2681912"	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	12.1	1.9	2.0	5.9	11.3	49.0	6.8	6.5	3.1	1.6	2.7	0.6	0.0	0.6	0.7	0.5	1.9	1.0	1.1	2.4	1.7	6.2	0.5	0.7	0.8	0.6	1.6	2.4	1.0	0.6	0.8	0.0	0.6	2.9	0.8	0.7	3.4	1.9	1.3	4.2	1.5	0.8	1.0	2.8	1.3	1.6	0.7	1.5	0.7	0.7	1.7	1.0	2.0	3.2	0.0	0.4	0.4	0.4	0.0	1.5	0.4	0.0	0.0	0.1	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.3	0.7	14.1	0.3	0.0	0.0	3.9	0.2	0.3	0.0	0.0	0.1	72.0	0.1	0.0	0.1	0.5	0.0	1.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.5	0.7	0.4	0.0	0.0	0.4	0.0	0.4	2.0	11.3	6.5	3.1	1.7	6.2	1.6	2.4	2.9	1.5	0.0	0.0	0.0	0.0	0.6	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.4	0.3	0.2	0.0	0.0	0.0
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase, receptor type C"		1	198638457-198757476	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	4	"blood: 116.9;lymphoid tissue: 172.5"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 266.4;granulocytes: 232.9;Kupffer cells: 338.8;Macrophages: 290.3;T-cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 47.1;HEL: 26.6;HL-60: 24.0;JURKAT: 61.5;MOLT-4: 35.5;THP-1: 19.7;U-266/70: 22.0;U-266/84: 20.0;U-698: 28.2;U-937: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	9.8	2.9	3.4	48.0	6.2	36.1	4.3	1.3	3.5	3.1	5.6	2.8	0.5	4.9	2.9	3.9	4.8	5.6	8.8	4.9	3.9	4.5	4.4	5.2	27.5	93.2	7.9	1.3	2.9	2.1	0.3	2.5	4.5	5.3	4.2	5.8	3.3	10.7	1.0	1.7	2.5	22.2	4.5	13.2	89.3	6.5	2.3	5.3	172.5	4.6	3.9	53.2	13.1	3.7	28.5	42.8	94.7	103.8	53.7	76.1	116.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	26.6	0.0	0.0	0.0	24.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	61.5	0.5	0.7	0.0	0.0	35.5	14.5	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.1	0.0	0.0	19.7	0.3	0.0	0.2	0.1	0.1	22.0	20.0	28.2	0.0	21.5	0.1	20.8	52.0	56.3	76.1	99.7	64.5	28.5	52.9	72.7	42.8	26.8	60.2	60.3	94.7	53.7	103.8	6.4	54.6	116.9	3.4	6.2	1.3	3.5	3.9	4.5	7.9	1.3	5.3	5.3	41.7	86.9	266.4	0.7	14.1	0.0	4.1	7.6	21.4	26.1	1.8	0.0	0.4	0.0	0.0	2.0	11.9	0.1	23.3	0.0	0.5	8.9	0.9	232.9	3.0	90.3	0.0	1.2	14.1	338.8	1.5	1.1	290.3	20.3	120.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	6.5	4.3	0.2	0.2	13.2	0.7	539.1	0.5	0.9
PTPRCAP	"CD45-AP, LPAP"	ENSG00000213402	"Protein tyrosine phosphatase, receptor type C associated protein"	Q14761	11	67435510-67438067	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 104.7;lymphoid tissue: 149.8"	"Cell type enhanced"	"Detected in some"	32	"Basal keratinocytes: 11.3;Melanocytes: 37.1;Suprabasal keratinocytes: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 40.0;HDLM-2: 28.0;HL-60: 16.4;MOLT-4: 23.7;NB-4: 113.3;U-698: 28.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	"Low region specificity"	"Detected in some"			HPA043734	Enhanced				"Intracellular and membrane"	NA	NA					"HPA043734: AB_10962214"																		1.8	1.2	1.0	79.2	1.3	8.5	1.6	1.8	0.6	2.6	10.1	0.4	0.4	5.5	1.9	1.8	5.9	3.0	6.2	1.5	1.0	0.8	3.9	2.3	6.9	71.4	1.2	0.3	1.9	1.4	0.2	1.7	1.1	0.4	3.8	1.0	1.5	14.6	0.9	1.3	1.1	21.5	0.6	1.8	56.5	8.4	2.5	0.3	149.8	5.0	4.2	67.1	3.0	2.1	104.7	50.3	4.1	0.4	45.5	97.2	58.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	16.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.1	4.2	0.0	0.4	23.7	113.3	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	28.1	0.0	0.0	0.0	1.2	0.3	4.1	97.2	0.3	82.7	80.5	60.5	85.6	0.7	104.7	44.9	68.9	2.0	45.5	0.4	50.3	78.4	58.1	1.0	1.3	1.8	0.6	1.0	0.8	1.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0
RARRES1	"LXNL, TIG1"	ENSG00000118849	"Retinoic acid receptor responder 1"	P49788	3	158696892-158732696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 105.0;vagina: 111.3"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 153.1;Glandular cells: 151.9;Paneth cells: 100.4;Urothelial cells: 237.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"CAPAN-2: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003892	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA003892: AB_1856079"	"unprognostic (5.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.09e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.88e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	49.4	6.1	0.4	26.5	0.5	0.0	54.5	0.3	0.4	18.5	29.9	0.6	10.0	2.1	6.8	24.2	11.5	40.6	8.3	105.0	0.6	0.3	26.8	2.7	13.4	13.3	0.5	0.5	75.5	3.9	0.0	19.7	1.6	2.0	46.2	15.7	19.4	49.0	17.9	10.5	3.3	9.3	20.7	2.4	3.2	6.6	19.0	0.2	1.0	31.5	1.7	5.9	39.6	111.3	1.0	1.2	0.0	0.9	0.2	0.7	0.1	2.5	0.8	0.0	0.1	0.5	1.6	0.0	0.2	0.7	0.1	0.2	0.1	162.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	17.8	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.2	2.2	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.4	1.0	0.7	0.3	0.0	0.2	0.9	1.2	0.3	0.1	0.4	0.5	0.3	0.4	0.6	0.3	0.5	0.5	2.0	0.2	0.0	1.1	0.0	153.1	0.5	0.4	0.8	7.6	28.1	30.7	14.0	0.0	2.4	0.0	8.0	19.5	1.6	68.0	0.0	4.2	0.6	13.4	151.9	29.9	3.8	10.7	0.0	35.9	16.5	1.5	25.5	10.0	2.9	5.0	0.0	75.6	3.4	1.6	100.4	1.1	18.7	0.4	0.0	1.0	2.3	0.5	0.4	9.5	0.0	69.1	237.5
RCN1	"FLJ37041, PIG20, Rcal, RCN"	ENSG00000049449	"Reticulocalbin 1"	Q15293	11	32090904-32105755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 123.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 242.1;Muller glia cells: 309.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038474, HPA062104"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		2300000	"Endoplasmic reticulum"		"HPA038474: AB_10672595, HPA062104: AB_2684683"	"unprognostic (1.65e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (7.13e-6)"	"unprognostic (8.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (2.70e-13)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.93e-3)"	25.0	19.8	9.6	14.3	38.8	1.6	38.2	7.6	11.4	22.3	13.6	5.8	17.0	10.8	23.3	123.1	12.2	18.2	15.3	19.4	9.2	9.8	12.4	33.7	17.9	20.2	7.0	5.9	35.2	16.4	17.9	34.9	32.6	9.7	22.6	12.6	11.4	37.0	24.2	12.8	9.1	10.5	19.2	10.9	11.5	11.8	11.4	6.9	5.4	16.8	10.0	6.9	25.3	32.3	4.3	11.0	0.5	11.8	7.5	12.4	6.5	13.4	14.5	33.6	22.4	82.6	63.0	38.7	46.2	56.4	32.6	58.9	12.7	17.2	0.0	32.0	75.3	40.8	16.6	12.1	13.7	49.1	6.5	26.4	2.9	10.5	4.6	61.1	2.1	4.4	87.7	17.1	20.6	23.3	36.9	71.4	6.2	1.7	2.4	37.3	11.1	6.1	4.1	14.4	0.1	16.4	4.7	42.1	3.9	27.8	31.3	9.0	4.7	12.3	2.9	35.4	24.6	17.7	8.5	37.2	42.3	24.1	36.6	39.1	0.1	0.1	0.1	58.7	2.7	23.9	0.2	10.0	0.3	12.4	11.8	9.7	4.3	5.7	9.9	11.0	3.5	4.2	8.0	0.5	7.5	7.2	6.4	2.0	6.5	9.6	38.8	7.6	11.4	9.2	9.8	7.0	5.9	9.7	6.9	50.6	33.3	14.5	59.0	37.0	39.4	8.5	35.7	38.8	54.6	45.4	11.8	140.9	6.6	116.4	132.8	75.8	7.0	0.0	39.7	242.1	157.4	112.2	12.7	53.4	41.2	14.3	51.0	85.3	14.3	130.4	74.5	21.1	30.4	70.3	54.8	309.5	40.2	24.6	68.6	12.6	14.1	25.8	71.0	10.7	6.4	24.7	181.5	9.2	62.9	78.0
RCN2	"E6BP, ERC-55, ERC55, TCBP49"	ENSG00000117906	"Reticulocalbin 2"	Q14257	15	76931619-76954392	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 147.5"	"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 314.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030694, HPA030695"	Enhanced	Supported	Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		41000	"Endoplasmic reticulum"		"HPA030694: AB_2673573, HPA030695: AB_2673574"	"unprognostic (1.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.67e-2)"	13.8	14.7	29.9	12.1	32.6	9.9	16.8	25.1	37.5	16.8	15.0	17.3	28.1	10.4	20.6	147.5	14.9	25.0	15.3	17.3	29.5	41.5	22.6	9.3	13.5	12.5	27.2	29.5	18.8	11.0	28.4	17.8	27.7	24.6	19.6	17.2	15.5	12.0	21.9	22.7	10.6	11.0	18.2	18.5	12.4	13.8	48.2	14.8	14.8	22.1	17.0	14.3	17.8	13.3	15.9	12.0	9.8	7.2	14.1	19.0	11.5	20.2	14.4	64.4	30.3	27.9	31.8	40.3	24.2	33.1	31.6	26.5	17.8	17.5	12.7	35.2	26.3	34.1	31.2	48.6	20.9	40.5	9.7	38.0	6.3	21.1	29.4	33.3	22.6	9.7	28.7	28.9	15.5	20.0	33.5	33.3	21.9	15.8	12.7	32.9	13.0	22.4	15.6	49.0	21.4	16.1	23.7	42.4	8.1	20.8	27.4	36.8	36.8	39.6	22.2	46.1	59.9	21.6	25.2	17.8	37.4	30.2	23.7	49.7	18.3	56.3	15.1	21.3	19.1	33.8	4.5	4.8	9.8	14.8	4.4	17.2	14.8	15.7	19.0	10.2	15.9	17.8	17.2	2.6	14.1	7.2	12.0	10.9	11.5	29.9	32.6	25.1	37.5	29.5	41.5	27.2	29.5	24.6	14.8	23.8	40.4	56.2	99.4	72.9	83.3	92.8	50.9	25.4	19.4	94.2	35.3	163.6	41.4	99.8	42.5	52.4	14.8	23.3	39.4	255.8	92.7	76.9	28.8	26.7	49.5	120.8	70.6	55.9	24.2	59.2	57.2	29.6	87.7	34.3	51.1	85.4	53.2	35.1	88.1	44.0	51.5	58.2	72.1	314.9	144.1	61.9	136.8	66.0	76.6	95.7
REPS2	POB1	ENSG00000169891	"RALBP1 associated Eps domain containing 2"	Q8NFH8	X	16946691-17153280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 29.8;Horizontal cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 4.6;eosinophil: 4.2;neutrophil: 14.2"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.0;Karpas-707: 9.7;RH-30: 7.0;RPMI-8226: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000565, HPA026073"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA000565: AB_1079800, HPA026073: AB_1856176"	"unprognostic (6.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.70e-3)"	"prognostic favorable (5.36e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.56e-4)"	2.5	12.3	10.6	1.4	24.1	2.9	3.7	13.2	24.7	17.7	4.6	11.6	8.1	2.4	4.7	14.0	1.6	2.4	2.3	1.8	10.2	10.0	11.6	8.0	5.0	0.6	11.3	16.0	4.7	10.9	10.1	5.8	2.9	9.8	9.1	5.1	4.7	5.1	9.0	1.1	1.1	2.2	4.6	9.6	1.3	6.7	2.3	9.4	0.0	2.3	0.0	0.8	2.5	1.3	0.2	0.4	14.2	0.3	0.0	0.0	0.1	1.1	0.5	0.0	0.1	0.7	0.5	0.1	0.0	0.0	0.1	0.2	0.1	4.3	0.0	0.5	0.0	3.2	0.2	0.9	2.3	0.4	24.0	0.5	0.0	0.6	0.0	0.6	0.0	0.1	4.5	0.8	0.0	3.9	4.1	1.3	0.0	0.0	9.7	0.2	1.1	0.0	0.3	0.1	3.5	0.7	0.0	7.0	7.4	0.3	2.3	3.5	0.2	1.8	1.7	1.4	1.5	3.2	0.2	0.2	0.0	0.2	0.1	0.3	0.4	0.0	0.3	0.0	0.3	0.2	4.6	0.3	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	14.2	0.0	0.2	0.3	0.0	0.1	10.6	24.1	13.2	24.7	10.2	10.0	11.3	16.0	9.8	9.4	29.8	9.1	0.8	7.8	0.6	14.4	4.5	5.1	1.4	11.4	14.0	0.0	0.2	1.7	2.1	0.0	1.4	5.1	0.0	12.5	8.6	1.7	12.7	0.0	11.9	4.0	36.5	9.1	3.7	3.5	0.4	8.6	5.5	1.7	2.8	8.5	1.1	7.1	5.8	12.0	6.3	2.4	0.0	1.2	0.7	0.7	1.1	0.6	0.0	9.2	5.4
RIC3	"AYST720, FLJ11608, PRO1385"	ENSG00000166405	"RIC3 acetylcholine receptor chaperone"	Q7Z5B4	11	8106093-8169055	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 168.2;Cone photoreceptor cells: 135.5;Rod photoreceptor cells: 208.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;HMC-1: 3.7;NTERA-2: 6.8;SCLC-21H: 11.6;SH-SY5Y: 8.0;SuSa: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065016	Approved				"Intracellular and membrane"	NA	NA					"HPA065016: AB_2685404"	"unprognostic (2.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.45e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-9)"	"unprognostic (4.37e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.52e-2)"	2.1	14.5	14.6	8.2	18.5	2.6	8.6	25.3	20.8	4.7	7.0	8.4	11.3	2.9	11.6	28.0	5.0	8.1	4.9	8.2	9.8	10.5	6.6	2.2	4.7	9.3	9.8	17.0	17.4	12.0	22.7	23.2	1.0	16.4	15.3	3.3	9.8	13.1	14.7	6.7	17.4	5.7	9.3	10.1	6.9	6.2	7.7	9.9	0.4	17.1	1.9	8.8	7.7	4.0	12.8	1.5	2.9	1.5	1.8	6.9	0.8	0.0	1.2	2.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	3.2	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.6	0.0	0.0	0.0	3.7	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.2	6.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	11.6	8.0	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	1.2	0.2	1.6	0.7	0.0	0.0	0.1	0.0	0.1	2.9	0.6	1.2	2.2	0.8	1.5	11.0	4.6	2.4	0.6	12.8	6.9	5.9	1.8	1.8	1.5	1.5	2.5	0.8	14.6	18.5	25.3	19.1	9.8	10.5	9.8	17.0	16.4	9.9	6.0	13.3	79.3	48.3	32.3	168.2	11.8	20.4	25.4	30.7	22.7	135.5	0.3	0.0	27.5	1.8	3.3	0.0	23.3	24.9	0.3	3.8	35.3	23.2	4.9	0.2	90.6	7.5	1.3	0.6	1.5	31.1	2.8	11.8	2.8	1.3	61.0	15.9	0.3	43.9	1.5	208.7	0.0	2.7	51.4	36.1	34.6	0.5	12.2	0.0	34.1
RNF150	KIAA1214	ENSG00000170153	"Ring finger protein 150"	Q9ULK6	4	140859807-141212877	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 45.5;Cardiomyocytes: 62.2;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 67.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 13.8;fHDF/TERT166: 17.7;SH-SY5Y: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037987	Uncertain				"Intracellular and membrane"	NA	NA					"HPA037987: AB_10669512"	"prognostic favorable (1.41e-4)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.88e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.41e-2)"	12.3	14.4	9.2	4.1	26.2	0.9	7.6	13.2	9.6	12.2	18.9	2.5	5.1	1.5	14.1	13.0	8.3	14.5	4.4	18.6	8.0	5.1	10.3	1.5	2.0	3.6	3.2	6.7	12.8	2.8	0.9	18.1	2.6	4.7	10.2	4.8	17.2	30.3	13.6	18.9	1.6	5.0	19.2	4.4	7.7	6.3	2.3	3.8	0.6	7.3	5.9	3.7	12.4	5.8	0.1	0.9	0.4	1.1	0.1	0.1	0.1	0.2	0.3	3.2	2.9	13.8	1.0	0.1	5.6	2.3	1.8	0.8	0.0	0.1	0.0	0.7	17.7	0.1	0.0	7.1	0.1	1.0	0.0	3.4	0.0	7.9	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.2	1.1	0.0	3.5	0.0	0.1	0.6	0.1	3.6	0.1	1.8	0.0	1.3	2.1	8.3	0.1	1.9	0.0	1.5	25.7	0.4	0.2	1.2	1.7	0.1	0.0	0.0	9.1	3.8	5.9	2.5	0.2	0.0	0.0	0.1	0.0	6.7	0.4	1.1	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.9	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.0	0.1	9.2	26.2	13.2	9.6	8.0	5.1	3.2	6.7	4.7	3.8	0.0	0.3	0.0	0.6	1.0	45.5	62.2	2.5	0.0	3.4	10.4	106.0	0.5	1.7	0.3	3.0	1.9	0.0	0.0	0.5	0.1	2.7	0.9	0.0	0.0	0.5	25.4	1.7	2.5	0.6	1.1	26.4	0.5	0.0	0.0	0.0	11.5	0.1	0.0	17.0	1.1	67.8	12.9	18.4	0.0	1.5	0.5	0.3	0.0	0.0	0.0
SAMD1		ENSG00000141858	"Sterile alpha motif domain containing 1"		19	14087840-14091036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041662, HPA049059"	Uncertain		Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			Cytosol	Mitochondria	"HPA041662: AB_2677605, HPA049059: AB_2680616"	"unprognostic (2.93e-2)"	"prognostic favorable (7.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.00e-1)"	"prognostic unfavorable (7.98e-5)"	"prognostic favorable (8.31e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.45e-1)"	16.0	9.5	23.5	17.4	20.2	19.6	47.9	17.2	21.2	15.3	21.3	19.7	12.2	20.6	14.7	9.8	18.2	14.0	12.8	16.8	21.2	17.9	13.1	11.1	15.9	20.1	20.9	10.3	14.5	20.3	7.2	7.3	11.3	16.5	12.7	15.5	7.8	15.4	16.1	27.2	25.9	21.5	12.4	21.3	18.0	16.7	11.4	16.1	79.1	14.8	10.8	17.9	12.9	20.5	3.5	2.3	4.5	2.9	8.0	2.7	1.5	22.8	17.4	15.4	21.7	9.7	9.9	23.5	12.6	3.0	12.9	10.4	13.1	11.3	39.9	17.2	8.1	6.1	18.6	16.8	9.4	6.5	26.7	13.8	17.4	23.1	23.6	8.6	10.2	10.9	6.9	15.6	8.9	3.0	12.5	7.6	25.6	21.1	10.9	7.4	34.4	21.7	40.3	31.6	16.7	15.5	29.6	13.6	28.6	10.9	11.1	28.3	28.3	11.1	15.1	8.4	8.7	9.5	22.0	8.2	22.6	20.8	22.6	15.9	20.7	17.8	32.9	13.5	28.0	9.1	0.3	2.9	4.5	1.7	0.9	2.0	3.5	1.9	2.0	2.3	2.1	2.7	2.0	0.5	8.0	1.0	1.8	2.1	1.5	23.5	20.2	17.2	19.6	21.2	17.9	20.9	10.3	16.5	16.1	3.0	7.9	9.7	3.5	10.2	27.7	10.1	20.4	2.7	2.3	10.4	5.9	1.6	1.7	9.4	0.3	9.0	29.0	23.3	9.6	7.2	8.0	6.8	8.1	13.5	13.4	49.3	23.8	14.7	17.4	0.5	17.8	9.4	10.1	9.0	25.3	18.6	10.9	17.3	17.7	5.0	8.6	12.9	8.4	0.7	16.2	15.1	1.5	4.9	24.7	3.9
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell type enriched"	"Detected in some"	6	"Intestinal endocrine cells: 576.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.6"	"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	99.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.3	0.1	0.0	4.7	0.0	0.0	0.1	0.0	576.5	1.8	0.0	0.0	0.6	0.0	0.0	1.8	2.8	0.0	7.8	2.9	0.0	2.2	0.0	12.9	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582860	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Melanocytes: 843.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 166.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 166.5;monocytes: 44.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 100.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1500000	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	106.2	32.0	28.5	37.6	45.2	51.5	67.4	20.9	29.0	42.7	28.4	18.8	22.2	19.7	38.4	28.2	37.8	28.0	47.9	36.9	32.1	25.8	41.4	41.7	73.1	49.7	33.4	16.9	35.5	20.1	36.4	16.4	68.5	47.6	35.5	33.6	53.0	41.5	20.7	22.5	24.7	34.3	37.9	39.0	70.1	31.0	25.4	22.2	34.3	44.4	23.4	21.4	50.0	44.2	5.9	21.7	166.5	44.8	3.4	9.8	29.7	14.5	22.6	24.1	12.5	90.5	78.0	10.6	15.0	53.8	21.9	28.8	9.0	30.7	0.0	24.2	20.1	40.3	6.1	13.0	17.3	27.1	2.6	11.1	22.0	20.1	7.2	100.5	5.6	35.8	53.2	23.4	22.0	66.1	34.2	52.4	15.3	10.8	12.9	49.6	3.8	12.3	6.6	15.1	57.5	6.5	6.0	7.3	2.8	34.8	15.3	10.6	19.1	16.0	6.9	73.8	27.9	6.3	15.3	45.0	21.1	9.1	24.9	9.6	3.9	5.2	8.8	53.8	0.0	18.9	52.9	44.8	43.7	5.7	30.0	7.1	5.9	7.6	6.0	21.7	5.4	9.8	7.4	166.5	3.4	26.4	6.0	8.5	29.7	28.5	45.2	20.9	29.0	32.1	25.8	33.4	16.9	47.6	22.2	196.5	114.3	99.6	291.9	300.9	9.9	48.4	58.6	61.6	77.3	195.4	15.7	224.5	190.6	334.0	5.9	318.0	108.1	46.7	256.7	631.9	182.6	258.8	390.0	80.9	683.1	14.3	107.7	330.8	517.6	7.7	216.6	535.9	843.5	212.0	105.0	74.6	227.0	96.2	150.3	153.5	9.7	97.0	282.9	12.5	6.5	151.4	403.9	126.8	84.4	372.9
SDF2		ENSG00000132581	"Stromal cell derived factor 2"	Q99470	17	28648356-28662189	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042799			Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA042799: AB_10794533"	"unprognostic (3.91e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.77e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.28e-3)"	"unprognostic (3.20e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-2)"	13.3	31.8	15.4	10.9	14.9	8.8	17.1	11.2	13.9	17.9	15.8	13.3	26.1	9.6	14.5	28.3	14.4	16.9	14.8	13.3	11.4	13.4	20.1	22.5	14.2	8.8	18.8	11.5	19.9	18.9	10.1	18.9	21.3	16.2	19.1	11.3	11.5	20.7	16.0	13.1	10.2	14.2	14.7	11.4	15.0	13.8	9.5	14.2	11.3	25.2	13.9	14.7	12.8	15.0	11.5	15.3	45.5	12.3	15.1	16.9	13.0	7.4	19.0	8.7	7.4	37.2	10.7	8.0	23.3	15.9	14.6	17.3	10.5	6.9	4.0	21.1	20.6	19.3	14.3	11.2	7.3	10.6	23.1	13.7	6.9	8.9	9.7	11.5	4.0	8.9	21.2	9.8	13.2	3.5	14.1	13.3	4.3	7.1	8.9	16.7	11.0	7.5	8.6	5.9	18.4	7.1	5.4	15.5	8.6	14.0	9.1	6.3	6.9	16.5	12.8	12.0	15.7	15.1	4.6	17.1	7.4	9.8	9.7	13.1	10.2	15.8	5.5	11.8	5.4	11.3	36.3	12.3	30.5	16.9	9.8	15.5	11.5	13.2	16.3	7.7	10.7	12.5	14.9	45.5	15.1	9.4	15.3	16.6	13.0	15.4	14.9	11.2	13.9	11.4	13.4	18.8	11.5	16.2	14.2	23.8	20.0	36.3	50.6	30.2	25.2	10.1	28.1	20.1	26.1	40.1	23.6	110.1	24.9	68.3	3.7	43.0	68.9	23.3	41.5	92.5	54.1	49.7	20.7	42.3	50.3	12.7	54.9	41.1	39.2	2.2	70.5	41.1	35.4	46.9	44.8	47.8	62.2	84.2	62.6	44.7	26.1	71.1	33.0	25.9	29.9	33.0	176.4	60.9	41.1	70.8
SDF2L1	"AP000553.C22.4, OTTHUMT00000075032"	ENSG00000128228	"Stromal cell derived factor 2 like 1"	Q9HCN8	22	21642261-21644298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 72.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005638	Approved				"Intracellular and membrane"	NA	NA					"HPA005638: AB_1079888"	"unprognostic (1.09e-1)"	"unprognostic (2.76e-2)"	"unprognostic (6.17e-2)"	"prognostic favorable (4.98e-5)"	"unprognostic (8.81e-3)"	"unprognostic (2.29e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.79e-2)"	7.0	10.9	5.7	19.0	12.4	13.9	15.8	3.6	6.5	8.5	13.3	3.8	18.0	16.0	8.9	15.0	7.6	8.3	9.4	11.2	5.4	7.3	13.3	44.2	11.3	20.7	11.2	3.6	6.7	54.7	6.3	21.6	9.0	12.4	8.5	6.5	5.5	37.0	14.2	4.3	4.5	14.7	5.5	6.0	18.2	18.6	9.9	8.7	8.7	44.2	7.1	11.4	7.8	14.0	32.8	57.5	24.3	27.1	24.6	48.3	27.0	17.1	14.6	3.7	12.3	2.1	2.8	23.2	15.2	3.8	7.3	8.1	15.0	10.3	15.7	13.9	3.6	11.9	14.2	6.9	10.4	2.0	11.4	41.1	11.9	15.5	32.4	12.6	11.9	21.0	2.1	4.5	6.8	7.2	2.5	7.1	8.5	72.4	40.8	3.0	32.5	11.6	17.0	4.1	18.6	25.3	10.8	8.4	13.0	5.0	12.8	7.9	12.2	7.6	13.1	7.8	3.0	12.6	14.2	8.1	3.9	21.8	12.9	9.3	37.7	15.1	11.5	7.7	14.0	11.4	24.3	27.1	11.2	48.3	27.0	36.2	32.8	31.2	43.8	19.2	26.1	24.8	30.0	8.0	24.6	24.8	57.5	31.4	27.0	5.7	12.4	3.6	6.5	5.4	7.3	11.2	3.6	12.4	8.7	23.8	22.0	50.0	90.4	101.4	5.3	23.8	53.5	8.1	11.4	47.1	33.4	93.3	21.6	95.5	41.4	41.9	171.0	163.5	154.7	269.0	72.3	151.7	113.7	248.0	202.6	4.8	178.2	62.0	58.0	25.6	30.0	95.1	200.8	61.3	71.1	40.4	144.5	80.7	15.6	70.8	12.9	38.8	56.7	143.3	239.5	98.2	140.6	71.0	61.7	107.3
SELENOF	SEP15	ENSG00000183291	"Selenoprotein F"		1	86862445-86914424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 217.7;Extravillous trophoblasts: 290.7;Hofbauer cells: 216.8;Syncytiotrophoblasts: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054937			Approved	Nucleoli,Cytosol	"Intracellular and membrane"	No	No			Nucleoli	Cytosol	"HPA054937: AB_2682642"	"unprognostic (6.15e-2)"	"unprognostic (6.98e-3)"	"prognostic favorable (6.53e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.65e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.34e-2)"	41.5	48.9	34.7	32.4	33.2	27.1	41.4	20.4	33.9	44.3	37.0	28.9	42.7	32.9	34.9	62.0	36.9	36.8	36.1	31.4	33.4	35.8	68.4	85.3	47.8	45.4	36.0	25.1	47.6	38.5	20.6	46.9	65.6	34.3	41.5	37.4	30.8	35.8	33.7	22.0	21.7	51.1	30.2	45.0	58.7	32.3	36.4	29.0	57.0	100.7	22.8	33.7	40.0	29.7	68.9	57.5	44.3	41.8	26.8	41.3	51.1	39.1	26.9	22.5	24.8	73.7	87.7	36.8	49.4	56.6	46.5	47.4	38.0	47.7	48.4	63.4	43.8	40.3	24.7	25.4	27.5	54.9	45.1	35.9	49.2	25.7	35.9	46.6	64.3	33.6	56.3	43.6	30.9	46.7	37.9	39.1	40.2	45.5	50.6	45.1	17.6	46.7	43.3	33.0	40.7	37.2	39.1	41.6	47.2	64.5	40.5	29.2	24.2	49.2	44.9	65.1	21.5	19.6	56.1	40.8	34.1	25.4	65.6	53.9	30.5	30.9	49.5	19.9	53.2	39.9	44.3	40.0	36.8	32.8	38.4	41.3	56.7	35.8	34.7	39.0	68.9	37.1	37.5	36.7	26.8	41.8	57.5	38.3	51.1	34.7	33.2	20.4	33.9	33.4	35.8	36.0	25.1	34.3	29.0	110.2	143.1	0.0	0.0	0.0	0.0	0.0	0.0	128.5	137.6	102.9	0.0	217.7	63.0	187.2	0.0	0.0	0.0	0.0	170.1	290.7	0.0	0.0	59.3	0.0	216.8	0.0	0.0	0.0	0.0	0.0	0.0	83.2	0.0	111.8	0.0	0.0	167.0	0.0	0.0	129.7	0.0	0.0	0.0	0.0	0.0	0.0	263.6	0.0	0.0	0.0
SELENOM	"SELM, SEPM"	ENSG00000198832	"Selenoprotein M"	Q8WWX9	22	31104772-31120069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 293.1;Distal tubular cells: 261.9;Exocrine glandular cells: 512.5;Pancreatic endocrine cells: 240.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 23.0;MAIT T-cell: 29.7;memory B-cell: 32.4;memory CD4 T-cell: 38.3;memory CD8 T-cell: 27.4;naive B-cell: 24.2;naive CD4 T-cell: 51.6;naive CD8 T-cell: 30.4;T-reg: 34.7"	"Group enriched"	"Detected in all"	6	"B-cells: 32.4;T-cells: 51.6"	"Cell line enhanced"	"Detected in many"		"BJ: 40.4;BJ hTERT+: 38.8;HHSteC: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008667, HPA019601"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		110000	"Nucleoplasm, Cytosol"		"CAB008667: AB_1622762, HPA019601: AB_1856666"	"unprognostic (5.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.51e-3)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.19e-2)"	35.9	19.5	19.8	31.3	20.6	2.4	33.4	13.5	20.8	83.5	66.2	9.1	38.3	22.0	67.5	34.2	53.4	46.1	67.2	25.5	19.1	20.6	19.2	6.6	18.2	35.1	20.7	11.7	49.9	38.1	18.1	27.2	22.1	15.9	59.5	10.7	41.4	57.3	89.1	29.4	11.6	24.0	76.2	14.1	18.2	35.2	21.9	8.8	1.4	45.7	12.2	12.8	92.5	36.1	32.4	1.3	2.4	7.5	7.5	51.6	21.9	3.2	6.8	2.0	11.4	19.1	22.4	22.3	40.4	38.8	18.8	13.7	0.2	0.5	0.4	8.4	23.7	8.5	0.3	1.8	2.4	1.3	1.8	6.8	0.7	2.1	3.4	51.1	0.0	3.5	21.8	7.3	8.9	3.4	9.0	2.4	0.6	0.6	3.9	4.7	1.7	0.1	0.4	2.6	3.0	7.3	0.0	0.0	4.6	2.9	0.0	4.4	9.7	12.6	11.2	0.1	0.7	15.5	0.2	8.2	5.7	16.1	21.1	0.0	3.6	1.6	0.2	22.8	0.0	3.6	2.4	2.2	0.9	23.0	3.8	29.7	32.4	38.3	27.4	1.3	24.2	51.6	30.4	1.6	7.5	7.5	0.4	34.7	21.9	19.8	20.6	13.5	20.8	19.1	20.6	20.7	11.7	15.9	8.8	50.6	112.8	0.0	0.0	0.0	0.0	0.0	0.0	37.5	59.1	293.1	0.0	11.2	261.9	97.3	0.0	0.0	0.0	0.0	512.5	132.0	0.0	0.0	27.9	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	74.9	0.0	0.0	240.3	0.0	0.0	109.7	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476761-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 99.3;skin 1: 60.7;tongue: 118.8"	"Cell type enhanced"	"Detected in many"	18	"Basal keratinocytes: 856.4;Suprabasal keratinocytes: 1062.2;Urothelial cells: 663.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 147.0;HBEC3-KT: 48.5;hTCEpi: 102.0;hTERT-HME1: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		660000	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavorable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavorable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.2	0.1	0.1	0.9	0.1	0.0	9.7	0.1	0.1	23.6	2.7	0.1	0.7	3.9	2.1	0.5	99.3	0.1	4.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	4.1	1.0	0.1	11.1	0.3	0.1	60.7	6.8	0.9	0.1	0.1	2.2	0.4	0.1	5.1	0.1	118.8	41.2	7.1	19.7	0.6	0.5	1.2	0.4	1.0	0.5	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.4	0.0	0.0	147.0	0.0	48.5	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	102.0	0.0	25.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	10.7	0.0	0.0	0.0	0.0	10.7	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.2	0.6	0.5	0.3	1.2	1.0	0.2	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	229.2	856.4	0.0	0.2	0.0	16.0	20.5	3.5	0.0	0.2	0.0	0.1	7.6	0.0	5.4	0.0	0.0	0.2	8.7	51.7	0.0	0.0	0.0	0.0	3.4	0.0	0.0	15.2	0.6	0.2	59.1	0.0	3.2	0.0	9.5	46.0	0.0	0.0	0.0	0.0	14.4	2.6	0.6	1062.2	0.1	0.0	7.0	663.3
SGCA	"A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1"	ENSG00000108823	"Sarcoglycan alpha"	Q16586	17	50164214-50175931	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.7"	"Cell type enhanced"	"Detected in many"	27	"Cardiomyocytes: 113.3;Early spermatids: 135.9;Late spermatids: 458.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.0"	"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.4;memory B-cell: 5.3;myeloid DC: 3.8;naive B-cell: 5.2;non-classical monocyte: 3.1"	"Group enriched"	"Detected in many"	19	"B-cells: 5.3;dendritic cells: 3.8;monocytes: 3.1"	"Cell line enriched"	"Detected in some"	15	"LHCN-M2: 42.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007537	Uncertain				"Intracellular and membrane"	NA	NA					"HPA007537: AB_1079944"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.15e-2)"	2.8	0.6	0.1	2.5	0.2	0.2	0.8	3.0	0.4	6.8	10.0	0.0	8.6	1.6	7.9	10.5	10.8	3.4	10.7	32.2	0.2	0.1	0.6	0.9	5.7	0.3	0.2	0.3	3.4	0.5	0.2	0.1	1.9	0.4	10.9	1.1	7.1	2.3	8.0	144.7	2.6	3.0	30.3	0.3	0.7	5.7	1.4	0.0	0.0	1.6	39.8	2.3	20.1	4.3	5.3	3.8	0.2	3.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.8	0.2	0.0	2.4	0.0	5.3	0.0	0.0	3.8	5.2	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.7	0.1	0.2	3.0	0.1	0.2	0.1	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	7.7	0.0	113.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	135.9	2.1	0.0	0.0	5.2	0.1	41.4	0.2	0.0	0.0	0.5	0.0	0.0	1.8	0.0	458.2	2.8	1.4	8.5	0.0	0.0	0.0	2.4	0.0	3.5	1.4	0.0	12.9	49.5	2.1	1.5	8.7	0.2	0.0	0.0	0.1
SMIM7	"C19orf42, MGC2747"	ENSG00000214046	"Small integral membrane protein 7"	Q9BQ49	19	16630751-16660442	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043127	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA043127: AB_10806378"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.64e-2)"	24.6	26.2	20.5	16.9	27.1	12.0	25.5	30.0	32.1	23.4	19.1	28.1	30.4	18.8	25.7	43.2	19.7	23.2	20.1	21.8	19.6	19.7	28.8	32.4	20.1	21.1	22.1	21.2	31.7	39.6	29.8	23.0	28.6	22.7	27.2	26.0	29.2	40.6	25.9	19.6	22.9	20.0	22.3	26.7	23.3	23.1	22.4	15.8	20.6	34.1	18.1	22.7	19.3	23.0	21.8	31.0	15.4	30.4	15.2	17.7	16.5	18.9	13.0	16.0	12.6	22.9	19.7	13.2	17.0	16.3	15.5	13.6	12.0	25.0	12.9	23.9	17.2	15.4	13.5	14.3	19.5	17.7	12.1	12.2	12.6	11.9	11.9	8.9	18.3	16.6	14.2	12.2	13.0	13.9	14.3	15.6	11.0	17.0	19.6	19.8	28.8	12.3	16.8	13.7	30.3	19.6	13.8	11.3	12.2	15.4	20.2	5.8	14.4	13.1	11.8	15.9	8.9	17.9	26.9	12.1	16.5	11.7	42.8	27.2	17.5	24.9	17.3	18.0	24.0	20.0	14.4	30.4	15.4	17.7	26.5	14.4	21.8	17.3	15.7	23.8	21.3	16.8	15.9	14.2	15.2	28.0	31.0	17.6	16.5	20.5	27.1	30.0	32.1	19.6	19.7	22.1	21.2	22.7	15.8	62.5	60.5	87.1	54.8	30.3	69.0	32.3	45.9	45.5	45.5	54.1	90.3	122.2	109.5	72.5	10.8	49.4	63.9	23.3	74.9	85.4	64.1	63.4	49.6	76.9	99.9	60.4	70.0	64.4	77.0	15.6	82.3	59.6	45.5	96.4	58.9	84.5	74.9	77.2	78.1	97.6	112.1	71.1	57.0	86.0	82.7	31.2	130.8	47.3	55.5	45.2
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89724099-89838315	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.2;bone marrow: 91.0;brain: 121.3"	"Group enriched"	"Detected in many"	7	"Erythroid cells: 630.8;Melanocytes: 334.0"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 25.4;plasmacytoid DC: 31.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 31.2;granulocytes: 10.1;monocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"HEL: 43.9;HUVEC TERT2: 53.5;RT4: 28.3;SK-MEL-30: 52.4;TIME: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	NA	NA		23000000			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	3.9	5.4	38.9	4.7	26.1	91.0	4.3	41.7	121.3	6.2	4.7	9.0	0.0	2.3	15.5	2.5	4.5	3.2	3.2	9.0	35.2	22.5	4.2	1.9	4.5	1.8	36.2	49.6	13.6	1.6	1.2	5.4	12.1	26.3	4.6	3.9	5.3	4.9	5.3	1.1	7.6	2.9	15.1	21.4	4.0	1.7	2.2	15.1	0.0	5.2	1.2	2.9	4.1	4.4	0.9	31.2	10.1	20.5	4.8	0.6	19.5	0.1	0.1	8.3	0.0	0.1	0.0	0.1	0.0	8.7	0.3	0.6	0.0	0.0	0.0	2.4	0.0	0.0	1.8	10.8	20.0	0.3	0.0	4.8	43.9	24.8	0.0	18.0	0.0	0.3	0.4	7.7	0.0	22.6	24.8	53.5	0.4	0.3	0.1	0.0	0.0	0.3	0.0	2.1	0.0	0.9	0.0	3.2	0.0	0.0	28.3	4.7	3.1	0.0	0.0	52.4	6.3	0.0	0.0	61.2	0.2	1.6	0.0	0.1	0.0	0.0	0.0	1.7	0.0	17.6	10.1	20.5	0.0	0.0	8.1	0.0	0.9	0.6	0.1	25.4	0.5	0.3	0.2	3.7	4.8	2.3	31.2	0.0	19.5	38.9	26.1	41.7	55.1	35.2	22.5	36.2	49.6	26.3	15.1	0.0	1.1	2.7	16.7	68.1	4.0	6.2	0.0	5.3	9.1	10.4	0.0	9.1	1.7	0.0	0.3	16.5	0.0	630.8	0.2	2.7	7.8	6.3	0.0	0.0	54.2	9.5	1.7	1.8	8.8	1.3	2.0	48.8	334.0	15.4	0.0	15.1	0.3	0.0	0.0	1.2	6.1	12.9	3.3	4.2	3.0	19.7	2.9	0.0	0.0	2.7
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.9;breast: 19.6"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 5.0;Pancreatic endocrine cells: 9.1;Proximal tubular cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 6.3"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 36.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA052824	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA052824: AB_2681964"	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.4	1.5	4.8	0.8	6.4	1.5	19.6	2.8	9.0	0.3	2.4	9.3	0.0	2.7	0.7	2.0	0.3	0.4	0.3	0.4	8.8	7.8	1.2	2.1	1.3	1.7	11.9	7.0	0.5	4.2	0.7	0.3	0.9	9.1	3.0	1.1	0.0	3.2	0.6	2.8	10.8	2.0	0.6	27.9	1.4	1.3	6.2	7.4	0.0	0.9	0.0	0.5	0.5	0.0	0.0	0.0	6.3	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.9	0.6	1.0	1.5	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.4	0.1	0.3	0.3	0.0	0.0	0.0	0.4	1.3	0.3	0.2	36.4	0.5	0.0	1.1	0.0	0.9	0.2	0.5	0.4	1.0	0.4	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	1.4	0.2	0.3	0.2	0.0	0.5	0.1	0.5	0.2	0.0	1.3	0.6	0.0	1.6	0.5	0.1	0.5	0.5	0.4	2.4	2.5	0.1	0.0	0.8	0.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.4	2.8	9.0	8.8	7.8	11.9	7.0	9.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.5	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
SRL		ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"heart muscle: 70.9;skeletal muscle: 104.1;tongue: 48.3"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 216.0"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.5;thyroid cancer: 5.9"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	13	"HSkMC: 9.8"					"Low region specificity"	"Detected in some"			"HPA041535, HPA045520"	Enhanced				"Intracellular and membrane"	NA	NA		26000			"HPA041535: AB_2677538, HPA045520: AB_2679358"	"unprognostic (1.24e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.04e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.40e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.78e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.68e-4)"	3.1	0.1	0.2	0.2	0.2	0.0	0.4	0.1	1.0	0.8	0.3	0.0	1.2	0.1	0.9	4.2	2.9	0.8	0.4	70.9	0.2	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.4	0.1	0.1	0.1	0.3	0.4	1.3	0.2	0.1	2.1	0.6	104.1	0.2	0.4	0.8	0.2	0.4	0.3	0.5	0.1	0.2	0.9	48.3	3.4	0.9	0.7	0.6	0.3	2.4	0.5	0.8	0.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.2	0.2	9.8	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.0	2.4	0.2	0.8	0.5	0.5	0.2	0.3	0.3	0.3	0.1	0.6	0.4	0.4	1.3	0.8	0.3	0.3	0.3	0.9	0.2	0.2	0.1	1.0	0.2	0.2	0.3	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.6	216.0	0.0	0.0	0.0	1.8	7.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	3.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.5	0.0	11.6	6.5	32.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0
STARD7	GTT1	ENSG00000084090	"StAR related lipid transfer domain containing 7"	Q9NQZ5	2	96184859-96208825	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033965, HPA064958, HPA064978"	Supported		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.56e-5)"	"prognostic favorable (3.89e-6)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.72e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.38e-6)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.42e-2)"	17.3	26.6	30.3	20.6	27.1	11.5	32.1	26.5	28.7	14.4	22.6	24.4	15.2	21.6	13.9	12.8	17.0	18.0	13.5	66.7	26.1	24.5	32.5	29.1	24.0	30.1	34.1	17.1	12.4	24.6	28.2	11.7	11.4	23.6	16.1	22.8	17.3	24.2	19.7	74.4	14.4	22.2	15.0	24.1	21.7	17.4	8.1	29.9	26.3	22.7	24.1	32.9	16.4	15.2	26.4	25.0	14.5	18.6	18.1	24.1	13.7	32.3	20.1	26.3	27.2	35.5	17.8	39.8	31.9	27.3	31.4	33.9	47.2	29.9	57.7	35.3	24.7	24.9	26.3	46.6	26.9	41.1	39.1	35.8	50.9	19.8	54.4	16.3	39.0	28.6	17.2	19.9	26.0	25.8	20.0	31.3	23.9	52.6	22.9	27.8	28.1	44.1	39.6	44.8	27.4	30.1	43.7	40.5	57.3	18.9	41.0	50.7	24.2	16.1	51.8	28.5	34.2	15.4	42.9	26.1	26.1	27.1	29.1	31.8	30.6	28.4	51.8	24.1	44.0	28.8	14.5	14.9	13.9	16.4	18.6	16.9	26.4	14.1	17.1	22.7	21.5	16.2	15.0	1.7	18.1	11.8	25.0	24.1	13.7	30.3	27.1	26.5	28.7	26.1	24.5	34.1	17.1	23.6	29.9	125.0	43.6	35.0	37.3	56.6	26.0	163.8	63.7	30.8	52.4	43.6	102.1	30.8	63.0	27.4	2.1	47.5	46.7	0.0	32.7	31.1	29.1	59.0	15.1	103.7	60.0	38.1	42.7	37.4	105.5	5.2	21.6	53.5	40.5	98.2	56.1	31.6	31.3	10.5	23.7	53.6	55.8	25.8	48.4	12.4	39.7	50.2	29.6	41.5	67.9	31.4
STMP1	"C7orf73, PL-5283"	ENSG00000243317	"Short transmembrane mitochondrial protein 1"	E0CX11	7	135662496-135693418	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 209.3;Extravillous trophoblasts: 217.6;monocytes: 256.1;Proximal tubular cells: 171.0;Syncytiotrophoblasts: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 71.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 71.6"	"Low cell line specificity"	"Detected in all"											HPA065565			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA065565: AB_2685512"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-1)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.21e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.62e-3)"	"unprognostic (6.81e-2)"	15.6	32.2	22.5	19.7	24.3	33.5	27.3	13.8	20.4	20.1	19.0	25.0	20.3	17.4	16.5	26.7	51.4	16.2	19.3	29.5	19.3	20.6	28.4	34.7	19.7	28.1	22.3	13.5	16.5	25.4	14.6	25.4	28.1	20.4	20.7	22.5	31.2	23.0	18.5	40.7	21.1	23.2	21.3	22.0	18.7	19.5	38.7	17.0	38.4	31.9	42.6	34.9	18.2	28.0	5.3	12.5	71.6	13.1	7.6	6.6	9.2	15.2	7.1	17.3	16.1	20.6	29.3	10.5	16.9	16.5	14.1	14.7	4.4	16.9	13.9	15.1	25.5	13.7	6.3	16.6	21.3	19.2	17.4	13.7	21.9	8.2	10.7	20.3	22.2	14.2	18.0	24.4	16.8	15.7	21.3	11.6	18.2	23.5	12.6	30.9	18.9	31.6	25.6	34.0	21.2	18.2	16.0	18.5	23.0	39.2	8.0	21.9	21.1	22.5	15.7	15.7	17.5	6.3	24.6	18.9	13.8	11.2	24.4	23.5	14.6	21.0	27.0	42.5	23.2	24.9	71.6	12.0	25.0	5.3	12.3	5.0	5.3	5.1	5.3	12.5	4.5	4.9	5.4	9.3	7.6	13.1	7.1	6.6	9.2	22.5	24.3	13.8	20.4	19.3	20.6	22.3	13.5	20.4	17.0	38.7	43.1	0.0	0.0	0.0	0.0	0.0	0.0	62.9	51.2	92.5	0.0	209.3	167.5	157.0	0.0	0.0	0.0	0.0	84.6	217.6	0.0	0.0	52.3	0.0	164.1	0.0	0.0	0.0	0.0	0.0	0.0	40.5	0.0	256.1	0.0	0.0	115.5	0.0	0.0	171.0	0.0	0.0	0.0	0.0	0.0	0.0	230.3	0.0	0.0	0.0
STOML2	"HSPC108, SLP-2"	ENSG00000165283	"Stomatin like 2"	Q9UJZ1	9	35099776-35103195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015944, HPA062016"	Supported		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		98000	"Plasma membrane, Cytosol"		"CAB015944: , HPA062016: AB_2684659"	"unprognostic (2.49e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.26e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.47e-2)"	23.2	38.6	20.5	24.8	20.7	26.9	25.3	20.9	30.3	22.1	30.8	19.9	17.4	26.6	26.6	25.5	32.9	28.2	35.4	49.6	18.6	19.1	38.6	67.1	17.1	31.7	18.8	18.8	30.9	48.3	20.4	17.4	28.5	20.7	25.6	33.6	25.0	32.1	25.5	59.2	26.3	39.0	26.7	13.8	23.1	28.7	23.2	14.3	32.4	34.8	46.3	33.8	24.8	21.1	34.7	44.4	20.5	27.1	33.8	40.3	37.7	47.0	54.7	29.4	43.8	21.6	26.0	31.5	23.3	34.4	66.6	48.7	61.6	22.2	39.9	16.5	29.8	47.7	20.2	44.8	52.4	44.6	34.0	41.0	24.4	46.4	58.2	63.3	46.1	28.0	32.9	40.9	54.0	64.9	21.0	43.4	40.7	39.6	24.5	32.5	38.1	41.0	81.8	46.0	35.3	34.6	35.9	24.8	42.6	36.0	28.4	27.3	33.2	13.1	35.5	30.1	21.9	24.6	29.8	23.4	22.8	32.2	18.8	41.1	17.2	29.4	37.6	30.3	29.3	30.5	20.5	27.1	14.8	25.5	23.1	30.0	34.7	28.8	28.7	35.8	30.2	27.8	25.3	4.7	33.8	16.6	44.4	40.3	37.7	20.5	20.7	20.9	30.3	18.6	19.1	18.8	18.8	20.7	14.3	38.7	30.7	67.8	97.0	85.6	32.1	74.2	99.3	64.3	54.6	47.1	7.9	204.6	212.2	112.4	62.9	62.9	121.7	46.7	133.0	205.2	74.7	89.1	82.0	100.2	114.0	17.5	94.8	54.6	32.3	17.5	69.6	50.8	94.5	110.0	124.3	59.7	118.2	126.3	65.4	214.3	28.6	51.8	82.4	68.9	106.7	100.1	139.1	53.3	180.1	119.6
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Yes	No		730000	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.71e-4)"	26.8	38.3	13.0	17.7	17.0	15.4	26.2	10.9	28.2	35.0	31.9	24.8	35.4	31.1	32.2	32.3	23.8	37.8	51.2	16.8	12.8	11.6	36.0	40.4	30.2	25.9	19.8	18.0	28.6	91.0	34.7	18.3	37.5	20.7	29.5	25.0	25.0	39.7	37.1	14.0	23.6	35.1	27.2	19.6	27.0	32.9	16.2	17.6	29.8	33.3	15.1	25.1	29.1	23.1	21.0	43.1	17.1	28.5	15.7	33.4	28.5	64.4	19.5	8.5	39.3	42.0	29.1	13.2	21.1	29.6	17.8	22.2	10.6	52.4	10.1	18.3	30.2	17.3	32.8	5.1	24.4	11.9	16.5	8.2	6.5	12.8	9.9	27.2	15.9	20.8	23.0	24.0	16.0	27.9	36.2	26.2	18.7	20.6	45.4	28.6	14.2	13.5	18.7	11.6	50.2	9.9	10.9	8.7	65.0	24.3	7.1	10.0	12.2	26.5	56.1	25.9	19.9	56.3	26.5	21.6	16.5	23.6	40.4	18.1	30.9	23.5	15.1	27.1	30.1	52.6	17.1	21.0	7.5	26.2	27.4	33.4	21.0	25.6	26.2	24.8	18.7	28.5	27.7	1.3	15.7	28.5	43.1	26.8	28.5	13.0	17.0	10.9	28.2	12.8	11.6	19.8	18.0	20.7	17.6	53.6	29.1	34.1	31.9	30.0	26.4	8.5	76.5	34.8	25.0	85.5	13.7	39.0	16.6	71.5	2.7	41.8	53.0	23.3	48.6	78.8	43.6	38.3	53.1	70.4	61.1	41.3	57.0	43.0	64.9	5.8	64.5	46.7	50.6	84.8	54.5	25.7	53.3	63.1	44.6	36.9	12.1	51.8	39.4	16.8	23.6	36.6	39.0	50.0	78.0	31.5
SUSD1	DKFZP761E1824	ENSG00000106868	"Sushi domain containing 1"	Q6UWL2	9	112040785-112175408	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 24.1;monocytes: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 24.9"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 24.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.7;HEL: 25.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048554	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		530000	Nucleoplasm		"HPA048554: AB_2680439"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (3.63e-6)"	"unprognostic (2.14e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	9.6	13.9	9.1	9.7	13.9	14.1	8.4	3.1	15.3	7.6	10.2	2.7	11.6	8.6	5.7	9.8	4.8	6.7	7.6	11.2	6.1	16.4	15.5	4.4	11.5	15.7	8.3	8.2	3.3	8.1	9.4	8.2	23.3	7.4	5.8	11.4	8.1	10.7	12.8	2.9	3.6	9.9	9.3	5.1	14.5	12.2	5.8	3.5	9.6	5.6	1.4	6.6	13.1	4.6	0.2	24.9	5.8	2.7	1.7	1.6	1.1	1.3	8.5	6.1	0.0	4.5	3.0	19.5	5.4	7.3	7.7	9.9	16.9	11.4	0.1	6.1	9.5	0.5	3.9	2.1	1.0	5.8	22.7	1.8	25.7	6.2	11.4	5.4	6.7	8.3	3.7	0.8	4.3	0.1	5.3	17.9	3.8	13.9	1.1	4.8	1.6	0.9	4.1	2.0	21.0	1.3	5.7	1.4	0.0	1.8	4.5	2.1	5.2	3.0	0.6	0.0	3.5	1.0	7.3	13.6	0.1	2.9	0.8	0.0	0.3	0.3	0.5	5.3	2.6	1.6	3.5	1.4	5.8	1.6	1.6	0.5	0.1	0.4	1.1	1.0	0.2	0.2	1.2	0.5	1.7	2.7	24.9	0.1	1.1	9.1	13.9	3.1	15.3	6.1	16.4	8.3	8.2	7.4	3.5	0.0	4.5	1.5	1.2	0.5	0.0	1.9	2.5	6.7	5.7	12.2	0.0	7.4	0.0	5.6	1.7	2.3	4.7	0.0	6.2	8.8	4.0	1.8	5.7	0.0	14.2	0.0	4.1	10.4	24.1	1.2	0.0	10.8	0.0	18.0	4.5	0.0	8.8	3.5	1.8	1.7	1.6	0.0	3.8	0.3	0.3	0.6	7.2	4.9	5.6	7.3
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925732	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 2167.7;monocytes: 1311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA		540000000	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavorable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	80.6	26.4	19.7	57.5	25.6	47.9	62.8	7.9	18.3	49.1	45.9	16.6	54.5	43.3	39.2	49.4	96.3	36.3	63.6	57.3	15.9	18.5	68.0	178.2	107.7	65.0	24.3	9.8	45.7	51.2	8.8	18.1	122.2	24.8	43.8	43.0	24.7	67.2	62.9	35.3	62.6	74.6	36.2	20.0	95.8	96.8	46.4	20.2	60.5	37.7	150.7	76.5	57.2	62.0	53.0	114.4	220.7	42.4	44.0	41.7	106.7	110.3	59.7	1.8	0.7	21.3	53.1	68.9	62.2	71.5	135.4	65.9	61.9	86.7	68.6	53.0	73.9	38.0	86.7	30.5	77.5	83.6	78.2	24.7	91.4	57.9	3.6	25.2	64.2	102.9	52.7	60.2	79.7	41.3	90.7	81.5	18.3	39.1	48.3	46.1	42.0	29.0	40.5	51.5	69.2	101.9	0.2	31.8	102.5	28.1	43.3	28.6	27.1	73.0	119.5	32.1	100.7	63.0	63.3	93.5	81.1	94.3	73.5	167.4	19.4	8.6	40.2	104.9	41.2	49.8	66.9	42.4	177.0	34.7	25.2	30.6	53.0	38.6	33.4	68.5	39.7	20.4	22.4	220.7	44.0	18.9	114.4	41.7	106.7	19.7	25.6	7.9	18.3	15.9	18.5	24.3	9.8	24.8	20.2	166.7	130.7	257.0	252.6	487.7	6.1	8.0	109.5	111.1	142.1	174.5	17.7	477.1	63.0	1095.0	40.8	397.3	292.6	0.0	1053.3	2167.7	440.6	225.0	408.8	47.4	432.7	3.2	305.0	192.1	247.2	61.8	109.9	313.3	317.2	1311.1	280.8	63.0	865.9	140.6	60.1	122.4	18.8	181.1	346.3	4.8	17.6	500.5	192.7	223.4	182.9	345.3
TEDC1	C14orf80	ENSG00000185347	"Tubulin epsilon and delta complex 1"	Q86SX3	14	105489855-105499575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Exocrine glandular cells: 11.1;Extravillous trophoblasts: 21.4;Hofbauer cells: 12.7;monocytes: 20.8;Pancreatic endocrine cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039049, HPA039050"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039049: AB_2676320, HPA039050: AB_10670918"	"unprognostic (8.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.73e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-3)"	5.1	2.0	10.5	8.5	13.6	10.8	5.2	5.1	10.3	3.3	7.6	10.7	2.0	9.4	5.5	5.0	5.2	4.0	5.5	3.4	10.3	7.4	2.9	4.0	6.2	8.8	7.9	4.6	2.7	6.4	2.5	4.5	7.9	7.1	3.7	3.2	3.9	5.8	4.6	3.9	10.1	8.3	2.1	7.4	5.9	10.6	9.1	9.5	16.0	5.1	7.1	11.8	6.1	3.5	0.8	5.7	1.4	2.2	0.1	3.7	0.7	7.9	18.5	4.4	6.6	0.4	0.7	12.0	6.4	2.5	7.7	7.4	6.6	15.1	12.1	13.4	1.0	3.0	21.3	1.5	6.8	1.5	14.3	7.6	3.2	10.2	6.5	0.3	6.1	8.9	0.1	2.3	5.2	1.6	1.0	3.0	11.3	5.0	15.2	1.2	30.8	12.7	13.9	5.7	6.8	19.6	10.4	6.8	8.4	2.1	6.8	12.6	7.4	6.6	7.8	4.6	1.0	12.4	6.1	3.8	5.4	9.2	16.4	10.5	8.9	3.7	7.3	6.9	7.0	8.7	0.0	1.2	1.4	1.5	2.2	1.0	0.3	2.2	3.7	1.7	0.8	1.4	0.4	0.4	0.1	2.0	5.7	1.6	0.7	10.5	13.6	5.1	10.3	10.3	7.4	7.9	4.6	7.1	9.5	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	1.2	1.8	0.0	3.9	3.3	8.1	0.0	0.0	0.0	0.0	11.1	21.4	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	20.8	0.0	0.0	10.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0
THSD1	TMTSP	ENSG00000136114	"Thrombospondin type 1 domain containing 1"	Q9NS62	13	52377167-52406494	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 26.3;Ito cells: 12.9;Spermatocytes: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 12.3;HBEC3-KT: 12.3;hTCEpi: 12.3;hTERT-HME1: 12.6;HUVEC TERT2: 25.6;LHCN-M2: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012611, CAB020796"	Uncertain		Supported	Cytosol	"Intracellular and membrane"	No	No		810000	Cytosol		"CAB020796: , HPA012611: AB_1857990"	"unprognostic (1.21e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.90e-2)"	9.7	1.8	8.3	1.8	7.2	0.4	11.1	2.9	6.4	7.6	2.6	1.9	3.6	1.2	6.8	4.9	4.4	5.7	4.9	9.0	8.1	2.2	2.0	2.1	19.8	4.7	2.2	4.6	2.3	1.2	2.5	3.4	16.8	2.1	8.5	2.3	5.5	3.9	3.2	9.7	6.0	2.3	7.4	2.2	6.6	1.9	2.7	1.1	0.7	5.2	5.2	2.5	5.9	4.5	0.3	0.0	0.0	0.0	0.4	0.7	0.0	0.5	2.4	0.2	2.2	2.0	6.7	0.5	5.2	2.6	2.0	3.3	0.0	0.3	0.2	0.6	12.3	2.0	2.7	0.0	12.3	3.2	5.7	1.8	0.3	0.0	0.0	1.2	1.2	0.3	2.6	12.3	9.9	12.6	1.1	25.6	0.7	0.0	0.1	11.7	0.0	0.4	0.2	0.1	0.1	0.5	0.3	2.7	0.0	2.8	0.1	0.0	0.4	0.1	0.0	0.4	0.1	0.2	0.2	5.9	0.6	1.1	0.0	3.8	0.4	0.0	0.0	1.1	0.4	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.5	0.7	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.3	7.2	2.9	6.4	8.1	2.2	2.2	4.6	2.1	1.1	0.0	1.4	1.4	0.9	1.3	0.8	2.7	0.0	0.0	1.2	1.8	2.0	4.2	3.3	0.2	0.8	26.3	0.0	0.0	0.6	1.5	2.7	1.3	0.0	1.6	2.4	0.0	0.0	12.9	2.6	0.0	3.1	0.7	5.0	0.0	0.2	1.2	0.2	0.0	3.5	0.8	2.8	6.5	1.9	19.1	9.1	1.4	2.9	1.9	0.4	0.3
TINF2	TIN2	ENSG00000092330	"TERF1 interacting nuclear factor 2"	Q9BSI4	14	24239643-24242674	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"parathyroid gland: 268.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059061, HPA069807"			Enhanced	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Nuclear bodies"		"HPA059061: AB_2683895, HPA069807: AB_2686203"	"prognostic favorable (4.96e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.78e-2)"	"unprognostic (7.44e-2)"	15.8	27.8	10.4	17.0	11.3	13.3	18.2	10.1	16.7	14.5	13.1	17.9	12.9	9.5	16.8	16.1	22.4	12.6	13.7	12.4	9.3	8.9	14.8	11.4	18.8	27.0	13.7	9.8	15.4	17.1	268.9	11.9	15.3	10.9	13.5	12.5	11.3	14.8	15.5	14.9	13.9	12.9	15.1	11.7	21.0	14.5	7.7	12.4	26.1	16.6	12.6	19.5	14.9	14.2	27.3	17.7	46.9	21.4	25.4	27.4	28.8	11.8	10.8	15.7	8.2	17.4	13.0	8.0	12.2	15.5	17.9	16.8	4.7	13.4	17.4	7.0	17.2	12.9	11.6	8.8	10.8	11.3	22.1	4.5	10.9	10.0	18.6	15.0	11.5	15.7	14.2	17.6	14.4	13.7	16.8	19.3	16.7	4.2	22.3	14.4	13.0	17.2	5.7	3.6	12.6	13.5	14.2	10.0	12.6	15.9	17.0	9.7	9.0	12.7	12.1	10.9	10.9	8.6	7.4	15.4	8.4	10.3	14.2	9.5	17.2	12.2	9.9	10.1	6.5	12.4	41.6	20.6	46.9	27.4	21.4	21.8	25.7	21.6	25.5	17.7	27.3	22.8	22.8	26.0	25.4	19.6	15.0	25.2	28.8	10.4	11.3	10.1	16.7	9.3	8.9	13.7	9.8	10.9	12.4	14.9	26.0	52.5	56.3	14.9	21.3	12.1	5.1	4.0	25.0	17.4	7.9	26.9	29.9	28.2	6.3	25.4	18.8	0.0	41.1	22.6	22.4	33.0	39.3	16.3	32.0	14.3	12.6	20.3	21.3	7.8	21.9	28.3	20.3	43.3	15.6	37.8	31.0	23.0	28.0	18.7	15.9	25.8	31.1	21.2	20.9	22.0	35.4	55.8	15.2	48.8
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 96.2;Early spermatids: 57.1;Late spermatids: 29.1;Rod photoreceptor cells: 56.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 11.8;LHCN-M2: 6.6;SCLC-21H: 10.3;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: AB_2684993"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.8	4.0	0.0	0.0	0.0	0.0	11.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.6	0.3	0.0	0.1	1.8	0.0	0.0	0.0	2.3	0.0	0.5	0.0	10.3	45.3	0.0	0.0	0.1	2.8	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.9	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3	3.0	2.9	0.0	0.5	2.2	11.4	1.2	0.0	0.0	9.1	0.0	96.2	1.8	0.0	0.0	57.1	1.4	0.0	0.0	0.3	7.2	1.1	0.2	1.1	0.0	0.2	1.6	0.0	0.0	0.0	29.1	0.9	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.7	0.0	56.3	0.0	1.4	19.1	8.0	1.4	0.9	0.0	0.0	0.3
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719310-19773598	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;pituitary gland: 12.6"	"Cell type enriched"	"Detected in some"	10	"Bipolar cells: 51.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 8.8;ASC TERT1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.7	3.7	8.0	0.6	8.6	0.4	0.4	0.3	15.0	1.2	0.6	0.3	0.0	0.4	3.8	1.5	0.5	1.2	0.4	0.4	3.6	10.1	0.6	0.4	0.4	0.4	2.9	7.4	0.4	3.0	0.7	12.6	0.4	5.0	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	1.0	1.4	0.4	2.6	0.5	2.8	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	8.8	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	8.6	0.3	7.3	3.6	10.1	2.9	7.4	5.0	2.8	0.0	0.0	0.0	0.0	0.0	51.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM25	FLJ14399	ENSG00000149582	"Transmembrane protein 25"	Q86YD3	11	118531041-118547280	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 20.3;SK-BR-3: 19.0;T-47d: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012163, HPA051562"	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		4900000	"Golgi apparatus, Vesicles"		"HPA012163: AB_1858112, HPA051562: AB_2681535"	"unprognostic (1.53e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.15e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.01e-2)"	4.8	15.0	15.0	3.7	23.3	1.7	12.0	28.0	36.5	9.4	19.4	9.5	6.7	35.5	10.1	21.2	9.0	9.2	7.1	6.4	11.9	17.0	14.7	10.6	8.0	3.5	10.7	19.5	19.4	14.1	17.3	15.9	4.9	14.0	12.5	3.2	14.4	16.1	15.5	12.7	6.2	26.2	8.7	9.7	4.0	6.7	3.9	5.1	1.5	12.7	4.3	4.6	8.3	6.1	3.8	3.4	0.5	0.2	6.6	11.1	3.8	1.8	0.4	3.3	5.3	3.4	0.5	3.2	2.9	5.5	2.7	5.6	14.7	10.4	0.1	11.4	2.8	6.2	8.2	0.0	10.0	2.4	6.3	6.1	0.2	2.9	3.4	9.0	0.1	0.2	4.2	6.1	3.0	0.5	20.3	3.9	7.5	1.3	6.5	2.7	2.2	3.1	0.2	2.7	0.0	7.1	4.3	2.3	6.5	14.1	0.2	9.8	6.5	2.8	19.0	0.0	5.1	24.7	0.3	1.3	1.2	6.1	0.2	0.8	6.6	4.3	1.6	0.2	0.1	0.1	0.5	0.2	0.2	5.6	0.2	7.5	3.8	7.9	3.1	0.5	3.0	11.1	5.8	0.4	6.6	0.2	3.4	6.1	3.8	15.0	23.3	28.0	36.5	11.9	17.0	10.7	19.5	14.0	5.1	6.0	3.8	3.4	10.2	5.0	24.2	5.0	2.5	10.7	7.9	15.7	27.5	30.1	10.0	14.8	1.7	4.9	1.4	0.0	5.8	13.6	6.0	5.5	9.2	7.7	2.5	11.1	10.9	2.5	0.0	3.8	21.6	0.2	6.8	5.4	3.2	24.3	5.9	1.4	21.9	20.2	34.1	0.0	6.1	4.1	5.1	3.1	13.6	4.1	2.9	2.7
TMEM44	DKFZp686O18124	ENSG00000145014	"Transmembrane protein 44"	Q2T9K0	3	194587673-194633689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 50.3;Mucus-secreting cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 3.2;NK-cell: 11.5"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.2;NK-cells: 11.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043718	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA043718: AB_10794662"	"unprognostic (8.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.31e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.78e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (6.55e-13)"	"unprognostic (1.23e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (5.66e-2)"	13.2	2.8	4.8	6.2	11.8	10.6	21.2	1.9	7.3	6.6	11.8	2.4	9.2	4.6	6.8	22.9	5.1	4.9	7.9	5.9	6.1	6.3	5.6	3.6	15.1	6.3	5.2	7.8	5.1	3.3	1.3	2.3	12.0	6.7	4.8	11.9	3.3	7.0	5.8	6.7	3.4	6.0	5.6	3.7	9.0	6.7	4.1	3.3	4.1	5.3	5.5	3.7	5.0	6.7	0.3	0.6	3.2	0.4	11.5	0.8	0.0	6.3	5.1	7.8	8.3	2.9	9.8	6.9	4.9	9.2	4.1	6.5	2.8	12.6	1.1	23.3	5.7	11.8	7.4	2.6	3.7	2.7	10.4	3.7	7.1	5.3	2.1	5.3	2.2	11.3	6.3	4.1	9.2	4.1	19.4	16.6	7.0	2.0	0.3	13.2	5.9	3.3	5.6	4.1	6.2	8.4	6.3	4.9	0.2	4.2	3.6	2.2	4.7	3.5	1.1	7.2	3.4	5.3	4.7	19.6	12.3	4.6	3.8	6.3	0.9	0.7	2.2	18.4	8.6	6.1	3.2	0.3	0.3	0.5	0.2	0.1	0.2	0.2	0.8	0.0	0.3	0.1	0.3	0.8	11.5	0.4	0.6	0.0	0.0	4.8	11.8	1.9	7.3	6.1	6.3	5.2	7.8	6.7	3.3	0.0	2.9	3.7	3.0	0.5	0.8	1.1	0.0	2.7	3.4	5.2	2.0	6.6	0.0	5.1	0.6	15.2	13.4	0.0	4.3	2.8	4.8	5.1	17.3	0.8	3.0	0.0	5.8	50.3	2.2	0.0	2.8	0.8	1.7	0.0	20.6	0.6	9.6	17.5	1.8	0.1	0.3	6.5	1.2	0.5	5.9	0.5	7.3	1.5	16.2	5.1
TMEM52		ENSG00000178821	"Transmembrane protein 52"	Q8NDY8	1	1917590-1919273	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"pancreas: 67.1;skeletal muscle: 77.9;tongue: 38.9"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 19.1;Hepatocytes: 22.7;Spermatocytes: 23.3;Spermatogonia: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 14.2;OE19: 12.8;RPMI-8226: 25.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (4.39e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.04e-5)"	"unprognostic (1.46e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.68e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	1.7	12.5	0.5	0.2	0.5	0.1	1.3	1.5	0.4	0.3	0.9	0.4	0.1	1.0	0.3	1.5	2.0	0.8	0.4	0.4	0.4	0.5	0.6	3.3	1.0	0.1	0.2	0.5	0.5	67.1	0.9	0.3	0.2	0.4	0.5	0.4	0.5	13.8	0.1	77.9	0.8	1.7	0.2	0.3	0.7	1.2	7.9	0.2	0.2	0.9	38.9	2.5	0.3	0.4	0.2	2.3	0.0	0.4	0.0	0.6	0.0	2.3	0.2	0.6	1.3	0.2	0.1	5.5	0.3	0.1	1.6	1.0	3.9	1.6	0.6	1.6	2.5	0.6	0.8	3.9	1.1	0.3	0.2	2.9	0.0	0.6	14.2	0.8	0.0	0.9	0.0	2.3	0.5	0.2	0.1	0.1	2.8	3.5	1.4	0.0	4.5	0.3	1.1	2.1	12.8	7.7	1.0	0.0	25.8	0.8	0.1	2.7	1.8	0.0	2.2	0.3	1.0	1.5	0.3	0.0	0.0	1.1	0.7	0.0	1.8	0.6	0.7	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.5	1.5	0.4	0.4	0.5	0.2	0.5	0.4	0.2	0.0	0.0	1.5	2.5	3.9	0.2	0.6	5.1	4.0	3.4	0.0	0.0	0.9	1.7	1.8	3.4	0.2	9.1	0.0	19.1	5.3	1.7	4.9	0.0	22.7	0.6	0.0	0.0	1.3	0.3	4.5	13.8	0.7	8.5	1.0	7.3	1.2	10.4	2.9	9.2	8.2	1.0	0.0	0.7	23.3	33.4	2.5	3.1	0.0	7.0	2.7
TMEM87A	DKFZP564G2022	ENSG00000103978	"Transmembrane protein 87A"	Q8NBN3	15	42210452-42273663	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018104, HPA018189"	Enhanced		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA018104: AB_1858135, HPA018189: AB_2205198"	"unprognostic (7.07e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.63e-1)"	22.0	18.2	15.6	15.6	24.9	38.9	49.1	15.9	19.6	23.2	28.0	35.8	30.6	13.2	26.0	25.8	34.5	23.3	16.4	14.8	17.4	15.2	16.9	16.2	36.3	16.8	38.9	17.9	20.5	25.0	29.3	20.8	35.3	24.9	41.5	31.2	20.8	45.1	27.4	18.9	30.8	19.5	23.7	37.2	14.7	21.1	20.9	32.5	16.0	38.7	24.3	21.2	24.8	25.2	19.2	15.8	29.3	21.0	25.3	26.6	15.8	13.5	6.8	10.5	9.2	20.7	17.6	16.5	18.8	27.8	18.4	18.4	9.9	29.9	5.8	18.7	19.9	20.7	35.4	9.3	17.2	14.8	15.2	8.5	11.8	18.0	11.1	22.3	21.5	16.9	18.4	38.9	13.4	22.7	17.7	14.1	10.3	12.7	23.3	17.5	8.6	7.1	12.7	8.8	20.4	9.9	11.2	16.4	12.1	11.9	43.4	11.6	14.5	18.0	24.1	16.5	8.8	9.3	20.7	14.0	36.6	9.0	23.9	27.7	16.2	30.5	12.5	14.2	16.0	22.7	29.3	17.6	19.8	20.1	20.7	22.9	19.2	24.8	23.3	15.8	15.4	23.8	23.5	10.3	25.3	21.0	14.3	26.6	15.8	15.6	24.9	15.9	19.6	17.4	15.2	38.9	17.9	24.9	32.5	116.1	211.9	35.6	79.3	60.9	30.3	12.0	48.4	97.7	96.7	47.1	47.1	65.0	1.7	51.1	4.3	44.9	54.6	46.7	55.6	59.7	51.6	111.8	57.8	26.1	37.2	19.1	30.9	49.7	38.0	5.5	38.0	40.0	59.1	64.9	67.4	76.8	46.4	45.6	50.5	14.7	60.4	84.1	44.3	47.1	62.2	57.2	92.3	39.2	65.5	90.7
TMEM95	"MGC129793, UNQ9390"	ENSG00000182896	"Transmembrane protein 95"	Q3KNT9	17	7355123-7357219	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	21	"testis: 19.3"	"Group enriched"	"Detected in some"	23	"Early spermatids: 20.4;Late spermatids: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;BJ: 1.0;hTERT-RPE1: 1.4"														"Intracellular and membrane"	NA	NA							"unprognostic (1.54e-1)"				"unprognostic (1.03e-1)"		"unprognostic (1.15e-1)"		"unprognostic (5.15e-2)"				"unprognostic (7.42e-2)"			"unprognostic (7.44e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712600-57740973	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	29.5	40.5	33.6	21.0	39.0	13.7	30.8	26.5	60.5	28.0	40.6	50.7	29.0	33.3	22.5	36.7	32.7	25.5	20.0	33.0	32.6	32.1	47.4	71.7	24.4	22.1	40.4	30.4	25.9	40.6	49.8	25.8	26.2	45.3	31.1	49.3	38.4	27.9	34.4	21.9	21.9	34.0	26.1	42.3	25.4	29.9	19.1	31.3	24.0	34.4	25.8	27.0	22.2	22.6	17.7	23.1	17.9	37.5	16.5	21.8	18.8	28.5	33.5	19.3	34.7	36.0	19.3	21.1	34.5	26.8	34.0	28.9	31.8	49.2	26.8	38.6	27.7	50.6	52.8	48.8	27.6	36.1	19.2	21.2	25.9	27.1	31.8	29.7	36.1	35.7	23.6	40.4	37.6	60.0	18.7	19.3	22.6	44.4	31.7	37.9	14.6	21.3	41.2	37.3	53.3	46.0	29.0	24.2	56.7	42.3	32.3	22.1	31.6	26.6	61.9	38.3	19.6	55.3	23.9	16.1	32.1	21.0	42.7	35.6	31.2	60.8	27.1	36.1	25.7	47.5	15.9	19.6	17.9	17.1	33.1	21.6	17.7	17.3	20.0	19.0	15.3	21.8	21.8	5.2	16.5	37.5	23.1	14.3	18.8	33.6	39.0	26.5	60.5	32.6	32.1	40.4	30.4	45.3	31.3	35.7	30.6	38.1	36.3	28.5	43.9	38.7	40.8	34.8	34.2	47.1	29.5	94.9	36.5	67.4	1.6	34.9	38.2	0.0	37.5	68.8	35.4	39.2	42.7	45.2	57.0	28.6	27.6	33.7	27.3	1.9	45.1	35.0	45.5	31.5	45.0	90.9	45.2	35.1	41.1	38.0	52.4	38.8	26.2	56.1	68.8	28.5	83.3	22.4	61.2	41.0
TNFSF12-TNFSF13	TWE-PRIL	ENSG00000248871	"TNFSF12-TNFSF13 readthrough"		17	7549099-7561601	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	40	"Alveolar cells type 2: 3.0;Ciliated cells: 2.7;Club cells: 6.8;granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.9;eosinophil: 10.5;intermediate monocyte: 6.5;myeloid DC: 2.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;granulocytes: 10.5;monocytes: 6.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.5;fHDF/TERT166: 3.2;HUVEC TERT2: 2.9;U-138 MG: 4.6;U-251 MG: 4.7"	"Low region specificity"	"Detected in many"							"HPA004863, HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA004863: AB_1078187, HPA035984: , HPA052967: AB_2682000"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.23e-2)"	10.0	8.6	3.2	6.1	3.1	5.6	5.6	3.2	6.1	5.9	3.5	1.9	4.8	2.7	3.8	5.0	7.0	3.1	8.9	4.3	3.1	3.1	3.1	3.1	6.6	7.1	3.1	3.4	5.9	3.3	2.0	3.1	2.4	1.3	8.2	1.7	5.4	4.4	4.4	3.1	3.1	3.6	6.9	3.1	5.6	5.7	3.1	1.6	0.0	3.1	1.9	4.8	7.5	11.5	1.2	2.7	10.5	6.5	0.4	1.1	1.6	0.0	0.4	0.0	0.0	0.0	0.6	0.4	1.3	4.5	1.6	2.5	0.0	0.2	0.0	0.8	3.2	0.0	0.0	1.4	0.0	0.9	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	0.5	1.0	0.9	0.0	0.0	2.9	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.4	0.9	0.0	0.0	0.0	1.7	0.0	0.0	2.2	0.4	0.0	1.1	0.0	0.0	0.0	1.3	4.6	0.3	0.0	4.7	0.0	0.0	0.0	1.0	0.0	0.6	0.8	3.9	10.5	0.4	6.5	0.5	0.8	0.7	0.4	2.7	1.2	0.4	0.3	0.5	0.4	0.5	1.4	1.1	1.6	3.2	3.1	3.2	6.1	3.1	3.1	3.1	3.4	1.3	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TOR3A	"ADIR, ADIR2, FLJ22345"	ENSG00000186283	"Torsin family 3 member A"	Q9H497	1	179081377-179098023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 59.3;U-266/84: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028766	Approved				"Intracellular and membrane"	NA	Yes					"HPA028766: AB_10602251"	"unprognostic (5.55e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.82e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (4.78e-8)"	"unprognostic (4.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.35e-1)"	12.3	13.5	8.0	22.9	11.4	20.6	14.9	4.5	15.5	11.0	15.9	12.5	9.5	13.8	14.3	13.2	12.9	13.3	21.3	9.9	7.4	8.4	12.4	17.3	13.5	28.1	8.2	11.8	13.4	26.8	14.2	14.9	10.7	8.7	13.3	15.5	11.0	22.2	14.6	20.4	12.0	18.0	13.3	8.3	31.3	16.0	6.5	6.2	18.1	17.7	13.6	25.0	14.8	11.1	31.3	29.3	6.4	23.0	9.7	13.6	16.5	11.0	13.6	3.9	10.8	7.9	6.2	12.1	8.3	9.9	9.7	7.0	5.8	17.5	17.8	14.9	8.0	5.9	14.4	10.7	6.9	5.1	13.7	10.0	19.4	8.1	8.8	12.8	21.1	16.9	6.9	6.3	7.6	6.5	4.0	7.0	7.0	23.4	34.1	6.6	23.6	13.0	11.8	7.9	13.2	7.6	10.0	6.8	17.3	6.1	15.5	7.8	10.4	12.3	19.5	5.1	6.9	14.6	15.5	4.4	7.7	5.4	12.6	10.8	59.3	64.0	15.1	5.4	15.0	5.5	1.7	23.0	6.4	10.9	17.9	13.6	31.3	10.1	12.2	26.4	21.8	7.9	9.3	4.7	9.7	17.2	29.3	13.5	16.5	8.0	11.4	4.5	15.5	7.4	8.4	8.2	11.8	8.7	6.2	3.0	9.4	42.4	12.5	15.0	3.2	9.3	15.3	10.7	3.4	10.4	9.8	27.3	3.3	27.9	0.8	16.4	11.8	0.0	39.1	50.7	19.2	15.1	10.4	8.6	51.9	0.0	13.8	11.1	22.5	0.0	15.8	26.1	15.1	72.1	16.3	15.7	18.6	14.0	17.7	7.7	9.0	6.5	14.4	0.9	5.1	13.8	9.2	23.6	24.3	10.7
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910814	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 23.3;Mucus-secreting cells: 19.0;Pancreatic endocrine cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.6;plasmacytoid DC: 17.5"	"Group enriched"	"Detected in many"	21	"B-cells: 9.6;dendritic cells: 17.5"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 162.2;U-266/84: 344.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		14000000	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	20.2	15.7	3.7	42.1	6.3	6.0	61.9	4.6	6.8	28.8	69.8	7.5	18.3	35.0	28.3	20.9	25.3	21.5	30.2	28.6	4.4	5.2	23.2	96.2	24.5	117.9	5.9	4.3	26.1	63.3	7.9	10.6	22.4	7.2	17.6	29.0	10.9	71.5	29.1	10.1	9.9	33.6	16.3	7.5	84.2	36.8	12.3	5.2	6.4	18.0	19.8	48.2	35.8	21.7	9.6	17.5	0.0	0.5	0.0	0.6	0.3	9.5	9.4	6.5	22.0	56.8	24.3	10.7	21.5	21.0	15.0	16.3	14.0	7.1	10.1	38.0	33.0	16.6	7.6	11.6	10.6	17.1	8.6	9.9	15.5	8.2	25.2	16.6	17.5	15.5	16.6	15.6	14.3	15.8	33.2	80.3	6.4	9.6	73.9	10.2	8.5	4.1	10.6	8.6	15.1	20.5	7.3	9.5	162.2	12.1	8.7	10.2	5.5	27.7	16.9	12.1	32.5	8.6	7.7	22.0	17.2	12.0	14.7	22.7	86.2	344.1	17.9	8.8	11.1	23.5	0.0	0.2	0.0	0.6	0.5	0.5	9.6	0.1	0.4	0.7	3.3	0.1	0.3	0.0	0.0	0.0	17.5	0.5	0.3	3.7	6.3	4.6	6.8	4.4	5.2	5.9	4.3	7.2	5.2	0.0	4.5	0.0	0.0	0.8	0.0	0.2	0.0	2.7	3.4	0.0	0.0	0.8	0.0	8.2	0.1	0.7	1.0	23.3	9.2	1.2	1.7	0.4	1.1	2.4	1.3	0.0	4.7	5.5	1.5	0.0	0.0	0.3	3.3	1.0	19.0	0.0	10.3	0.0	0.4	0.2	0.2	6.5	0.4	0.0	0.1	0.1	1.0	0.0	7.0	0.1
UBXN8	"D8S2298E, REP8, UBXD6"	ENSG00000104691	"UBX domain protein 8"	O00124	8	30732247-30767006	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 30.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 162.1;Hepatocytes: 56.2;Late spermatids: 132.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017725, HPA077538"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Nucleoli"	"HPA017725: AB_1847462, HPA077538: AB_2686844"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.13e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.25e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-2)"	5.0	5.3	3.9	1.4	4.8	1.4	4.3	1.5	9.2	3.0	3.5	4.0	6.7	3.1	3.8	14.3	4.1	3.6	3.8	2.8	5.7		8.2	21.5	2.1	3.9	7.6	4.0	30.6	10.3	6.2	3.5	6.2	6.2	4.8	4.7	1.6	1.8	6.1	1.7	4.1	2.9	2.9	7.1	5.7	3.3	11.5	6.1	0.9	9.1	2.8	2.3	2.9	3.7	6.0	8.2	1.0	6.1	3.3	8.4	3.4	7.6	7.7	5.6	5.8	9.1	12.2	6.3	13.7	8.0	7.5	9.2	12.2	2.8	12.2	11.3	11.1	12.4	6.8	1.1	7.6	11.6	6.4	12.5	34.3	6.3	14.9	13.7	7.8	19.4	9.6	7.9	12.0	5.9	6.4	6.5	5.6	33.5	9.2	16.5	7.2	7.9	6.0	10.8	22.8	5.8	9.5	5.4	8.5	12.8	10.0	3.2	8.1	3.8	11.3	24.7	7.0	8.4	13.6	8.3	8.5	3.7	3.8	12.7	4.0	12.5	9.2	7.6	12.6	12.1	0.0	6.0	0.7	8.4	6.1	7.3	6.0	4.5	8.0	6.7	2.9	4.4	7.4	1.0	3.3	3.0	8.2	4.3	3.4											3.0	8.0	3.0	4.1	0.0	1.9	3.2	15.3	1.4	5.7	14.0	19.6	20.6	6.6	7.1	162.1	6.2	6.3	0.0	4.5	16.0	9.4	4.1	13.9	56.2	19.0	11.1	8.2	27.0	14.2	132.0	13.3	6.9	0.0	10.0	6.4	6.6	3.9	3.5	9.2	22.0	1.8	6.5	3.9	14.1	20.4	0.0	12.7	7.2	10.0	2.4
VPREB1	"CD179A, VpreB"	ENSG00000169575	"V-set pre-B cell surrogate light chain 1"	P12018	22	22244675-22245515	"CD markers, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.1;bone marrow: 23.8;lymphoid tissue: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 5.8;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 8.1"	"Group enriched"	"Detected in some"	11	"Daudi: 8.6;MOLT-4: 18.3;RPMI-8226: 4.9"					"Not detected"	"Not detected"			HPA055886	Uncertain				"Intracellular and membrane"	NA	NA					"HPA055886: AB_2682956"																		0.0	0.0	0.0	2.2	0.0	23.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	1.3	0.0	4.8	0.0	0.0	1.2	0.0	0.0	8.1	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
VPREB3	8HS20	ENSG00000128218	"V-set pre-B cell surrogate light chain 3"	Q9UKI3	22	23752743-23754468	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 90.4;epididymis: 27.9;intestine: 32.7;lymphoid tissue: 77.9"	"Cell type enriched"	"Detected in some"	41	"B-cells: 216.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	730	"memory B-cell: 79.9;naive B-cell: 90.4"	"Lineage enriched"	"Detected in single"	775	"B-cells: 90.4"	"Group enriched"	"Detected in some"	45	"Daudi: 58.3;REH: 68.9;U-698: 18.2"	"Not detected"	"Not detected"							HPA003041	Supported				"Intracellular and membrane"	NA	NA					"HPA003041: AB_1080577"	"unprognostic (2.06e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.84e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.12e-1)"	0.5	9.2	0.7	62.6	0.9	7.5	0.3	0.7	0.8	0.3	1.3	0.3	0.2	0.2	0.3	27.9	2.3	0.1	0.7	0.4	0.6	0.7	1.1	0.9	1.2	77.9	0.8	0.2	0.3	0.3	0.1	1.4	0.3	0.2	0.6	0.9	0.4	4.8	0.2	0.8	0.4	32.7	0.2	0.5	31.6	1.4	1.4	0.2	1.6	0.8	1.0	36.0	3.1	0.2	90.4	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	58.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.3	68.9	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.1	0.8	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.3	0.0	18.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.9	0.0	0.0	0.0	90.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.7	0.9	0.7	0.8	0.6	0.7	0.8	0.2	0.2	0.2	0.0	0.3	216.6	0.6	0.3	4.6	0.4	2.5	0.0	1.2	0.0	2.0	0.0	1.7	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.2	0.0	5.2	0.0	0.3	0.0	0.0	0.0	5.0	0.0	0.6	0.7	0.1	0.0	0.0	1.4	1.7	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.6	0.4
WDR81	"CAMRQ2, FLJ33817, PPP1R166, SORF-2"	ENSG00000167716	"WD repeat domain 81"	Q562E7	17	1716523-1738599	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023044, HPA063703"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA023044: AB_1858822, HPA063703: "	"unprognostic (1.00e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.90e-3)"	"unprognostic (6.10e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.60e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (3.26e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.90e-2)"	12.7	12.2	8.9	12.1	8.4	10.7	22.9	7.0	11.7	12.6	9.1	10.5	26.4	11.3	14.9	11.6	7.4	12.8	9.3	9.0	8.4	4.3	9.6	22.7	17.2	21.4	9.2	4.4	18.5	8.3	3.5	9.9	8.9	8.5	11.9	4.6	10.6	10.1	21.8	13.1	16.7	12.7	11.6	5.0	19.0	8.4	6.3	8.2	17.3	8.1	5.2	10.3	11.6	16.2	2.8	6.9	5.1	5.0	4.2	3.0	1.9	0.5	10.8	1.5	7.3	10.5	5.8	8.0	0.6	0.1	0.4	0.0	1.4	4.0	4.2	5.8	4.3	5.6	10.2	5.3	7.2	0.3	7.9	11.3	0.1	7.4	4.9	18.0	3.4	6.6	14.5	7.4	5.2	3.2	2.1	4.0	3.4	0.3	5.4	6.0	5.2	1.1	5.8	3.4	3.2	7.6	5.5	2.5	5.6	3.0	1.5	2.1	4.6	3.9	3.3	12.6	0.1	4.9	5.0	6.0	4.2	5.0	6.7	5.5	0.4	0.9	2.4	6.5	5.5	2.9	0.0	3.1	5.1	2.6	5.0	3.0	2.8	2.7	2.6	3.8	2.3	1.8	2.4	0.6	4.2	4.3	6.9	2.4	1.9	8.9	8.4	7.0	11.7	8.4	4.3	9.2	4.4	8.5	8.2	11.9	9.3	4.7	2.5	2.3	4.7	2.6	5.1	4.0	3.4	0.0	3.9	2.1	1.7	2.5	0.5	2.9	5.9	0.0	3.8	1.7	3.1	2.4	4.6	20.9	20.3	4.8	1.2	5.5	17.2	0.4	15.3	9.1	0.0	5.4	4.0	2.8	4.7	3.4	14.2	11.1	1.7	19.4	2.0	0.5	1.5	1.5	1.9	2.9	3.5	1.3
WSCD1	KIAA0523	ENSG00000179314	"WSC domain containing 1"	Q658N2	17	6057807-6124427	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;lymphoid tissue: 16.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 70.9;Enterocytes: 18.3;Late spermatids: 67.5"	"Group enriched"	"Detected in many"	7	"glioma: 18.8;renal cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.9;HUVEC TERT2: 13.4;OE19: 13.9;PC-3: 13.5;RH-30: 27.7;SCLC-21H: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015919	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA015919: AB_2216211"	"unprognostic (1.50e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	3.9	2.6	11.2	1.6	7.3	0.4	1.3	17.1	24.7	1.5	8.7	11.2	0.0	4.7	1.5	1.4	1.2	1.7	1.6	3.8	10.5	9.7	6.2	1.1	1.8	1.9	11.9	5.3	0.8	2.4	2.3	2.7	6.5	8.5	1.2	5.4	1.1	1.8	1.3	13.3	2.0	5.7	2.1	12.2	16.7	1.4	12.9	10.5	0.6	1.3	0.0	1.6	1.0	2.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	3.1	21.9	1.7	0.1	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	5.4	0.1	0.0	0.0	7.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	13.4	0.0	0.0	0.5	0.6	0.4	0.0	0.0	7.3	13.9	13.5	0.0	27.7	0.8	4.6	1.1	8.5	0.0	0.1	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.2	7.3	17.1	7.3	10.5	9.7	11.9	5.3	8.5	10.5	0.0	0.0	0.0	0.0	0.3	5.6	2.8	0.0	0.0	0.0	1.8	0.0	0.7	1.7	0.3	70.9	3.0	18.3	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	1.6	0.0	8.0	0.3	67.5	0.6	0.0	1.7	0.0	2.8	9.1	0.3	5.7	0.0	1.2	2.8	0.0	1.4	0.5	2.8	0.5	0.0	0.0	5.6	0.1
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129471-108250537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 35.7;Horizontal cells: 20.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Region enhanced"	"Detected in all"		"cerebellum: 44.0"	"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.5"	"Cell line enriched"	"Detected in some"	21	"RT4: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	1.4	1.2	6.5	0.5	12.5	0.4	1.0	44.0	15.2	5.4	1.7	1.6	0.0	0.7	6.9	3.0	3.8	2.0	0.5	0.5	10.0	3.0	1.3	0.4	0.8	0.5	1.3	6.0	0.6	2.1	0.4	0.9	0.6	1.9	6.0	0.7	9.9	0.5	18.2	0.5	0.6	0.9	9.2	1.5	0.5	2.0	0.6	2.0	0.0	21.8	0.2	0.5	3.0	0.9	0.8	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	6.5	12.5	44.0	15.2	10.0	3.0	1.3	6.0	1.9	2.0	0.0	0.0	0.5	0.0	0.1	35.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.6	0.0	1.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;gallbladder: 6.7;kidney: 2.6"	"Cell type enhanced"	"Detected in some"	18	"Cholangiocytes: 7.6;Ductal cells: 2.6;Late spermatids: 3.6;Muller glia cells: 11.4;Pancreatic endocrine cells: 3.1"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 3.0"	"Cell line enriched"	"Detected in some"	8	"RPTEC TERT1: 12.4"	"Region enriched"	"Detected in single"	7	"olfactory region: 3.4"	"Low region specificity"	"Detected in all"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA077519: AB_2732349"	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5			2.5	1.0	0.0	0.0	0.2	6.7	0.3	0.0	0.6	2.6	0.3	0.0	0.0	0.3		0.7	0.2	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.1	1.9			0.0		0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	1.3	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	12.4	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	11.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0